Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3028192	s-igg2	g/l (g/l)	3431	4677	0.00%
3028192	s-igg2	— (—)	1517	2044	100.00%	Distribution not available
3028192	s-immunoglobuliinig,alaluokka2	g/l (g/l)	117	154	0.00%
3028192	s-igg2	g/l_______ (g/l)	61	67	0.00%
3028192	s-igg2	g/L (g/l)	22	27	0.00%
3028192	s-igg2	G/L (g/l)	22	43	0.00%
3028192	immunoglobuliinig2	g/l_______ (g/l)	17	17	0.00%	Distribution not available
3028192	s-immunoglobuliinig,alaluokka2	g/l_______ (g/l)	14	15	0.00%
3028192	immunoglobuliinig2	g/l (g/l)	11	13	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other systemic involvement of connective tissue (FG)

566

936

6.15

318.42

1.8

1.3

2.84

2.90

g/l

0.27

425

661

Asthma, unspecified (mode), excluding more controls

907

928

7.16

307.65

1.5

1.3

2.87

3.19

g/l

3.99

645

608

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1622

3143

3.54

307.65

1.6

1.3

2.68

3.06

g/l

11.14

1184

2275

Asthma-related infections

1338

2546

5.28

307.65

1.5

1.3

2.80

2.97

g/l

2.44

1028

1812

Asthma/COPD (KELA code 203)

1476

2915

3.44

307.65

1.5

1.3

2.80

3.00

g/l

3.93

1134

2032

Bronchiectasis

328

198

18.27

307.65

1.5

1.3

2.88

2.86

g/l

0.04

257

147

Asthma, hospital admissions 3, pneumonia

838

1402

6.17

307.65

1.5

1.3

2.68

2.93

g/l

3.40

643

994

All pneumoniae

1628

3185

3.38

307.65

1.4

2.67

3.09

g/l

15.32

1218

2256

Oral corticosteroids

2249

2183

6.20

307.65

1.6

1.2

2.83

3.11

g/l

7.01

1662

1518

Acute pancreatitis

585

699

8.85

307.65

1.6

1.3

2.85

2.99

g/l

0.79

295

517

Asthma, hospital admissions , main diagnosis only

1511

3385

3.97

307.65

1.5

1.3

2.82

2.99

g/l

3.01

1144

2391

Certain disorders involving the immune mechanism

677

817

8.89

307.65

1.9

1.3

2.47

2.96

g/l

6.66

512

582

Asthma, hospital admission 2, infections

1338

2546

5.28

307.65

1.5

1.3

2.80

2.97

g/l

2.44

1028

1812

Acute pancreatitis (for exclusion)

585

805

7.67

307.65

1.6

1.3

2.85

2.97

g/l

0.67

295

603

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1464

1995

4.37

307.65

1.4

2.67

3.13

g/l

14.52

1101

1373

Undetermined asthma, excluding more controls

374

250

15.76

307.65

1.7

1.2

2.89

3.17

g/l

1.35

283

167

Influenza and pneumonia

1674

3099

3.39

307.65

1.4

2.69

3.10

g/l

14.69

1256

2192

Abnormal findings on diagnostic imaging of lung

925

1793

5.03

307.65

1.4

2.88

2.94

g/l

0.36

694

1278

Asthma-related pneumonia or sepsis

838

1402

6.17

307.65

1.5

1.3

2.68

2.93

g/l

3.40

643

994

Chronic lower respiratory diseases

1826

2924

3.34

307.65

1.5

1.3

2.89

3.00

g/l

1.45

1383

2038

Second line medication for Crohn's disease

1068

2859

3.82

307.65

1.7

1.3

2.84

2.94

g/l

0.93

772

2078

Immunodeficiency with predominantly antibody defects

318

50.11

307.65

2.2

1.3

1.89

2.77

g/l

4.99

265

Asthma (only as main-diagnosis), excluding more controls

1406

985

8.11

307.65

1.5

1.3

2.83

3.19

g/l

6.43

1067

637

Systemic connective tissue disorders

806

1517

5.51

307.65

1.7

1.3

2.77

2.93

g/l

1.60

599

1089

L04AX Other immunosuppressants

1040

2780

3.83

307.65

1.6

1.3

2.84

2.93

g/l

0.69

755

2022

First line medication for Crohn's disease

2011

2029

5.45

307.65

1.5

1.2

2.84

3.12

g/l

6.57

1476

1421

Asthma, excluding more controls

1359

985

7.25

307.65

1.5

1.3

2.88

3.19

g/l

4.78

1024

637

1464

1995

4.37

307.65

1.4

2.67

3.13

g/l

14.52

1101

1373

Asthma-related pneumonia

837

1399

6.18

307.65

1.5

1.3

2.68

2.94

g/l

3.42

642

992

Asthma, unspecified (mode)

917

983

6.89

307.65

1.5

1.3

2.87

3.17

g/l

3.57

650

642

Undetermined asthma

374

252

15.63

307.65

1.7

1.2

2.89

3.23

g/l

1.69

283

170

Asthma

1397

1043

7.07

307.65

1.5

1.3

2.87

3.18

g/l

4.85

1055

674

Immunodeficiencies

405

174

29.20

307.65

2.0

1.3

2.02

2.89

g/l

7.56

327

130

ILD medications

2167

2034

5.88

307.65

1.5

1.2

2.83

3.13

g/l

7.75

1599

1413

Asthma (only as main-diagnosis)

1430

1043

7.87

307.65

1.5

1.3

2.83

3.18

g/l

6.20

1081

674

Asthma (diagnoses ohter than nonallergic)

1607

3325

3.99

307.65

1.5

1.3

2.83

2.98

g/l

2.58

1211

2368

Pneumonia, organism unspecified

1501

2930

3.58

307.65

1.4

2.66

3.10

g/l

14.43

1124

2069

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

341

135

18.75

307.65

1.5

1.2

2.94

3.28

g/l

1.11

242

ILD medications: prednisolone, methylprednisolone, prednisone

2166

1990

6.20

307.65

1.5

1.2

2.82

3.14

g/l

8.34

1601

1381

Inflammatory bowel disease treatment related agents

2261

2284

5.63

307.65

1.5

1.2

2.86

3.09

g/l

5.12

1665

1594

Asthma, including avohilmo

1729

3112

3.10

307.65

1.5

1.3

2.88

2.99

g/l

1.47

1309

2177

ILD medications: immunosuppressive drugs

1300

1891

6.40

307.65

1.6

1.2

2.82

3.11

g/l

4.96

944

1311

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1214

2538

4.26

307.65

1.5

1.4

2.95

2.93

g/l

0.07

882

1832

Fever of other and unknown origin

1085

1999

4.82

307.65

1.4

1.3

2.68

3.07

g/l

8.16

794

1435

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1587

3213

3.35

307.65

1.4

2.69

3.08

g/l

13.02

1192

2275

Pneumonias (Asthma/COPD co-morbidities)

1623

3186

3.38

307.65

1.4

2.69

3.09

g/l

13.51

1215

2260

1109

1952

5.84

307.65

1.5

1.3

2.81

2.95

g/l

1.70

862

1402

Asthma (mode)

1353

1049

6.93

307.65

1.5

1.3

2.89

3.18

g/l

4.18

1024

678

Chronic sinusitis

920

1775

5.34

307.65

1.6

1.4

2.91

3.01

g/l

0.90

732

1229

Autoimmune diseases related-to ILD

1289

3399

3.22

304.59

1.4

2.93

2.95

g/l

0.14

911

2464

Asthma and opportunity respiratory infection

234

123

21.67

304.52

1.5

1.3

2.81

2.82

g/l

0.02

181

Cough

719

1464

4.69

296.79

1.5

1.4

2.90

2.97

g/l

0.47

556

1025

Other pulmonary diagnosis

935

1054

4.50

290.04

1.4

1.3

2.86

3.19

g/l

4.23

686

682

Other systemic involvement of connective tissue

582

1114

5.41

287.73

1.9

1.3

2.82

2.90

g/l

0.41

437

800

Abnormalities of breathing

1265

2176

3.37

285.86

1.4

2.86

3.03

g/l

2.26

941

1508

Non-allergic asthma (mode), excluding more controls

343

378

9.26

279.69

1.6

1.2

2.79

3.18

g/l

2.73

269

254

Acute sinusitis

912

2251

3.76

279.14

1.5

1.4

2.90

3.04

g/l

1.35

706

1577

Allergic asthma (mode), excluding more controls

398

516

7.72

278.51

1.5

1.3

2.87

3.21

g/l

2.86

333

340

Disorders of gallbladder, biliary tract and pancreas

1421

2966

3.03

278.36

1.5

1.4

2.97

2.96

g/l

0.06

902

2268

Excluding asthma or asthma-COPD overlap

914

1054

4.40

276.43

1.4

1.3

2.89

3.19

g/l

3.60

668

682

Other respiratory diseases principally affecting the interstitium

427

630

7.09

276.15

1.4

1.3

2.94

g/l

0.02

301

455

COPD differential diagnosis

909

1050

4.39

274.43

1.4

1.3

2.89

3.18

g/l

3.36

664

678

Allergic asthma (mode)

398

526

7.57

273.94

1.5

1.3

2.87

3.21

g/l

2.93

333

347

ILD differential diagnosis

907

1049

4.39

273.41

1.4

1.3

2.88

3.18

g/l

3.56

663

678

Non-allergic asthma (mode)

343

390

8.98

272.98

1.6

1.2

2.79

3.18

g/l

2.73

269

265

ILD, hospital admission 2, with pulmonary infections

275

237

12.29

271.09

1.4

2.78

3.17

g/l

1.97

196

169

COPD/asthma related infections

1297

1995

3.30

270.11

1.4

2.79

3.13

g/l

7.43

962

1373

COPD/asthma/ILD related infections

1297

1995

3.30

270.11

1.4

2.79

3.13

g/l

7.43

962

1373

Other and unspecified immunodeficiencies with predominantly antibody defects

160

54.85

268.15

2.2

1.3

1.72

2.86

g/l

3.56

135

Other interstitial pulmonary diseases

382

520

7.72

266.07

1.4

1.3

2.97

2.90

g/l

0.28

270

379

Interstitial lung disease endpoints

382

525

7.64

263.83

1.4

1.3

2.97

2.90

g/l

0.28

270

381

Interstitial lung disease

382

525

7.64

263.83

1.4

1.3

2.97

2.90

g/l

0.28

270

381

ILD medications: azathioprine

342

414

8.62

262.70

1.8

1.2

2.87

3.08

g/l

1.00

259

300

ILD, hospital admissions

378

519

7.65

261.33

1.4

1.3

2.97

2.89

g/l

0.30

266

376

Obesity related asthma

628

1449

4.45

247.61

1.4

1.3

2.75

3.00

g/l

2.80

464

1027

Reimbursement for rheumatic diseases

923

2764

3.39

247.06

1.5

1.4

2.80

2.94

g/l

1.47

672

2007

1446

2557

2.90

246.95

1.5

1.4

2.81

3.06

g/l

4.74

1088

1774

Azathioprine

342

449

7.94

245.45

1.8

1.2

2.87

3.02

g/l

0.62

259

326

GASTRO-related operations

957

1275

3.81

243.73

1.4

1.3

2.87

2.98

g/l

0.87

653

1049

Any gastric operation

957

1275

3.81

243.73

1.4

1.3

2.87

2.98

g/l

0.87

653

1049

ILD, hospital admissions 3, with pneumonia sepsis

243

208

12.41

240.75

1.3

1.4

2.75

3.21

g/l

2.26

171

152

Bacterial pneumonia (organism specified)

713

1639

4.02

239.73

1.4

2.54

3.06

g/l

11.06

527

1170

ILD, hospital admissions 1, main diag only

339

465

7.67

234.68

1.4

1.3

3.01

2.94

g/l

0.24

240

335

Bacterial pneumoniae

646

1351

4.29

234.16

1.4

2.60

3.14

g/l

10.67

484

955

Chronic rhinitis, nasopharyngitis and pharyngitis

587

1346

4.47

233.15

1.5

1.4

2.87

2.98

g/l

0.84

482

942

Autoimmune diseases excluding thyroid diseases

1392

2723

2.80

229.45

1.4

2.90

2.97

g/l

0.71

1008

1971

General symptoms and signs

1338

2353

2.88

225.18

1.5

1.3

2.85

3.07

g/l

3.67

975

1670

Autoimmune diseases excluding thyroid diseases, strict definition

1339

2629

2.80

220.96

1.4

2.90

2.98

g/l

0.79

975

1911

Bacterial pneumonia, not elsewhere classified

601

1254

4.30

218.59

1.4

2.61

3.14

g/l

9.31

448

882

Dyspnoea

1239

3302

2.74

213.82

1.4

2.82

2.99

g/l

2.50

914

2386

Other acute lower respiratory infections

843

2536

3.22

206.60

1.5

1.4

2.64

3.00

g/l

7.01

641

1818

Bronchitis

1422

3359

2.57

205.33

1.4

2.77

3.06

g/l

6.89

1074

2368

Nonhereditary hypogammaglobulinemia

124

50.25

205.23

2.3

1.4

1.57

3.13

g/l

3.60

Chronic pancreatitis

295

412

7.51

200.88

2.0

1.2

3.12

3.04

g/l

0.25

165

313

Symptoms and signs involving the circulatory and respiratory systems

1217

2178

2.83

198.91

1.4

2.91

3.03

g/l

1.36

894

1508

Asthma and allergy, excluding more controls

246

283

8.84

193.26

1.5

1.4

2.87

3.15

g/l

1.29

211

190

Acute upper respiratory infections

1308

3069

2.58

191.07

1.5

1.4

2.84

3.01

g/l

2.55

990

2153

Asthma and allergy

246

288

8.69

190.49

1.5

1.4

2.87

3.15

g/l

1.28

211

190

Pain in joint

772

1404

3.43

183.52

1.4

2.94

2.98

g/l

0.17

585

988

Bacterial infection, other or unspecified

760

2005

3.25

183.48

1.4

2.55

3.05

g/l

10.05

553

1447

Kela reimbursement Agammaglobulinemia (D80-84)

106

57.53

180.53

2.2

1.4

1.81

3.33

g/l

2.00

Anaemias

395

440

5.89

179.74

1.4

1.3

2.93

3.13

g/l

0.94

282

328

Other bacterial diseases

1225

3223

2.55

178.98

1.4

2.68

3.03

g/l

7.83

899

2312

Bacterial infection, other or unspecified, including avohilmo

812

2187

3.09

178.95

1.4

2.59

3.04

g/l

8.78

595

1575

Acute bronchitis

644

1882

3.42

175.08

1.5

1.4

2.61

2.98

g/l

6.25

491

1351

Examination and observation for other reasons

769

1300

3.38

174.19

1.5

1.3

3.01

3.00

g/l

0.05

656

801

Other diseases of biliary tract

217

251

9.09

173.29

2.2

1.3

3.20

3.00

g/l

0.56

132

187

Tramadol

996

2139

2.83

173.25

1.4

2.74

3.16

g/l

9.24

728

1527

Selective deficiency of immunoglobulin G [IgG] subclasses

66.31

171.80

2.6

1.3

2.18

3.13

g/l

1.36

Other diseases of pleura

629

1590

3.50

171.77

1.5

1.4

2.60

2.99

g/l

5.32

447

1132

Suggestive for eosinophilic asthma

234

306

8.06

169.05

1.9

1.3

2.97

2.98

g/l

0.04

192

217

Acute upper respiratory infections of multiple and unspecified sites

994

2717

2.70

167.39

1.4

1.3

2.77

3.02

g/l

3.99

757

1913

Diseases of the respiratory system

655

876

3.79

165.92

1.4

1.3

2.82

3.19

g/l

4.36

476

563

Other bacterial diseases, including avohilmo

1270

3316

2.42

163.88

1.4

2.69

3.04

g/l

8.56

940

2375

Used for control exclusion in common control thyroid runs

1224

2466

2.53

162.75

1.4

2.99

g/l

0.00

859

1804

Autoimmune diseases

1305

2736

2.44

162.52

1.4

2.94

2.97

g/l

0.17

941

1980

Enlarged lymph nodes

314

577

5.62

162.51

1.6

1.3

2.85

3.06

g/l

1.10

230

422

Cholangitis (primary sclerosing, PSC)

178

175

10.81

160.77

2.0

1.2

3.44

2.97

g/l

1.68

105

135

Diseases of oesophagus, stomach and duodenum

1301

3281

2.37

157.93

1.4

2.96

g/l

0.03

952

2357

FESS (DNB20)

302

559

5.65

155.71

1.8

1.4

3.06

2.97

g/l

0.30

232

405

Headache

812

2213

2.87

155.43

1.5

1.3

2.84

3.07

g/l

3.29

626

1578

Ethmoidectomy

307

578

5.55

155.32

1.8

1.3

3.07

2.96

g/l

0.42

236

418

Pain in throat and chest

957

2117

2.70

152.45

1.4

2.85

3.03

g/l

2.14

724

1462

Other necrotizing vasculopathies

191

223

9.09

151.73

1.4

2.49

2.93

g/l

2.01

139

174

Other specified/unspecified systemic involvement of connective tissue

178

192

9.94

150.60

2.5

1.4

2.78

2.99

g/l

0.69

147

142

Abnormal findings on examination of blood, without diagnosis

661

1967

3.09

149.70

1.6

1.4

3.08

2.96

g/l

0.80

468

1417

Other diseases of upper respiratory tract

1222

2668

2.41

148.91

1.4

1.3

2.85

3.00

g/l

1.89

921

1830

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

671

2188

3.00

146.71

1.5

1.4

2.86

3.03

g/l

1.75

482

1509

Early onset COPD, excluding more controls

247

399

6.31

145.52

1.6

1.3

2.63

3.23

g/l

4.63

181

272

Other necrotizing vasculopathies (FG)

164

166

10.49

145.11

1.5

1.3

2.54

2.78

g/l

0.69

119

125

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

190

233

8.58

144.85

1.7

1.4

3.22

2.96

g/l

0.73

125

169

Finngen Rheumatological endpoints

1129

2675

2.42

142.47

1.5

1.3

2.91

3.02

g/l

1.12

823

1889

Diseases of liver

532

1609

3.38

142.29

1.3

1.4

3.10

2.90

g/l

1.47

362

1178

Any reimbursement code in KELA

652

980

3.37

140.97

1.4

1.3

2.92

3.17

g/l

2.45

479

720

Bacterial Sepsis

624

1687

3.10

139.24

1.4

2.59

3.01

g/l

5.84

447

1210

Vasomotor and allergic rhinitis

526

1566

3.34

137.89

1.5

1.4

2.89

2.98

g/l

0.57

431

1077

Other specific joint derangements/joint disorders

934

2291

2.57

136.89

1.4

2.97

3.00

g/l

0.16

700

1641

Other diseases of pancreas

187

242

8.10

136.20

1.7

1.2

2.96

3.05

g/l

0.21

103

183

Polyarthropathies

840

2032

2.69

135.40

1.4

2.78

3.00

g/l

2.80

624

1454

Septicaemia

555

1610

3.19

133.11

1.4

2.59

3.01

g/l

5.27

390

1168

L04AA Selective immunosuppressants

406

1080

3.87

132.42

1.5

1.3

2.63

2.92

g/l

2.64

306

772

Gastrointestinal diseases

627

962

3.30

131.54

1.4

1.3

2.95

3.05

g/l

0.60

448

740

Other soft tissue disorders, not elsewhere classified

1104

2699

2.35

130.94

1.4

2.91

2.98

g/l

0.66

831

1911

Codeine

1038

2342

2.42

129.09

1.4

2.81

3.15

g/l

7.12

744

1678

Opioids

1077

2382

2.36

125.05

1.4

2.85

3.15

g/l

5.25

770

1707

Explicit Sepsis

582

1804

2.98

124.33

1.4

2.62

2.99

g/l

4.30

413

1303

Explicit Sepsis, including avohilmo

594

1855

2.95

124.01

1.4

2.64

2.99

g/l

4.00

424

1338

Malaise and fatigue

604

1625

2.96

123.16

1.4

1.3

2.72

3.05

g/l

4.10

439

1174

Infections, IBD-co-morbidities

227

241

6.76

122.55

1.5

1.2

2.75

3.18

g/l

2.02

163

171

Implicit bacterial Sepsis

528

1462

3.14

121.60

1.5

1.4

2.59

3.04

g/l

5.77

379

1048

Other immunodeficiencies

28.09

121.38

2.4

1.3

2.65

2.73

g/l

0.09

Primary Sclerosing Cholangitis, IBD and UDCA required

101

17.96

120.84

1.5

1.3

3.48

2.75

g/l

2.10

Gastro-oesophageal reflux disease

828

2867

2.46

120.25

1.4

2.87

2.94

g/l

0.49

591

2069

Implicit viral Sepsis, including avohilmo

437

1304

3.41

118.93

1.4

2.59

3.00

g/l

4.66

325

948

Dermatitis

792

3184

2.46

118.43

1.5

1.4

2.90

2.94

g/l

0.22

587

2300

Medical observation and evaluation for suspected diseases and conditions

714

1300

2.84

118.37

1.5

1.3

2.89

3.00

g/l

0.72

554

801

Other septicaemia, including avohilmo

492

1480

3.17

117.53

1.5

1.4

2.61

3.03

g/l

4.75

351

1068

Implicit bacterial Sepsis, including avohilmo

567

1614

2.96

117.23

1.4

2.61

3.01

g/l

5.22

411

1157

Symptoms and signs involving the digestive system and abdomen

1062

2332

2.30

116.20

1.4

2.91

2.96

g/l

0.43

742

1712

Certain infectious and parasitic diseases

1034

2245

2.33

115.89

1.4

2.84

3.08

g/l

3.42

751

1589

Other septicaemia

481

1448

3.18

115.80

1.5

1.4

2.61

3.01

g/l

4.14

342

1044

Abdominal and pelvic pain

1059

2332

2.30

115.74

1.5

1.4

2.92

2.96

g/l

0.31

738

1712

Other and unspecified dermatitis

687

2692

2.59

114.43

1.6

1.4

2.89

2.94

g/l

0.32

513

1955

Sicca syndrome [Sjögren]

189

304

6.51

112.88

1.6

1.4

2.75

2.83

g/l

0.22

129

228

Other diseases of intestines

1205

3184

2.13

112.69

1.4

2.89

2.98

g/l

0.93

878

2289

Implicit Sepsis

883

2796

2.35

112.28

1.4

2.75

3.03

g/l

3.88

626

2025

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

336

357

4.77

111.66

1.3

2.96

3.05

g/l

0.31

241

249

Vocal cord dysfunction

200

288

6.25

110.94

1.6

1.2

2.78

3.25

g/l

2.40

140

204

Low back pain

896

2607

2.34

110.77

1.5

1.4

2.83

3.03

g/l

2.76

660

1845

Viral Sepsis

329

862

3.91

109.53

1.4

2.50

3.00

g/l

5.18

246

635

Implicit viral Sepsis

328

859

3.91

109.26

1.5

1.4

2.49

3.00

g/l

5.43

245

633

Nasal polyp

293

711

4.22

108.46

1.7

1.3

3.02

3.03

g/l

0.00

252

493

Haemorrhage from respiratory passages

399

1052

3.40

105.68

1.4

2.89

3.02

g/l

0.62

283

722

Noninfective enteritis and colitis

627

2450

2.59

104.87

1.4

2.88

2.92

g/l

0.23

437

1798

Primary_lymphoid and hematopoietic malignant neoplasms

351

997

3.60

103.81

1.4

2.16

2.98

g/l

10.61

256

709

All influenza

345

1009

3.48

97.34

1.5

1.4

2.71

3.11

g/l

3.31

261

725

Disorders of other endocrine glands

585

2256

2.59

97.29

1.5

1.4

2.65

2.91

g/l

2.81

351

1669

Pain, not elsewhere classified

358

1072

3.39

97.29

1.7

1.3

2.76

3.07

g/l

3.05

292

774

Other disorders of adrenal gland

135

179

8.04

96.80

1.8

1.3

2.38

2.99

g/l

2.67

135

Exclusions for E4_PCOS_BROAD

315

874

3.70

96.64

1.6

1.4

2.59

2.85

g/l

1.54

165

652

Cholelithiasis, broad definition with cholecystitis

892

2713

2.21

95.91

1.5

1.4

2.99

2.95

g/l

0.22

598

2078

Other diseases of blood and blood-forming organs, wide

345

1021

3.46

95.90

1.4

2.65

2.93

g/l

1.55

238

733

Adrenocortical insufficiency

120

140

9.24

95.80

1.8

1.3

2.37

3.02

g/l

2.51

107

Codeine or tramadol medication

1199

3278

2.00

95.37

1.4

2.80

3.04

g/l

4.53

857

2347

Disorders of lacrimal system

566

2175

2.60

94.72

1.5

1.4

2.89

g/l

0.01

414

1565

Dorsalgia

1056

2686

2.10

94.60

1.5

1.4

2.87

3.02

g/l

1.92

782

1902

Idiopathic pulmonary fibrosis

141

201

7.29

94.27

1.5

1.2

3.14

2.94

g/l

0.53

104

151

Diagnoses used for exclusion with ILD

358

1096

3.33

94.10

1.4

3.13

2.94

g/l

0.88

247

803

Liquid cancers

396

1211

3.15

93.77

1.4

2.22

2.99

g/l

10.90

285

873

Provisional assignment of new diseases of uncertain etiology

661

2766

2.40

93.70

1.5

1.4

2.72

2.99

g/l

3.75

506

1977

Implicit Sepsis, including avohilmo

906

3028

2.16

93.54

1.4

2.77

3.02

g/l

3.34

638

2203

Pain in limb

898

2630

2.19

93.52

1.4

2.86

2.98

g/l

1.23

673

1864

Other special examinations and investigations of persons without complaint or reported diagnosis

661

1300

2.60

93.45

1.4

1.3

2.91

3.00

g/l

0.55

495

801

Codes for special purposes

661

2769

2.40

93.45

1.5

1.4

2.72

2.99

g/l

3.71

506

1980

Other heart diseases

580

1428

2.67

93.12

1.5

1.4

2.82

3.00

g/l

1.52

416

1047

Drug-induced adrenocortical insufficiency

15.48

92.70

2.0

1.4

2.33

2.72

g/l

0.79

Budesonide

198

398

5.09

92.66

1.4

1.2

3.13

3.04

g/l

0.23

141

283

Nausea and vomiting

347

1029

3.34

91.44

1.4

1.3

2.81

2.88

g/l

0.29

259

776

Eosinophilic disease (BM)

23.05

91.23

1.6

1.2

3.14

2.87

g/l

0.27

Unspecified acute lower respiratory infection

257

646

4.08

90.87

1.5

1.4

2.70

3.06

g/l

1.93

194

468

General examination and investigation of persons without complaint and reported diagnosis

642

1300

2.59

90.76

1.5

1.3

2.87

3.00

g/l

0.99

532

801

Covid-19 confirmed case

474

1734

2.77

90.56

1.6

1.4

2.54

2.99

g/l

6.38

337

1230

Cardiovascular diseases

706

1543

2.45

90.19

1.4

1.3

2.91

3.03

g/l

0.97

503

1147

Other arthritis (FG)

395

1314

3.05

90.14

1.5

1.3

2.84

2.99

g/l

0.78

289

938

Other disorders of lacrimal gland

485

1804

2.73

90.05

1.6

1.4

2.91

2.88

g/l

0.14

354

1297

Parasetamol

732

1541

2.42

89.85

1.4

1.3

2.93

3.12

g/l

1.80

527

1075

Dermatitis and eczema

1207

3713

1.94

89.74

1.5

1.4

2.91

2.95

g/l

0.37

890

2656

Pneumonia due to other infectious organisms, not elsewhere classified

11.15

89.31

1.4

1.3

2.01

3.07

g/l

4.05

Respiratory disorders in diseases classified elsewhere

18.71

88.16

1.8

1.4

2.29

2.86

g/l

1.35

Osteoporosis

337

939

3.36

87.96

1.6

1.4

2.54

2.85

g/l

2.07

235

676

Other disorders of white blood cells

133

193

7.27

87.83

1.5

1.4

2.82

2.86

g/l

0.05

142

Oedema, not elsewhere classified

372

1181

3.12

87.74

1.6

1.3

2.82

3.02

g/l

1.11

287

851

Heart failure, not strict

803

2457

2.22

87.56

1.5

1.4

2.71

2.99

g/l

3.95

590

1754

Biological medicines for asthma

11.95

87.36

1.4

1.3

2.78

2.92

g/l

0.30

Cholelithiasis

841

2668

2.17

87.34

1.4

2.97

2.94

g/l

0.18

560

2044

Viral pneumonia

207

455

4.67

87.18

1.4

1.3

2.51

3.07

g/l

3.36

149

330

Irritable bowel syndrome

384

1282

3.05

87.18

1.5

1.4

2.86

2.95

g/l

0.40

285

929

Other disorders involving the immune mechanism, not elsewhere classified

102

110

10.00

86.49

2.8

1.3

2.63

2.94

g/l

0.76

Other respiratory disorders and diseases

283

795

3.63

85.17

1.5

1.4

2.33

2.97

g/l

8.05

206

582

Other diseases of the respiratory system

283

795

3.63

85.17

1.5

1.4

2.33

2.97

g/l

8.05

206

582

Lower back pain or/and sciatica

1153

3748

1.93

85.14

1.5

1.4

2.86

3.00

g/l

1.91

855

2667

Other heart diseases, wide

1018

3078

2.02

85.10

1.4

2.82

2.97

g/l

1.80

729

2234

Complications of surgical and medical care, not elsewhere classified

1071

3665

1.96

85.07

1.4

2.84

2.98

g/l

1.63

785

2638

Oxycodone

443

1358

2.82

84.93

1.5

1.4

2.61

3.12

g/l

6.54

315

976

Sulfasalazine

294

850

3.51

84.43

1.4

1.2

2.79

3.11

g/l

2.15

210

595

Cardiovascular diseases (excluding rheumatic etc)

730

1828

2.31

83.61

1.4

1.3

2.86

3.04

g/l

1.65

515

1345

Pain (limb, back, neck, head abdominally)

688

1445

2.40

83.13

1.4

2.84

2.96

g/l

0.97

497

1017

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

962

3240

2.02

82.80

1.3

1.4

2.79

3.02

g/l

3.18

683

2338

Defects in the complement system

29.45

82.71

2.7

1.4

2.68

2.89

g/l

0.17

Disorders of eyelid, lacrimal system and orbit

944

3470

2.01

81.58

1.5

1.4

2.91

2.95

g/l

0.30

695

2514

COPD (mode)

246

478

4.06

81.02

1.3

1.2

2.74

3.14

g/l

2.49

181

317

Allergic rhinitis

438

1613

2.72

80.74

1.5

1.4

2.90

2.95

g/l

0.29

369

1139

Diseases of salivary glands

441

1655

2.71

80.59

1.5

1.4

2.97

2.91

g/l

0.26

321

1187

Condition for Implicit Sepsis (Organ dysfunction codes)

905

3100

2.04

80.37

1.4

2.77

3.01

g/l

3.28

637

2255

Autoimmune hepatitis, wide definition

108

138

8.22

79.68

1.4

3.02

3.03

g/l

0.01

103

Other specified/unspecified arthritis

351

1173

3.04

79.57

1.4

1.5

2.85

2.96

g/l

0.49

253

851

Cholangitis (primary sclerosing, PSC), with reimbursement 202

12.88

79.52

2.1

1.3

3.49

2.74

g/l

1.58

Dental caries

332

1006

3.16

79.43

1.5

1.3

2.72

3.02

g/l

2.14

250

705

Other inflammatory liver diseases

139

234

6.20

79.38

1.3

1.4

3.04

3.00

g/l

0.08

172

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

100

10.01

79.02

2.9

1.3

2.52

2.97

g/l

1.36

Disorders of thyroid, IBD co-morbidities

194

266

5.06

78.94

1.4

1.3

2.97

3.26

g/l

1.17

148

187

Candidiasis, including avohilmo

415

1527

2.76

78.83

1.4

2.79

2.91

g/l

0.81

315

1101

Childhood asthma (age<16), excluding more controls

165

235

5.58

78.32

1.3

2.90

3.35

g/l

1.92

125

151

Wegener granulomatosis

17.62

78.11

1.8

1.4

2.39

2.78

g/l

0.53

Hernia of abdominal wall, postoperative

192

429

4.51

78.09

1.5

1.3

2.81

3.07

g/l

0.78

134

366

Other functional intestinal disorders

523

1955

2.46

77.12

1.5

1.4

2.71

2.93

g/l

2.17

378

1423

Simple and mucopurulent chronic bronchitis

9.91

77.08

1.3

2.63

2.58

g/l

0.08

Childhood asthma (age<16)

165

239

5.48

76.99

1.3

2.90

3.35

g/l

1.93

125

153

5-aminosalicylic acid

244

664

3.73

76.89

1.4

1.2

3.05

3.10

g/l

0.13

163

465

13.82

76.75

1.5

1.3

2.75

g/l

0.00

COPD

421

1251

2.76

76.72

1.4

1.3

2.68

2.98

g/l

2.64

308

876

Osteopathies and chondropathies

647

2678

2.23

76.59

1.5

1.4

2.68

2.94

g/l

2.95

457

1953

Intestinal infectious diseases

1017

3983

1.91

76.53

1.5

1.4

2.76

2.99

g/l

4.17

742

2869

Neurological diseases, wide definition

310

428

3.68

76.04

1.4

1.2

2.92

3.02

g/l

0.35

220

306

Spondylopathies

787

2198

2.13

75.87

1.4

2.83

3.04

g/l

2.49

561

1546

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1066

3639

1.89

75.30

1.4

2.80

3.00

g/l

3.23

770

2609

Diseases of the skin and subcutaneous tissue

967

2449

1.99

74.86

1.5

1.3

2.92

2.99

g/l

0.55

707

1711

Diarrhoea and gastroenteritis of presumed infectious origin

784

3445

2.05

74.38

1.4

2.76

3.00

g/l

3.77

568

2482

Caries of dentine

299

920

3.19

72.78

1.5

1.3

2.70

3.01

g/l

2.00

226

645

Implicit fungal Sepsis, including avohilmo

135

240

5.83

72.77

1.4

2.43

2.92

g/l

2.11

182

Other headache syndromes

488

2013

2.44

72.50

1.4

2.99

2.94

g/l

0.21

361

1479

Symptoms and signs involving the skin and subcutaneous tissue

793

3750

2.01

72.47

1.5

1.4

2.88

2.95

g/l

0.50

616

2698

Aplastic and other anaemias

495

1873

2.45

72.37

1.4

2.76

2.94

g/l

0.98

318

1367

Episodal and paroxysmal disorders

1095

2968

1.88

72.19

1.4

2.91

2.96

g/l

0.45

780

2173

Other chronic obstructive pulmonary disease

401

1212

2.74

71.98

1.4

1.3

2.67

2.97

g/l

2.54

293

849

Eosinophilia

14.30

71.94

1.6

1.3

3.14

2.76

g/l

0.46

Soft tissue disorders

1016

2720

1.93

71.69

1.4

2.93

2.98

g/l

0.41

745

1925

Rheumatoid arthritis

368

1167

2.83

71.47

1.5

1.4

2.64

2.98

g/l

3.04

280

841

Liquid cancers, including Hilmo

425

1446

2.63

71.37

1.4

2.25

2.99

g/l

11.52

308

1053

Other dorsopathies, not elsewhere classified

995

2697

1.93

70.82

1.4

2.88

3.02

g/l

1.52

733

1910

Respiratory insufficiency

119

8.13

70.58

1.4

1.3

2.23

3.14

g/l

4.55

Sleep apnoea

979

3262

1.91

70.46

1.4

2.90

2.97

g/l

0.60

671

2367

Mycoses

373

1384

2.74

69.81

1.5

1.4

2.95

g/l

0.00

261

999

Sarcoidosis

210

553

3.90

69.79

1.4

1.3

3.37

2.99

g/l

1.42

140

407

Certain infectious and parasitic diseases, including avohilmo

669

1503

2.25

69.77

1.4

2.85

3.10

g/l

2.85

492

1046

L04AD Calcineurin inhibitors

205

534

3.97

69.35

1.4

2.65

2.90

g/l

1.00

144

396

Other joint disorders

885

2330

1.99

69.29

1.4

2.97

2.99

g/l

0.08

653

1667

Neurological diseases

852

2127

2.03

68.83

1.4

2.87

3.00

g/l

1.22

605

1552

Other noninfective gastroenteritis and colitis

330

1157

2.90

68.65

1.5

1.3

2.72

2.86

g/l

0.71

242

850

Migraine

580

2017

2.26

68.60

1.4

2.97

2.94

g/l

0.11

431

1500

Intestinal infectious diseases, including avohilmo, including avohilmo

1158

3597

1.80

68.37

1.4

2.77

3.00

g/l

4.61

845

2574

Cardiac arrhythmias

658

1952

2.18

68.28

1.3

1.4

2.91

2.99

g/l

0.49

467

1447

Other and unspecified anaemias

454

1747

2.47

68.06

1.4

2.72

2.96

g/l

1.50

292

1272

Sciatica+with lumbago

550

2172

2.26

67.17

1.4

2.82

3.04

g/l

2.42

415

1535

Other anaemias

455

1758

2.45

67.14

1.4

2.73

2.96

g/l

1.42

293

1282

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

964

4076

1.85

66.71

1.5

1.4

2.75

2.98

g/l

3.38

722

2921

All kidney diseases

1013

3710

1.84

66.58

1.5

1.4

2.72

3.00

g/l

5.20

710

2714

Symptoms and signs concerning food and fluid intake

160

355

4.61

66.48

1.5

1.3

2.94

3.05

g/l

0.27

117

274

Fibrosis and cirrhosis of liver

139

276

5.22

66.38

1.2

1.4

3.37

3.00

g/l

1.22

104

204

Dorsopathies

1007

2726

1.88

66.35

1.4

2.90

3.01

g/l

1.12

729

1936

Fibromyalgia

154

333

4.75

66.35

1.6

1.3

2.91

2.97

g/l

0.16

119

237

Pleural effusion

193

496

3.97

66.21

1.6

1.4

2.93

3.05

g/l

0.31

128

368

Diseases of the musculoskeletal system and connective tissue

519

1066

2.46

66.01

1.4

1.3

2.89

3.02

g/l

0.83

374

755

Diseases of the eye and adnexa

806

1998

2.04

65.99

1.4

1.3

2.93

3.00

g/l

0.52

596

1417

Hypertensive diseases (excluding secondary)

553

1392

2.33

65.52

1.5

1.3

2.83

3.07

g/l

2.39

382

1014

Hypothyroidism, levothyroxine purchases

272

439

3.51

65.52

1.4

1.3

2.87

3.20

g/l

1.92

183

324

Hypothyroidism and >3 levothyroxin purchases

272

439

3.51

65.52

1.4

1.3

2.87

3.20

g/l

1.92

183

324

Methotrexate

160

363

4.49

64.75

1.6

1.2

2.58

2.98

g/l

1.83

119

263

Complications of medical and surgical care

772

3570

1.96

64.75

1.4

2.81

2.97

g/l

1.62

565

2587

ILD-related respiratory insufficiency

9.39

64.60

1.2

2.42

2.88

g/l

1.04

Hypothyroidism (congenital or acquired)

272

443

3.48

64.56

1.4

1.3

2.87

3.19

g/l

1.82

183

328

Persons encountering health services in other circumstances

481

2067

2.33

64.07

1.4

2.84

2.96

g/l

0.68

300

1464

Pneumocystosis, including avohilmo

11.49

63.96

1.6

1.4

1.90

2.72

g/l

2.21

Pneumocystosis

11.49

63.96

1.6

1.4

1.90

2.72

g/l

2.21

Complications of procedures, not elsewhere classified

835

3547

1.91

63.80

1.4

2.84

3.00

g/l

1.65

614

2549

Diseases of the digestive system

491

2151

2.29

62.97

1.6

1.4

2.98

2.95

g/l

0.12

341

1542

Abnormalities of heart beat

349

1274

2.68

62.86

1.3

1.4

2.82

3.01

g/l

1.17

243

890

Sleep apnoea, including avohilmo

1006

3356

1.82

62.85

1.4

2.92

2.98

g/l

0.41

691

2438

Protozoal diseases, including avohilmo

109

8.32

62.78

1.5

1.4

2.16

2.90

g/l

2.40

Inflammatory bowel disease

401

1629

2.50

62.36

1.3

1.4

3.08

2.97

g/l

0.52

271

1172

Viral infections characterized by skin and mucous membrane lesions

498

2224

2.26

62.17

1.5

1.4

2.62

2.94

g/l

3.66

379

1608

Infection due to other mycobacteria

15.77

62.04

1.4

2.95

3.01

g/l

0.07

Arthropathies

884

2341

1.92

61.83

1.3

1.4

2.93

2.98

g/l

0.35

655

1678

Sleep disorders (combined)

1075

3145

1.80

61.73

1.4

2.91

2.97

g/l

0.49

756

2293

Protozoal diseases

107

8.29

61.06

1.5

1.4

2.15

2.90

g/l

2.44

Implicit fungal Sepsis

121

7.63

61.01

1.5

1.3

2.31

2.88

g/l

1.88

Fungal Sepsis

136

7.16

60.97

1.5

1.3

2.38

2.83

g/l

1.29

103

Cholecystectomy

719

3126

1.97

60.65

1.4

3.05

2.91

g/l

1.05

477

2294

Urticaria and erythema

446

1924

2.35

60.59

1.5

1.4

2.81

2.94

g/l

0.87

343

1396

Chronic laryngitis and laryngotracheitis

186

497

3.82

60.46

1.4

1.3

2.87

2.98

g/l

0.35

139

342

Other intervertebral disc disorders

787

2419

1.95

60.25

1.4

2.94

3.05

g/l

0.88

573

1702

Colitis, primary sclerosing

12.13

60.08

1.4

1.3

3.44

2.64

g/l

1.88

Hypopituitarism

150

346

4.50

59.85

1.6

1.3

2.68

2.87

g/l

0.52

263

Biological medication for rheuma

275

944

2.97

59.80

1.3

1.4

3.09

2.93

g/l

0.65

188

678

Other diseases of liver

254

837

3.10

59.32

1.3

2.93

2.90

g/l

0.10

172

612

Other general symptoms and signs

105

177

6.09

59.08

1.7

1.3

2.63

2.98

g/l

1.15

139

Persons encountering health services in other circumstances, wide

1105

3251

1.76

58.81

1.5

1.4

2.82

3.01

g/l

2.65

825

2305

Dysphagia

267

913

2.96

58.22

1.4

1.3

2.92

2.99

g/l

0.25

188

676

Persons encountering health services for specific procedures and health care

1077

3661

1.75

57.98

1.4

2.77

3.00

g/l

4.12

787

2639

Depression medications

291

467

3.16

57.82

1.3

2.98

3.20

g/l

1.04

208

347

Primary biliary cholangitis, wide definition

11.60

57.80

1.3

1.5

3.27

2.95

g/l

0.54

Voice disturbances

330

1272

2.64

57.37

1.5

1.4

2.75

2.91

g/l

1.09

249

916

Myalgia

292

1060

2.79

57.07

1.5

1.3

2.87

2.98

g/l

0.48

214

740

Coagulation defects, purpura and other haemorrhagic conditions

267

925

2.94

57.05

1.6

1.4

2.60

2.91

g/l

2.22

202

670

Persons encountering health services for examination and investigation

568

1300

2.21

57.03

1.4

1.3

2.94

3.00

g/l

0.34

441

801

Anxiety disorders, excluding more controls

847

2929

1.86

57.03

1.5

1.4

2.89

3.01

g/l

1.09

637

2097

Functional dyspepsia

310

1165

2.70

56.63

1.5

1.4

2.98

2.91

g/l

0.26

229

828

Rheumatoid arthritis, including avohilmo

420

1827

2.33

56.04

1.5

1.4

2.68

2.92

g/l

2.00

313

1307

Constipation

893

3368

1.81

55.65

1.4

2.75

2.95

g/l

2.82

625

2483

Disorders of conjunctiva

874

3777

1.80

55.58

1.5

1.4

2.78

2.95

g/l

1.97

673

2702

Seropositive rheumatoid arthritis

263

910

2.91

55.54

1.5

1.3

2.62

2.92

g/l

1.97

204

643

Endocrine, nutritional and metabolic diseases

777

2042

1.93

55.48

1.4

1.3

2.89

3.04

g/l

1.43

532

1513

Antihypertensive medication - note that there are other indications

636

1620

2.07

54.95

1.4

1.3

2.94

3.00

g/l

0.36

457

1192

Infection due to other mycobacteria, including avohilmo

12.64

54.71

1.4

2.95

3.00

g/l

0.06

Bleeding

814

3121

1.84

54.18

1.4

2.93

g/l

0.01

583

2256

All chronic kidney diseases

557

2154

2.08

54.04

1.5

1.4

2.70

3.00

g/l

3.29

393

1566

Ulcerative colitis

310

1195

2.63

53.92

1.3

3.06

2.96

g/l

0.41

210

865

Chronic kidney disease

325

1227

2.58

53.91

1.5

1.4

2.59

2.98

g/l

3.20

220

894

Renal failure

464

1797

2.22

53.84

1.5

1.4

2.68

2.95

g/l

2.31

310

1286

Symptoms and signs involving the nervous and musculoskeletal systems

605

3076

1.98

53.72

1.6

1.4

2.81

2.93

g/l

0.93

446

2233

Other disorders of fluid, electrolyte and acid-base balance

339

1279

2.53

53.63

1.5

1.4

2.61

3.01

g/l

4.01

229

914

Primary biliary cholangitis (PBC)

11.44

53.54

1.2

3.38

2.99

g/l

0.65

Other pleural conditions

128

284

4.61

53.42

1.5

1.4

2.82

3.12

g/l

0.86

210

Intestinal malabsorption

156

6.21

53.40

1.5

1.3

3.10

2.88

g/l

0.48

120

Rheumatism, unspecified

177

501

3.61

52.93

1.8

1.4

2.95

2.88

g/l

0.20

135

358

Purpura and other haemorrhagic conditions

197

599

3.36

52.73

1.6

1.4

2.62

2.93

g/l

1.62

147

436

COPD, hospital admission 2, with asthma infections

323

1091

2.58

52.33

1.5

1.4

2.54

2.96

g/l

3.89

237

775

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

143

6.40

52.13

1.7

1.4

2.79

3.00

g/l

0.29

108

Renal tubulo-interstitial diseases

853

3537

1.78

51.16

1.5

1.4

2.63

3.00

g/l

7.07

593

2585

Symptoms and signs involving speech and voice

374

1612

2.35

51.06

1.4

2.73

2.92

g/l

1.61

279

1156

Other diseases of pericardium

140

6.38

50.86

1.5

1.2

2.71

3.14

g/l

1.02

101

Osteoporosis with pathological fracture (FG)

184

5.52

50.85

1.6

1.2

2.06

2.82

g/l

4.78

140

Other disorders of skin and subcutaneous tissue

721

3309

1.85

50.71

1.4

2.86

2.94

g/l

0.58

538

2389

Lumbar disc prolapse

613

2322

1.97

50.59

1.4

2.88

3.04

g/l

1.37

442

1633

COPD, hospital admissions 3, with asthma pneumonia sepsis

272

854

2.76

50.42

1.5

1.4

2.48

2.97

g/l

4.44

203

614

Atrial fibrillation and flutter

312

767

2.65

49.78

1.3

2.74

3.12

g/l

3.05

223

545

Drug-induced osteoporosis with pathological fracture

12.57

49.53

1.8

1.3

2.23

2.66

g/l

0.74

Spondylosis

506

1914

2.08

49.20

1.5

1.4

2.70

3.03

g/l

4.16

338

1351

Nerve, nerve root and plexus disorders

1013

3613

1.69

49.18

1.4

2.91

2.98

g/l

0.72

723

2594

Mycoses, including avohilmo

917

4088

1.72

49.16

1.4

2.87

2.97

g/l

1.06

668

2939

Non-Hodgkin lymphoma, all, including Hilmo

174

512

3.47

49.08

1.5

1.4

2.19

2.93

g/l

5.35

129

376

Polymyalgia rheumatica

152

409

3.79

48.98

1.6

1.3

2.86

2.88

g/l

0.04

112

301

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1031

3251

1.69

48.80

1.5

1.4

2.75

3.01

g/l

4.82

815

2305

Other symptoms and signs involving the nervous and musculoskeletal systems

457

2176

2.12

48.79

1.6

1.4

2.80

2.93

g/l

0.95

329

1567

Later onset COPD, excluding more controls

146

274

4.10

48.71

1.2

2.73

2.98

g/l

0.83

108

183

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

604

3109

1.92

48.68

1.4

2.80

2.98

g/l

1.61

441

2246

Ulcerative colitis, NAS

202

656

3.14

48.53

1.3

1.4

3.09

2.95

g/l

0.46

142

480

Erysipelas, including avohilmo

665

2627

1.89

48.51

1.5

1.4

2.81

3.08

g/l

3.42

491

1873

Anxiety disorders

904

3613

1.73

48.43

1.5

1.4

2.91

2.94

g/l

0.25

682

2576

Abnormal results of function studies

136

342

4.08

48.35

1.5

1.3

3.02

3.01

g/l

0.02

252

Neoplasms

751

2134

1.86

48.23

1.4

2.95

3.02

g/l

0.50

525

1569

Nutritional anaemias

500

2350

2.05

48.12

1.5

1.4

2.84

2.92

g/l

0.47

368

1692

Conjunctivitis

787

3586

1.78

48.10

1.5

1.4

2.79

2.93

g/l

1.38

612

2568

Other and unspecified iron deficiency

370

1627

2.30

47.95

1.4

2.81

2.91

g/l

0.45

267

1176

Neurotic, stress-related and somatoform disorders

895

3598

1.72

47.71

1.5

1.4

2.90

2.94

g/l

0.29

677

2563

Abnormal findings on diagnostic imaging of other body structures

179

546

3.34

47.66

1.5

1.3

3.24

2.87

g/l

1.52

119

400

Pneumonia due to Streptococcus pneumoniae

123

6.58

47.58

1.4

1.2

2.33

3.04

g/l

2.57

Chronic hepatitis, not elsewhere classified

114

6.90

47.51

1.5

1.4

2.99

2.71

g/l

0.58

Metabolic disorders

912

3188

1.73

47.47

1.5

1.4

2.75

3.02

g/l

4.79

656

2301

Diaphragmatic hernia

367

1622

2.29

47.26

1.4

2.79

2.90

g/l

0.71

284

1169

Migraine without aura

245

907

2.74

46.21

1.4

2.90

2.98

g/l

0.29

183

676

Pulmonary heart disease, diseases of pulmonary circulation

325

1379

2.38

46.00

1.4

2.75

2.94

g/l

1.09

245

986

Iron deficiency anaemia

440

2069

2.11

45.98

1.5

1.4

2.78

2.93

g/l

0.97

319

1494

Abnormal serum enzyme levels

309

1237

2.44

45.69

1.6

1.4

3.11

3.02

g/l

0.36

234

903

Tumor necrosis factor alpha inhibitors

233

852

2.79

45.20

1.3

1.4

3.14

2.92

g/l

0.93

160

603

Giant cell arteritis

104

6.99

45.19

1.2

1.5

2.72

2.76

g/l

0.06

Aspergillosis, including avohilmo

15.42

44.98

1.4

1.3

2.66

2.71

g/l

0.05

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

428

1244

2.19

44.88

1.5

1.3

2.94

3.09

g/l

0.91

291

898

Explicit bacterial Sepsis, including avohilmo

141

383

3.75

44.87

1.4

2.72

3.05

g/l

0.91

289

Other chronic obstructive pulmonary disease, including avohilmo

492

2013

2.02

44.77

1.5

1.4

2.71

2.98

g/l

2.75

359

1443

Syncope and collapse

383

1449

2.22

44.68

1.4

2.91

3.06

g/l

0.84

274

1045

Benign neoplasm of colon, rectum, anus and anal canal

591

2659

1.89

44.59

1.5

1.4

2.80

2.97

g/l

1.60

454

1884

Explicit bacterial Sepsis

138

371

3.79

44.59

1.4

2.63

3.06

g/l

1.41

283

Acute renal failure

242

908

2.70

44.52

1.5

1.4

2.71

3.00

g/l

1.42

150

665

Early onset COPD

247

940

2.67

44.21

1.6

1.4

2.63

2.98

g/l

2.30

181

664

Colitis, primary sclerosing, strict definition

10.97

43.57

1.4

1.3

3.37

2.63

g/l

1.67

Inflammatory diseases of the central nervous system

129

337

3.93

43.56

1.4

2.82

3.00

g/l

0.42

101

241

Candidiasis

191

641

3.04

43.38

1.5

1.3

2.92

2.90

g/l

0.04

139

462

Diverticular disease of intestine

628

2098

1.88

43.36

1.6

1.4

2.90

3.01

g/l

0.81

477

1507

Mood disorders, excluding more controls

879

3054

1.70

43.30

1.4

2.90

3.01

g/l

0.95

632

2181

Aspergillosis

15.05

43.28

1.4

1.3

2.69

2.71

g/l

0.02

Urticaria

353

1595

2.24

43.18

1.5

1.4

2.83

2.92

g/l

0.48

274

1158

Chronic diseases of tonsils and adenoids

675

2344

1.83

43.09

1.3

2.77

2.99

g/l

2.56

520

1613

Other/unspecified dorsalgia

367

1662

2.20

43.08

1.3

1.4

2.88

3.02

g/l

0.81

267

1187

Heart failure,strict

457

1552

2.07

42.86

1.4

2.68

3.01

g/l

3.13

320

1092

Heart failure and antihypertensive medication

252

606

2.73

42.66

1.5

1.3

2.64

3.03

g/l

2.39

182

445

Diseases of middle ear and mastoid

597

2638

1.86

42.56

1.4

2.87

2.97

g/l

0.70

435

1892

Polyarthrosis

218

707

2.81

42.36

1.6

1.5

2.70

2.85

g/l

0.68

153

519

Depression

924

3751

1.66

42.31

1.4

2.90

2.97

g/l

0.50

670

2691

Other antidepressants

942

2896

1.67

41.95

1.4

2.83

3.03

g/l

2.84

663

2097

COPD, hospital admissions

398

1591

2.13

41.55

1.4

2.66

2.96

g/l

2.59

292

1123

Other specified/unspecified necrotizing vasculopathies

13.01

41.51

1.4

2.52

2.70

g/l

0.16

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

933

3596

1.65

41.49

1.4

2.75

2.99

g/l

4.01

668

2655

Spondyloarthritis

200

705

2.88

41.47

1.4

1.3

3.06

3.00

g/l

0.14

139

511

COPD, early/later onset

401

1606

2.11

41.23

1.4

2.67

2.95

g/l

2.47

293

1135

Benign neoplasms

912

2991

1.67

41.15

1.4

2.89

3.02

g/l

1.30

652

2142

Migraine with aura

273

1128

2.45

41.05

1.4

2.96

2.98

g/l

0.09

208

827

Diseases of arteries, arterioles and capillaries (FINNGEN)

230

577

2.78

40.95

1.4

2.81

3.16

g/l

2.02

171

412

Noninfectious colitis NAS

181

609

3.03

40.95

1.5

1.3

2.84

2.92

g/l

0.25

140

454

Hypothyroidism, drug reimbursement

142

267

3.76

40.91

1.8

1.3

3.15

3.19

g/l

0.10

107

199

Benign neoplasm: Colon

501

2458

1.93

40.74

1.5

1.4

2.82

2.95

g/l

0.94

386

1747

Drug-induced cataract

7.94

40.72

1.5

1.3

2.60

2.75

g/l

0.23

Recurrent or chronic depression

415

1378

2.11

40.66

1.3

1.4

2.96

3.06

g/l

0.56

303

1003

Ischemic heart diseases

761

2622

1.74

40.66

1.4

2.76

2.95

g/l

2.29

549

1889

Hypermobility syndrome

216

4.64

40.58

1.7

1.4

2.80

2.95

g/l

0.37

162

Pulmonary eosinophilia, not elsewhere classified

14.23

40.45

1.7

1.4

3.26

2.89

g/l

0.43

Non-invasive ventilation

231

755

2.67

40.32

1.3

1.4

2.45

3.11

g/l

4.70

104

557

IBD patients in KELA-register

274

1147

2.42

40.16

1.2

1.4

3.16

2.98

g/l

0.79

178

831

Personal history of allergy to drugs, medicaments and biological substances

11.18

40.13

1.6

1.1

3.06

2.92

g/l

0.14

Atopic dermatitis, strict definition with reimbursement

339

1488

2.21

40.06

1.4

1.3

2.81

2.94

g/l

0.81

262

1073

Disorders of orbit

153

5.42

40.03

1.7

1.4

2.88

2.97

g/l

0.15

111

Erysipelas

486

2173

1.94

39.83

1.5

1.4

2.81

3.09

g/l

2.40

362

1542

Ulcerative colitis (strict) with PSC

14.86

39.79

1.3

3.49

2.78

g/l

1.00

Visual disturbances and blindness

521

2789

1.88

39.75

1.5

1.4

2.91

2.92

g/l

0.03

399

2010

Visual disturbances

493

2597

1.92

39.69

1.6

1.4

2.94

2.90

g/l

0.15

378

1874

Disorders of sclera, cornea, iris and ciliary body

549

2994

1.85

39.63

1.5

1.4

3.04

2.94

g/l

0.62

395

2170

Hypertension, essential

720

2329

1.76

39.55

1.4

2.81

3.03

g/l

2.79

509

1672

IBD (strict) with PSC

12.28

39.53

1.3

3.45

2.94

g/l

0.59

Herpesviral [herpes simplex] infections

165

538

3.13

39.49

1.5

1.4

2.94

2.93

g/l

0.02

128

392

Infections of the skin and subcutaneous tissue

594

3266

1.80

39.40

1.4

2.78

2.98

g/l

2.16

452

2334

Spondylopathies (FG)

166

544

3.10

39.30

1.5

1.3

3.18

2.98

g/l

0.72

118

378

Multiple myeloma, including Hilmo

127

5.86

39.26

1.4

1.75

2.97

g/l

2.94

Unspecified jaundice

127

5.83

39.20

2.0

1.2

3.10

2.99

g/l

0.16

102

Hypertensive diseases

745

2435

1.74

39.17

1.4

2.84

3.00

g/l

1.63

528

1757

Care involving use of rehabilitation procedures

620

3147

1.78

39.16

1.4

2.77

2.99

g/l

2.55

442

2282

Other gastritis (incl. Duodenitis)

224

863

2.63

39.13

1.5

1.4

3.03

2.97

g/l

0.17

174

617

Percutaneous Coronary Intervention

715

2504

1.75

39.10

1.4

2.76

2.95

g/l

2.25

533

1807

Shoulder lesions

651

2184

1.80

39.00

1.4

2.92

3.02

g/l

0.70

484

1528

Nonsuppurative otitis media

274

995

2.42

38.97

1.5

1.3

2.85

2.95

g/l

0.40

207

721

Streptococcal septicaemia, including avohilmo

119

319

3.81

38.71

1.5

1.3

2.63

3.09

g/l

1.27

245

Crohn disease

181

629

2.93

38.71

1.2

1.3

3.21

3.00

g/l

0.69

125

462

Hypertension

742

2433

1.73

38.57

1.4

2.83

3.00

g/l

1.78

525

1756

Gout

239

808

2.56

38.52

1.4

1.5

2.60

3.01

g/l

3.21

165

574

Suppurative and unspecified otitis media

403

1760

2.05

38.46

1.4

2.80

2.98

g/l

1.38

300

1267

Mood disorders

959

3843

1.60

38.40

1.4

2.90

2.97

g/l

0.58

692

2766

Pollen allergy

250

1010

2.48

38.35

1.5

1.4

2.95

2.87

g/l

0.33

217

726

Unspecified chronic bronchitis

7.56

38.30

1.3

3.06

2.55

g/l

0.87

Concussion

458

1818

1.97

38.21

1.5

1.4

2.84

3.01

g/l

1.34

334

1326

Pulmonary embolism

289

1265

2.31

38.19

1.5

1.4

2.76

2.93

g/l

0.89

214

910

Mood [affective] disorders

956

3842

1.60

38.12

1.4

2.90

2.97

g/l

0.54

690

2765

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

369

1783

2.09

38.11

1.6

1.3

2.80

2.85

g/l

0.23

224

1298

Intracranial trauma

515

1838

1.90

38.04

1.5

1.4

2.85

3.01

g/l

1.19

371

1342

Streptococcal septicaemia

116

310

3.82

37.91

1.5

1.3

2.51

3.09

g/l

1.92

239

Spinal stenosis

428

1576

2.02

37.89

1.4

2.75

3.03

g/l

2.40

318

1112

Hypothyroidism, strict autoimmune

580

2090

1.83

37.76

1.4

3.03

2.99

g/l

0.21

413

1534

Pulmonary heart disease

289

1272

2.30

37.70

1.5

1.4

2.76

2.93

g/l

0.84

214

918

Temporomandibular joint disorders, including avohilmo

474

2424

1.91

37.70

1.5

1.4

3.05

2.93

g/l

0.78

340

1782

Depression or dysthymia

614

1852

1.82

37.66

1.4

2.91

3.07

g/l

1.21

433

1339

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

551

2920

1.82

37.64

1.6

1.3

2.82

2.95

g/l

1.11

435

2097

Emergency coronary revascularization (for ACS)

751

2678

1.70

37.47

1.4

2.78

2.94

g/l

1.79

558

1917

All influenza (not pneumonia)

169

575

2.98

37.46

1.4

1.3

2.64

3.15

g/l

2.89

123

409

Glomerular diseases

210

803

2.66

37.37

1.7

1.3

2.50

3.03

g/l

3.67

146

585

Zoster [herpes zoster], including avohilmo

487

2510

1.89

37.34

1.5

1.4

2.64

2.94

g/l

3.68

376

1788

Coronary revascularization (ANGIO or CABG)

709

2508

1.73

37.29

1.4

2.75

2.95

g/l

2.37

529

1809

Hard cardiovascular diseases

760

2662

1.70

37.26

1.4

2.76

2.94

g/l

2.01

562

1902

Inflammatory bowel disease, strict (require KELA)

274

1187

2.34

37.21

1.2

1.4

3.16

2.96

g/l

0.93

178

862

Disturbances of skin sensation

311

1420

2.22

37.19

1.3

2.89

2.97

g/l

0.33

234

1008

Multiple myeloma and malignant plasma cell neoplasms

141

5.42

37.16

1.4

1.3

1.71

2.95

g/l

3.08

104

Acute suppurative otitis media

315

1342

2.21

37.05

1.4

2.66

3.01

g/l

3.60

235

966

Dialysis, with operation codes

161

538

3.05

36.95

1.4

2.34

3.04

g/l

4.59

114

397

Benign neoplasm of other and ill-defined parts of digestive system

202

763

2.69

36.84

1.5

1.4

2.83

2.85

g/l

0.08

152

542

Benzodiazepine use

928

3947

1.59

36.73

1.4

2.88

2.98

g/l

0.96

662

2848

Other nutritional deficiencies

662

3548

1.71

36.59

1.4

2.83

2.98

g/l

1.46

486

2586

Nephropathy related operations

157

521

3.08

36.50

1.5

1.4

2.38

2.98

g/l

3.58

111

386

Nonsuppurative otitis media, including avohilmo

353

1459

2.11

36.49

1.5

1.3

2.96

2.95

g/l

0.04

272

1046

SLE (Finngen)

6.39

36.24

1.5

1.4

2.74

2.99

g/l

0.40

Alcohol-induced acute pancreatitis

134

5.52

36.14

1.3

3.29

3.03

g/l

0.38

Collagenous colitis

127

374

3.47

35.96

1.4

2.64

2.86

g/l

0.63

274

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

536

2986

1.80

35.79

1.4

2.80

2.95

g/l

1.15

387

2155

Polyarteritis nodosa and related conditions

10.72

35.78

1.6

1.3

2.86

2.73

g/l

0.16

Major coronary heart disease event

741

2643

1.69

35.68

1.4

2.76

2.95

g/l

2.28

548

1893

Transplanted organ and tissue status

138

431

3.27

35.57

1.5

1.4

2.45

2.96

g/l

2.19

330

Other bacterial intestinal infections

199

759

2.66

35.57

1.4

1.3

2.78

2.91

g/l

0.51

147

545

Cholecystitis

140

440

3.23

35.56

2.1

1.2

3.10

2.97

g/l

0.30

323

Urinary track infection

565

1541

1.85

35.54

1.5

1.4

2.83

2.94

g/l

0.75

418

1131

Personal history of allergy to analgesic agent

15.86

35.45

1.4

1.1

2.86

2.91

g/l

0.04

Anxiety (asthma-related co-morbidities)

611

2666

1.75

35.44

1.4

2.96

2.97

g/l

0.08

475

1929

Corticotropin deficiency

12.16

35.28

2.0

1.4

2.66

2.43

g/l

0.24

COPD related to multimorbidity

336

1349

2.12

35.12

1.4

2.60

2.94

g/l

3.04

241

947

Other reaction to severe stress, and adjustment disorders

383

1931

2.00

35.08

1.6

1.4

2.82

2.98

g/l

1.04

284

1387

Pneumonia derived septicemia

106

6.07

34.98

1.5

1.3

2.33

2.89

g/l

1.28

Other and unspecified disorders of white blood cells

131

5.46

34.84

1.4

1.3

2.80

2.77

g/l

0.02

Heart failure, strict

483

1793

1.88

34.84

1.4

2.69

2.97

g/l

2.50

339

1281

Diseases of the ear and mastoid process

1032

3336

1.56

34.76

1.4

2.92

2.98

g/l

0.47

743

2419

Abnormal weight loss

122

359

3.47

34.59

1.4

3.03

2.93

g/l

0.24

270

Other complications of surgical and medical care, not elsewhere classified

130

400

3.32

34.33

1.3

1.4

2.81

2.98

g/l

0.44

102

292

Disorders of synovium and tendon

481

2215

1.85

34.28

1.5

1.4

2.89

3.01

g/l

0.94

347

1564

Enterocolitis due to Clostridium difficile

122

361

3.44

34.23

1.4

2.62

2.91

g/l

1.00

270

Allergic conjunctivitis

571

3163

1.75

34.15

1.6

1.3

2.82

2.93

g/l

0.91

452

2273

Herpesviral [herpes simplex] infections, including avohilmo

290

1334

2.20

34.11

1.4

3.08

2.97

g/l

0.40

218

951

Any mental disorder

970

3105

1.57

34.02

1.4

2.83

3.00

g/l

2.06

703

2222

Polypectomy (DHB20)

252

4.00

33.96

2.0

1.3

3.04

2.92

g/l

0.28

179

DVT of lower extremities and pulmonary embolism

374

1885

1.99

33.92

1.4

2.83

2.94

g/l

0.53

272

1354

Viral pneumonia (unknown virus, not influenza)

248

4.01

33.84

1.2

1.3

2.70

3.04

g/l

0.77

182

All-cause Heart Failure

474

1770

1.88

33.69

1.4

2.69

2.97

g/l

2.44

334

1270

Mucosal proctocolitis

167

600

2.83

33.64

1.4

1.3

2.97

2.99

g/l

0.03

109

444

Other and unspecified tonsillitis

327

1299

2.11

33.56

1.4

2.87

3.07

g/l

1.36

249

895

Seropositive rheumatoid arthritis, wide

263

1172

2.27

33.44

1.5

1.4

2.62

2.86

g/l

1.46

204

836

All anxiety disorders

621

2829

1.71

33.42

1.4

2.97

g/l

0.02

483

2019

Weight loss

131

412

3.24

33.39

1.4

2.93

2.92

g/l

0.03

308

Cerebrovascular diseases (FINNGEN)

276

853

2.29

33.26

1.3

2.81

3.12

g/l

2.14

203

607

Suppurative and necrotic conditions of lower respiratory tract

192

4.45

33.12

1.4

1.2

2.89

2.94

g/l

0.07

138

Atrial fibrillation and flutter with reimbursement

225

563

2.54

33.09

1.4

2.70

3.14

g/l

2.70

157

405

Postviral fatigue syndrome

12.92

32.99

2.0

1.4

3.12

3.06

g/l

0.04

Other symptoms and signs involving the digestive system and abdomen

167

606

2.79

32.91

1.4

1.3

2.70

2.89

g/l

0.63

110

461

Drug-induced osteoporosis

9.58

32.88

2.3

1.4

2.43

2.65

g/l

0.28

Venous thromboembolism

474

2517

1.83

32.87

1.5

1.4

2.78

2.94

g/l

1.10

344

1808

Rotator cuff syndrome

520

1994

1.81

32.81

1.4

2.95

3.01

g/l

0.25

394

1395

Congenital malformations of the respiratory system, including avohilmo

6.79

32.80

1.5

1.4

2.51

2.54

g/l

0.04

Continuous positive airway pressure

172

518

2.80

32.69

1.4

1.3

2.53

3.10

g/l

3.49

156

385

Pain in thoracic spine

167

610

2.78

32.54

1.4

1.3

2.84

3.05

g/l

0.87

129

428

Thrombocytopenia, unspecified

100

269

3.81

32.49

1.7

1.3

2.69

2.94

g/l

0.68

193

Other disorders of urethra and urinary system

628

2582

1.70

32.31

1.4

2.76

2.98

g/l

2.59

447

1893

Conjunctivitis (acute, non atopic), including avohilmo

901

3494

1.56

32.26

1.5

1.4

2.87

2.99

g/l

1.13

675

2467

Disorders of skin appendages

499

2802

1.78

32.22

1.3

1.4

3.10

2.92

g/l

1.38

374

2026

COPD, hospital admissions 1, only main diagnosis

290

1159

2.17

32.18

1.3

1.4

2.55

2.97

g/l

3.81

214

824

Bacterial intestinal infections, IBD co-morbidities

198

792

2.53

32.15

1.4

1.3

2.76

2.90

g/l

0.50

147

567

Somatoform disorder

188

737

2.59

31.87

1.4

1.3

2.99

2.90

g/l

0.26

138

513

Sequelae with surgical and medical care as external cause

219

924

2.40

31.69

1.5

1.4

2.83

2.93

g/l

0.35

165

650

Systemic lupus erythematosus

113

5.59

31.66

1.5

1.3

2.74

2.81

g/l

0.10

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

625

3423

1.67

31.63

1.4

2.87

2.94

g/l

0.49

449

2474

Migraine with aura and triptan purchases

197

793

2.52

31.61

1.4

2.96

3.00

g/l

0.11

152

578

Other/unspecified seropositive rheumatoid arthritis

256

1156

2.24

31.56

1.5

1.4

2.61

2.86

g/l

1.55

200

823

Secondary hypertension

243

3.88

31.43

1.3

1.2

2.63

3.10

g/l

1.35

178

Adalimumab

143

492

2.97

31.29

1.3

1.4

3.33

2.98

g/l

1.23

101

356

Iridocyclitis

244

1086

2.27

31.19

1.5

1.4

2.97

2.94

g/l

0.10

180

781

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

253

1147

2.23

30.91

1.5

1.4

2.58

2.88

g/l

2.32

197

817

Polyneuropathies and other disorders of the peripheral nervous system

220

942

2.36

30.79

1.4

2.74

2.95

g/l

0.96

167

682

Hypo-osmolality and hyponatraemia

178

686

2.61

30.67

1.4

2.77

2.92

g/l

0.50

111

493

Symptoms and signs involving cognition, perception, emotional state and behaviour

868

3756

1.55

30.60

1.4

2.91

2.96

g/l

0.40

630

2720

Paralytic ileus and intestinal obstruction

230

1005

2.31

30.57

1.4

2.77

2.99

g/l

1.08

158

713

Other bacterial intestinal infections, including avohilmo

237

1052

2.28

30.47

1.3

2.83

2.95

g/l

0.49

178

751

Other and unspecified polyneuropathies, also in other diseases

195

795

2.49

30.45

1.4

2.72

2.96

g/l

1.10

149

578

Congenital malformations, deformations and chromosomal abnormalities

569

3203

1.69

30.41

1.5

1.4

2.81

2.95

g/l

1.18

409

2322

Cervicobrachial syndrome

218

935

2.36

30.36

1.6

1.3

3.02

3.05

g/l

0.09

173

657

Alcohol-induced chronic pancreatitis

259

3.77

30.35

1.3

3.11

2.96

g/l

0.28

189

Deviated nasal septum

285

1362

2.11

30.29

1.3

1.4

2.91

3.06

g/l

0.67

199

919

Congenital malformations of the respiratory system

6.91

30.17

1.5

1.4

2.44

2.54

g/l

0.12

Disorders of lens

575

2084

1.72

30.17

1.4

2.79

2.96

g/l

1.48

410

1547

Temporal arteritis

6.08

30.10

1.2

1.5

2.71

2.73

g/l

0.02

Pericarditis

5.85

30.03

1.4

1.2

2.70

3.19

g/l

0.94

Factors influencing health status and contact with health services

219

437

2.53

29.96

1.3

1.4

2.91

3.13

g/l

0.89

161

291

Other Crohn's disease

103

299

3.53

29.93

1.2

1.3

3.42

3.01

g/l

1.10

217

Non-follicular lymphoma

112

343

3.33

29.87

1.5

1.4

2.10

3.02

g/l

6.08

249

Nonorganic sleeping disorders, excluding more controls

218

942

2.34

29.86

1.4

2.97

3.08

g/l

0.42

157

669

Gout, FINNGEN

239

1069

2.24

29.61

1.4

2.60

3.08

g/l

4.22

165

762

Other specified/unspecified inflammatory spondylopathies

171

4.45

29.60

1.6

1.4

3.00

3.01

g/l

0.02

121

Migraine without aura and triptan purchases

199

831

2.43

29.52

1.4

2.93

3.01

g/l

0.28

151

607

Paroxysmal tachycardia

206

714

2.42

29.34

1.5

1.3

3.06

3.08

g/l

0.08

145

507

Use of hypnotics and sedatives

938

3541

1.52

29.34

1.4

2.79

3.02

g/l

3.86

683

2543

COPD-related respiratory insufficiency

117

372

3.19

29.28

1.4

2.31

3.09

g/l

5.19

273

Disorders of oesophagus in diseases classified elsewhere

7.79

29.08

1.5

1.2

3.23

2.73

g/l

0.69

Non-Hodgkin lymphoma, all

111

5.36

28.99

1.5

1.4

2.44

3.09

g/l

1.32

Other diseases of lip and oral mucosa

408

2244

1.83

28.89

1.4

2.79

2.92

g/l

0.82

309

1615

Other (seronegative) rheumatoid arthritis, wide

191

791

2.45

28.85

1.5

1.4

2.60

2.86

g/l

1.24

145

560

Cervical disc disorders

310

1559

2.00

28.79

1.4

2.80

3.05

g/l

1.90

220

1105

Other arthrosis

432

1584

1.84

28.79

1.3

1.4

2.95

3.01

g/l

0.30

314

1126

Sequelae of external causes of morbidity and mortality

259

1222

2.14

28.66

1.5

1.4

2.76

2.93

g/l

0.83

193

869

Other ulcerative colitis

233

3.83

28.53

1.4

1.3

3.21

3.01

g/l

0.38

165

Dentofacial anomalies [including malocclusion]

673

3296

1.61

28.36

1.4

3.00

2.92

g/l

0.61

474

2402

Glomerulonephritis

122

407

3.06

28.22

1.8

1.4

2.60

2.95

g/l

1.08

299

Giant cell arteritis with polymyalgia rheumatica

5.70

28.17

1.2

1.5

2.71

2.82

g/l

0.14

Other skin changes

202

868

2.36

28.10

1.7

1.3

2.83

2.87

g/l

0.10

151

608

Other encephalitis

5.82

28.07

1.3

3.12

2.89

g/l

0.21

Zoster [herpes zoster]

187

777

2.44

28.05

1.5

1.4

2.40

2.90

g/l

4.00

147

552

Vasculitis limited to skin, not elsewhere classified

6.24

27.85

1.5

1.2

2.63

2.95

g/l

0.43

Cirrhosis of liver, NAS

188

4.15

27.83

1.3

3.28

2.88

g/l

0.83

133

Other arrhythmias

555

2478

1.68

27.80

1.4

2.95

2.98

g/l

0.17

387

1802

Other anxiety disorders

456

2213

1.76

27.78

1.4

1.3

2.93

2.98

g/l

0.27

363

1574

Insulin, combination of fast acting with intermediate-acting or long-acting

536

2910

1.68

27.66

1.5

1.4

2.84

2.97

g/l

0.91

360

2106

Follow-up examination after treatment for conditions other than malignant neoplasms

330

1116

1.98

27.48

1.4

1.3

2.83

3.00

g/l

0.99

257

700

Acute and subacute iridocyclitis

203

884

2.33

27.41

1.5

1.3

2.98

2.94

g/l

0.11

146

637

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

162

637

2.58

27.40

1.4

3.41

2.95

g/l

1.67

111

466

Exposure to unspecified factor

910

4156

1.49

27.25

1.4

2.78

2.97

g/l

2.54

598

3061

Disorders of the thyroid gland

815

3463

1.53

27.21

1.5

1.4

2.98

2.95

g/l

0.14

566

2541

Pneumococcal septicemia

118

5.09

27.16

1.5

1.3

2.33

2.86

g/l

1.11

Mixed connective tissue disease

8.39

27.10

1.7

1.3

2.68

2.77

g/l

0.08

Obesity and other hyperalimentation

597

3477

1.62

27.07

1.4

2.82

2.98

g/l

1.53

438

2537

Non-rheumatic valve diseases

383

1475

1.86

27.07

1.5

1.4

2.78

2.95

g/l

0.96

265

1067

Valvular heart disease excluding rheumatic fever

386

1493

1.86

26.98

1.5

1.4

2.77

2.94

g/l

0.96

267

1082

Viral pneumonia (known virus, not influenza)

5.91

26.96

1.5

1.3

2.38

2.79

g/l

0.57

Systemic sclerosis (FG)

6.93

26.95

1.3

2.86

2.82

g/l

0.04

Obesity

593

3460

1.62

26.86

1.4

2.82

2.98

g/l

1.44

434

2527

Pain and other conditions associated with female genital organs and menstrual cycle

212

781

2.29

26.80

1.4

2.90

2.92

g/l

0.04

158

564

Insulin medication

536

2676

1.67

26.75

1.5

1.4

2.84

2.96

g/l

0.76

360

1941

GI-bleeding

272

1342

2.04

26.68

1.4

2.98

2.95

g/l

0.09

191

967

Papulosquamous disorders

371

2033

1.84

26.64

1.5

1.4

3.09

2.89

g/l

1.25

277

1452

Encephalitis

105

5.34

26.64

1.3

3.07

2.86

g/l

0.19

Hypoparathyroidism

117

5.03

26.41

2.4

1.4

2.59

2.93

g/l

0.56

158

625

2.56

26.39

1.6

1.4

2.87

3.00

g/l

0.32

433

Presence of other functional implants

487

1946

1.72

26.29

1.4

2.79

2.95

g/l

1.11

290

1443

Anterior Iridocyclitis

212

959

2.24

26.17

1.5

1.3

2.96

2.94

g/l

0.06

153

688

L04AC Interleukin inhibitors

296

3.36

26.14

1.4

1.3

3.04

2.99

g/l

0.09

208

Multiple myeloma

6.21

26.08

1.3

1.71

2.90

g/l

1.60

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

6.21

26.08

1.3

1.71

2.90

g/l

1.60

Hypokalaemia

133

487

2.77

25.94

1.6

1.3

2.61

2.98

g/l

1.44

351

Ulcerative colitis (strict definition, require KELA)

193

843

2.32

25.93

1.3

1.4

2.89

2.98

g/l

0.29

125

607

Adverse effects, not elsewhere classified

220

1015

2.19

25.87

1.6

1.3

2.63

2.95

g/l

2.35

169

740

Convulsions, not elsewhere classified

203

894

2.26

25.79

1.4

1.3

2.74

3.06

g/l

1.54

149

633

Lung cancer and mesothelioma

112

310

3.09

25.71

1.2

1.3

2.67

3.01

g/l

1.07

209

Asthma mixed form (mode), excluding more controls

5.67

25.70

1.5

1.3

2.63

3.36

g/l

1.79

Other or unspecified ileus, impaction or obstruction

166

680

2.47

25.67

1.3

1.4

2.64

3.02

g/l

1.92

108

484

Other viral diseases, including avohilmo

386

2143

1.80

25.66

1.5

1.3

2.65

2.97

g/l

3.31

290

1552

Gastroduodenal ulcer

202

901

2.25

25.51

1.4

3.09

2.94

g/l

0.47

134

637

Arthrosis

551

1814

1.67

25.49

1.3

1.4

2.97

3.01

g/l

0.21

402

1288

Otitis media, unspecified

136

464

2.74

25.47

1.4

1.3

2.74

2.94

g/l

0.66

100

355

Other and unspecified vasculitis limited to skin

6.19

25.32

1.4

1.2

2.67

2.95

g/l

0.32

Other specified/unspecified soft tissue disorders

129

4.67

25.28

1.5

1.3

2.85

2.92

g/l

0.09

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

187

815

2.33

25.27

1.3

1.4

2.88

2.98

g/l

0.31

122

590

Other enthesopathies

267

1336

2.01

25.22

1.7

1.4

2.82

2.99

g/l

0.72

207

952

Non-selective monoamine reuptake inhibitors

325

1664

1.89

25.22

1.5

1.4

2.69

2.96

g/l

2.37

229

1210

Unknown and unspecified causes of morbidity

220

3.70

25.21

1.3

2.67

3.10

g/l

1.65

170

Hypogonadotropic hypogonadism

130

4.71

25.18

1.2

1.3

3.15

3.12

g/l

0.02

Agranulocytosis

129

473

2.77

25.15

1.4

1.3

2.43

2.90

g/l

2.13

339

Seronegative rheumatoid arthritis

112

380

2.99

25.13

1.4

1.3

2.68

2.86

g/l

0.37

261

Atopic dermatitis

542

2654

1.63

24.73

1.4

2.92

2.94

g/l

0.13

418

1930

Other diseases of urinary system

837

3143

1.50

24.69

1.4

2.87

2.99

g/l

1.14

583

2315

Disorders of parathyroid gland

182

782

2.32

24.62

1.8

1.3

2.58

2.88

g/l

1.39

129

551

Nonalcoholic fatty liver disease

135

513

2.68

24.59

1.3

1.4

2.98

2.95

g/l

0.08

367

Thyroiditis, ILD-related definition

127

468

2.76

24.51

1.5

1.3

2.92

2.89

g/l

0.07

347

Heart failure and coronary heart disease

320

1181

1.91

24.31

1.3

1.4

2.65

2.99

g/l

2.57

234

810

Cervicalgia

190

847

2.27

24.29

1.7

1.4

3.05

3.07

g/l

0.06

146

596

Psoriatic and enteropathic arthropathies

123

448

2.79

24.26

1.3

2.85

3.01

g/l

0.45

316

Asthma mixed form (mode)

5.36

24.20

1.5

1.3

2.63

3.31

g/l

1.69

Other inflammation of eyelid

153

623

2.49

24.09

1.5

1.3

3.19

2.88

g/l

0.93

112

451

Hypothyroidism, other/unspecified

745

3235

1.52

24.09

1.4

3.01

2.96

g/l

0.30

518

2376

Other and unspecified effects of external causes

281

1457

1.95

24.04

1.5

1.3

2.75

2.94

g/l

1.15

214

1048

Cystitis

707

2737

1.54

23.99

1.4

2.87

2.97

g/l

0.77

513

2015

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

109

375

2.96

23.94

1.5

1.3

2.49

3.01

g/l

2.47

272

Dermatitis due to substances taken internally

187

3.88

23.87

1.5

2.40

2.95

g/l

1.53

139

Secondary right heart disease

112

4.85

23.71

1.3

2.43

2.90

g/l

1.17

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

197

903

2.21

23.61

1.3

1.4

2.90

2.98

g/l

0.25

128

653

Diseases of spleen

6.92

23.60

1.8

1.3

2.72

2.91

g/l

0.20

Other diseases of the digestive system

263

1342

1.97

23.55

1.4

3.00

2.94

g/l

0.18

187

970

Emphysema

184

3.87

23.54

1.2

1.3

2.63

2.98

g/l

0.78

134

Other and unspecified urticaria

211

995

2.15

23.52

1.5

1.3

2.69

2.94

g/l

1.38

156

712

Cutaneous abscess, furuncle and carbuncle

261

1330

1.98

23.51

1.3

2.89

3.00

g/l

0.50

199

956

Other pulmonary heart/vessel disease

133

4.47

23.48

1.4

1.2

2.46

2.86

g/l

1.05

101

Myocarditis

137

4.39

23.45

1.5

1.2

2.76

3.10

g/l

0.79

Recurrent aphthous stomatitis , including avohilmo

161

680

2.40

23.42

1.4

2.97

2.88

g/l

0.28

132

492

Acute tubulo-interstitial nephritis

524

2741

1.62

23.42

1.4

2.64

2.99

g/l

4.23

379

2008

Migraine, single triptan purchase ok & required. ICD-code if available is included

693

3079

1.53

23.33

1.4

2.98

2.91

g/l

0.39

498

2232

Triptan medication for migraine, single purchase ok

693

3079

1.53

23.33

1.4

2.98

2.91

g/l

0.39

498

2232

Triptan medication for migraine, min. 3 purchases

531

2459

1.62

23.30

1.4

2.96

g/l

0.03

396

1787

Hernia

799

3586

1.49

23.27

1.4

2.87

2.96

g/l

0.67

581

2565

Psychiatric diseases

819

2753

1.50

23.26

1.3

1.4

2.81

2.99

g/l

2.20

583

1986

Stomatitis and related lesions

210

993

2.14

23.25

1.4

2.88

2.92

g/l

0.13

171

714

Acute laryngitis and tracheitis

128

479

2.66

23.15

1.3

2.98

2.99

g/l

0.02

332

Chronic gastritis

210

995

2.13

23.06

1.3

1.4

2.87

2.90

g/l

0.08

170

709

Systemic sclerosis

5.90

23.06

1.3

2.86

2.83

g/l

0.04

Non-ischemic cardiomyopathy

254

1010

2.01

22.93

1.4

2.96

g/l

0.01

180

707

Diseases of arteries, arterioles and capillaries

528

2403

1.62

22.93

1.4

2.77

2.97

g/l

1.87

383

1712

Persons with potential health hazards related to communicable diseases

375

2143

1.75

22.70

1.4

2.69

2.95

g/l

1.84

235

1586

Dizziness and giddiness

641

3252

1.54

22.67

1.4

2.97

2.94

g/l

0.12

466

2363

Haemorrhoids and perianal venous thrombosis

277

1450

1.91

22.49

1.3

1.4

2.80

3.01

g/l

1.45

192

1033

Glomerular disorders in diseases classified elsewhere

122

461

2.69

22.47

1.5

1.4

2.37

3.09

g/l

4.19

337

Pyothorax

138

4.31

22.42

1.4

1.3

2.83

2.92

g/l

0.13

Hypothyreosis and Thyroxine purchase for inclusion criteria

768

3395

1.49

22.42

1.4

2.99

2.95

g/l

0.26

533

2492

Symptoms and signs involving the urinary system

643

3171

1.54

22.40

1.5

1.4

2.93

2.94

g/l

0.04

468

2276

Other symptoms and signs involving the circulatory and respiratory systems

196

3.68

22.28

1.5

1.3

2.77

3.07

g/l

0.68

143

Other inflammation of eyelid, including avohilmo

409

2432

1.69

22.17

1.4

3.00

2.95

g/l

0.20

301

1762

Diabetes mellitus

877

3508

1.45

21.91

1.4

2.92

2.95

g/l

0.23

606

2567

Lymphoid leukaemia

185

3.76

21.87

1.5

1.2

1.87

2.79

g/l

4.39

137

Other viral diseases, not elsewhere classified

202

961

2.12

21.85

1.5

1.4

2.57

2.89

g/l

2.11

156

711

Other abnormal immunological findings in serum

5.87

21.82

1.7

1.3

3.76

2.91

g/l

1.32

Subjective visual disturbances

241

1228

1.98

21.77

1.5

1.3

2.80

2.91

g/l

0.42

181

864

Deforming dorsopathies

242

1234

1.98

21.75

1.5

1.4

2.75

2.98

g/l

1.28

185

875

6-mercaptopurine

5.17

21.72

2.1

1.2

2.55

2.97

g/l

0.75

Benign neoplasm: Transverse colon

115

430

2.72

21.65

1.6

1.4

2.73

3.00

g/l

1.06

308

Obesity due to excess calories

440

2685

1.65

21.61

1.3

1.4

2.85

2.97

g/l

0.78

319

1953

Other viral diseases

298

1626

1.84

21.58

1.5

1.3

2.60

2.93

g/l

2.87

225

1184

Care involving dialysis

316

3.03

21.57

1.4

2.25

3.08

g/l

4.21

234

Other diseases of hard tissues of teeth

432

1315

1.71

21.52

1.4

1.3

2.95

2.99

g/l

0.14

305

927

Other medical care

408

2037

1.69

21.45

1.3

1.4

2.72

2.96

g/l

1.77

289

1469

Gonarthrosis [arthrosis of knee](FG)

530

1904

1.61

21.43

1.4

1.3

2.94

3.02

g/l

0.55

395

1342

Dermatographic urticaria

286

3.14

21.43

1.8

1.4

2.87

2.97

g/l

0.25

205

Other disorders of eye and adnexa

158

690

2.32

21.35

1.4

2.84

2.91

g/l

0.21

123

491

Diabetes, varying definitions

869

3503

1.44

21.32

1.4

2.91

2.95

g/l

0.27

598

2563

Other viral diseases, not elsewhere classified, including avohilmo

278

1486

1.88

21.31

1.4

2.65

2.93

g/l

2.08

216

1079

Bronchitis, not specified as acute or chronic

271

3.18

21.31

1.6

1.3

2.78

2.97

g/l

0.56

193

Total colectomy operation

148

4.09

21.30

1.6

1.3

2.99

2.88

g/l

0.15

108

Total colectomy

148

4.09

21.30

1.6

1.3

2.99

2.88

g/l

0.15

108

Insulin, fast-acting

320

1797

1.79

21.27

1.5

1.3

2.79

2.98

g/l

1.12

220

1304

Ovarian cyst

296

897

1.90

21.24

1.3

1.4

2.80

2.84

g/l

0.16

216

633

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

806

3509

1.46

21.12

1.4

2.97

g/l

0.01

563

2549

Chronic iridocyclitis

172

3.81

20.97

1.5

1.3

3.03

2.97

g/l

0.08

129

Idiopathic thrombocytopenic purpura

108

4.69

20.92

1.4

1.3

2.73

2.82

g/l

0.12

Soft tissue disorders related to use, overuse and pressure

232

1183

1.98

20.90

1.4

2.85

2.97

g/l

0.52

179

836

Other metabolic disorders

144

610

2.39

20.87

1.7

1.3

2.84

3.00

g/l

0.39

100

437

Lung diseases due to external agents

122

480

2.57

20.70

1.3

2.67

2.94

g/l

0.87

361

Volume depletion

318

2.96

20.67

1.3

2.47

2.95

g/l

1.72

221

Heart failure and bmi 25plus

257

885

1.95

20.62

1.4

2.65

2.93

g/l

1.37

171

587

Other diseases of stomach and duodenum

202

3.53

20.62

1.4

1.3

2.74

2.93

g/l

0.38

147

Intestinal stricture

264

1416

1.88

20.45

1.4

2.87

2.92

g/l

0.15

185

1009

Crohn's disease of small intestine

295

3.04

20.33

1.3

3.34

2.95

g/l

0.95

216

Extracorporeal dialysis

229

3.35

20.28

1.5

1.3

2.03

2.86

g/l

3.95

167

Selective serotonin reuptake inhibitors

815

2929

1.45

20.20

1.4

2.87

3.02

g/l

1.53

584

2127

Viral infections of the central nervous system, including avohilmo

324

2.92

20.06

1.4

2.67

3.00

g/l

0.67

231

Type 2 diabetes

817

3289

1.44

20.06

1.4

2.92

2.98

g/l

0.36

570

2392

Enthesopathies of lower limb, excluding foot

203

1003

2.04

20.03

1.4

1.3

2.78

3.05

g/l

1.47

157

707

Conjunctivitis (acute, non atopic)

272

1477

1.85

20.00

1.4

1.3

2.82

2.91

g/l

0.28

207

1070

Secondary and unspecified malignant neoplasm of lymph nodes

303

2.99

19.99

1.4

2.33

2.97

g/l

1.97

220

Internal derangement of knee

297

1647

1.80

19.93

1.5

1.4

2.92

3.01

g/l

0.45

207

1180

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

5.51

19.86

1.4

1.3

2.62

2.88

g/l

0.43

Viral infections of the central nervous system

292

3.00

19.44

1.4

2.54

3.01

g/l

1.54

204

Behavioural syndromes associated with physiological disturbances and physical factors

809

3843

1.43

19.43

1.3

1.4

3.00

2.93

g/l

0.46

585

2784

Type 2 diabetes, wide definition

586

2428

1.53

19.41

1.5

1.4

2.82

2.96

g/l

1.03

439

1819

Diseases of tongue

191

3.51

19.36

1.6

1.3

2.84

3.04

g/l

0.38

138

Acute pharyngitis

145

631

2.30

19.26

1.3

1.4

2.86

2.98

g/l

0.38

100

444

Pruritus

116

462

2.54

19.25

1.6

1.4

2.94

2.86

g/l

0.18

335

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

784

3242

1.44

19.13

1.4

2.88

2.94

g/l

0.35

540

2367

Insulin, fast-acting or short human

321

1862

1.73

19.13

1.5

1.3

2.80

2.98

g/l

1.06

221

1345

Other diseases of intestine

139

603

2.33

19.09

1.4

2.89

2.99

g/l

0.17

424

Hyperkinetic disorders, excluding more controls

141

571

2.33

19.09

1.3

2.79

3.03

g/l

1.00

110

408

Sleep disorders

778

3751

1.43

19.06

1.3

1.4

3.02

2.94

g/l

0.60

561

2707

SLE, ICD10

134

4.08

19.00

1.6

1.4

2.64

2.88

g/l

0.35

103

SLE, strict definition

134

4.08

19.00

1.6

1.4

2.64

2.88

g/l

0.35

103

Seropositive rheumatoid arthritis, strict definition

144

637

2.29

18.93

1.5

1.3

2.65

2.92

g/l

1.28

111

450

Atopic dermatitis, strict definition

295

1641

1.77

18.82

1.4

2.81

2.92

g/l

0.59

228

1185

Other and unspecified types of non-Hodgkin lymphoma, hilmo

126

4.15

18.81

1.6

1.3

2.31

2.80

g/l

0.91

Coxibs

220

571

2.03

18.77

1.3

2.99

3.10

g/l

0.34

157

406

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

122

4.21

18.76

1.5

1.3

2.90

2.94

g/l

0.04

Ocular pain

102

387

2.68

18.75

1.5

3.06

2.97

g/l

0.23

279

Panniculitis, unspecified

16.06

18.74

1.4

2.89

3.10

g/l

0.15

Systemic sclerosis, icd10

4.84

18.61

1.3

2.86

2.80

g/l

0.08

Insomnia

764

3731

1.43

18.50

1.3

1.4

3.04

2.94

g/l

0.86

552

2693

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.57

18.47

1.4

1.3

2.56

2.85

g/l

0.48

Ascites

222

3.25

18.45

1.3

1.2

2.77

3.05

g/l

0.52

166

Other disorders of ear

764

3460

1.43

18.42

1.5

1.4

2.88

2.94

g/l

0.45

556

2513

Insulin, intermediate and long-acting

443

2715

1.58

18.39

1.4

2.84

2.97

g/l

0.77

303

1967

Localized swelling, mass and lump of skin and subcutaneous tissue

279

1575

1.78

18.36

1.7

1.3

2.88

2.92

g/l

0.14

234

1120

Excessive, frequent and irregular menstruation

313

941

1.79

18.33

1.4

1.3

2.83

2.86

g/l

0.10

217

670

Cluster headache, strict

120

4.18

18.29

1.2

1.3

2.71

3.12

g/l

0.86

Genitourinary diseases

473

1489

1.60

18.28

1.3

2.94

2.99

g/l

0.27

350

1063

Heartburn

104

403

2.61

18.27

1.4

1.3

2.66

3.06

g/l

1.79

294

Abnormal findings on diagnostic imaging of central nervous system

189

3.46

18.27

1.6

1.4

3.02

2.98

g/l

0.05

141

Coronary atherosclerosis

478

1920

1.58

18.26

1.4

2.74

2.96

g/l

2.08

350

1367

Other infectious diseases, including avohilmo

341

2.77

18.26

1.4

1.3

2.95

3.01

g/l

0.12

247

Gout, idiopatic and unspecified

199

1011

1.98

18.22

1.4

2.59

3.04

g/l

3.40

135

734

Radiculopathy

132

572

2.33

18.19

1.4

1.3

2.85

3.09

g/l

0.91

411

Malignant neoplasm of pancreas, including Hilmo

276

2.98

18.18

1.6

1.4

3.17

2.96

g/l

0.60

203

Meniscus derangement

403

1641

1.64

18.12

1.3

1.4

3.00

3.02

g/l

0.05

269

1163

Exposure to other specified factors

697

4173

1.44

18.09

1.5

1.4

2.86

2.95

g/l

0.79

520

3005

Rare circulating lymphoid malignancy, including Hilmo

4.70

18.07

1.9

1.2

1.94

2.75

g/l

2.05

Other CVD (FINNGEN)

261

2.80

18.03

1.4

1.3

2.87

3.08

g/l

0.39

179

Chronic apical periodontitis

927

3769

1.38

17.91

1.4

2.93

2.97

g/l

0.25

645

2739

Panhypopituitarism

5.83

17.89

1.9

1.3

2.77

2.86

g/l

0.09

Gastric ulcer

135

596

2.28

17.81

1.4

3.04

2.95

g/l

0.17

426

Senile cataract

472

1831

1.57

17.78

1.4

2.78

2.95

g/l

1.28

338

1364

Other and unspecified drugs and medicaments

352

2.71

17.75

1.4

2.59

2.97

g/l

1.29

256

Other cataract

345

1531

1.68

17.65

1.5

1.4

2.90

2.94

g/l

0.13

246

1141

Psoriasis

254

1412

1.81

17.64

1.3

1.4

3.20

2.95

g/l

1.28

188

1012

Cluster headache, wide

128

3.99

17.59

1.2

1.3

2.68

3.08

g/l

0.85

Ehlers-Danlos syndrome, including avohilmo

6.31

17.51

1.4

1.3

2.54

2.92

g/l

0.55

Ulcerative enterocolitis

107

4.32

17.49

1.4

1.3

3.05

3.02

g/l

0.03

Viral and other specified intestinal infections, including avohilmo

261

1409

1.79

17.45

1.5

1.3

2.78

2.97

g/l

1.29

191

1018

Gonarthrosis

452

1614

1.59

17.45

1.3

1.4

2.93

3.00

g/l

0.39

335

1151

Fissure and fistula of anal and rectal regions

199

1028

1.95

17.38

1.3

1.4

3.01

g/l

0.01

135

732

Type 2 diabetes, definitions combined

763

3134

1.42

17.37

1.5

1.4

2.91

2.97

g/l

0.33

535

2284

Other meningitis

5.98

17.25

1.6

1.3

2.74

2.84

g/l

0.13

Misadventures to patients during surgical and medical care

135

606

2.25

17.18

1.5

1.3

3.00

2.98

g/l

0.03

438

Hepatic failure, not elsewhere classified

113

4.17

17.12

1.4

1.3

3.01

2.73

g/l

0.40

Disorders of ocular muscles, binocular movement, accommodation and refraction

430

2739

1.56

17.11

1.5

1.4

3.03

2.88

g/l

0.99

317

1989

Reactive arthropathies, FINNGEN

259

2.98

17.11

1.4

1.3

3.09

2.97

g/l

0.20

182

Other infectious diseases

270

2.93

17.07

1.5

1.3

2.88

2.97

g/l

0.15

201

Abscess of lung

5.88

16.96

1.3

1.4

3.06

2.79

g/l

0.23

Diffuse large B-cell lymphoma

150

3.67

16.92

1.5

2.07

2.99

g/l

3.03

115

Diffuse large B-cell lymphoma, helper endpoint

150

3.67

16.92

1.5

2.07

2.99

g/l

3.03

115

Diffuse large B-cell lymphoma, including Hilmo

150

3.67

16.92

1.5

2.07

2.99

g/l

3.03

115

Nonorganic sleeping disorders

218

1172

1.88

16.91

1.4

2.97

g/l

0.02

157

837

Ulcerative ileocolitis

155

3.64

16.91

1.3

2.94

3.06

g/l

0.20

113

Inflammatory diseases of female pelvic organs

525

2388

1.51

16.86

1.4

2.82

2.90

g/l

0.56

387

1746

Congenital malformations and deformations of the musculoskeletal system

110

454

2.45

16.81

1.6

1.4

2.83

2.64

g/l

0.65

353

Other abnormalities of plasma proteins

6.68

16.78

2.1

1.4

2.66

2.94

g/l

0.27

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

5.60

16.77

1.5

1.2

3.25

2.83

g/l

0.49

Type 2 diabetes, strict (exclude DM1)

766

3172

1.41

16.69

1.5

1.4

2.91

2.97

g/l

0.37

538

2302

Keratitis

311

1860

1.68

16.68

1.5

1.4

3.02

2.94

g/l

0.32

217

1331

Polyarthritis, unspecified

111

4.15

16.66

1.8

1.4

2.73

3.01

g/l

0.46

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

130

579

2.26

16.65

1.5

1.4

3.03

2.71

g/l

1.48

442

Chronic nephritic syndrome

134

3.82

16.54

2.0

1.3

2.74

2.92

g/l

0.23

Substance abuse, excluding more controls

441

2389

1.55

16.44

1.3

1.4

2.79

3.06

g/l

2.41

305

1696

Diabetes medication

858

3646

1.38

16.43

1.4

2.91

2.95

g/l

0.24

600

2664

Crohn's disease NAS

266

2.91

16.35

1.2

1.3

3.12

2.93

g/l

0.34

194

Crohn's disease of large intestine

203

3.22

16.34

1.3

2.82

3.01

g/l

0.36

149

Missing teeth due to accident, extraction or parodontitis

494

2942

1.51

16.32

1.5

1.4

2.83

2.94

g/l

0.76

356

2118

Obesity, other/unspecified

306

1836

1.68

16.24

1.5

1.4

2.83

2.98

g/l

0.85

246

1326

Brachial plexus disorders

104

428

2.47

16.21

1.5

1.4

3.12

2.98

g/l

0.34

304

Dental operations

435

1420

1.58

16.21

1.4

2.98

g/l

0.00

310

1033

Other diseases of oesophagus

306

2.75

16.15

1.2

1.3

2.93

2.96

g/l

0.08

220

Exclusions for E4_PCOS_CONSORTIUM

619

2671

1.45

16.08

1.5

1.4

2.77

2.92

g/l

1.42

394

1989

Cardiomyopathy

137

636

2.17

16.03

1.3

2.92

3.08

g/l

0.48

101

468

Acute generalized exanthematous pustulosis

171

3.41

15.94

1.5

1.3

2.29

2.91

g/l

1.81

125

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

396

2.51

15.89

1.4

2.63

2.94

g/l

1.00

295

Ischaemic heart disease, wide definition

588

2482

1.46

15.89

1.5

1.4

2.82

2.96

g/l

1.22

423

1778

Oxicams

176

490

2.05

15.82

1.3

2.99

3.13

g/l

0.45

136

349

Other/unspecified rheumatoid arthritis

106

445

2.41

15.80

1.6

1.4

2.54

2.84

g/l

1.05

312

Complications of internal orthopaedic prosthetic devices, implants and grafts

173

882

1.98

15.76

1.4

2.81

2.90

g/l

0.27

124

631

Gout, unspecified

161

802

2.02

15.68

1.4

2.56

3.03

g/l

3.04

111

591

Pneumothorax

208

3.12

15.66

1.3

2.63

3.10

g/l

1.30

156

Trochanteric bursitis

125

566

2.23

15.61

1.6

1.4

2.80

2.88

g/l

0.19

402

Invasive ventilation

273

2.83

15.59

1.3

1.96

2.93

g/l

6.13

203

Diseases of oral cavity, salivary glands and jaws

405

1315

1.59

15.58

1.4

1.3

2.96

2.99

g/l

0.13

296

927

Chronic ulcer of skin, not elsewhere classified

214

3.08

15.56

1.9

1.4

3.15

3.06

g/l

0.11

157

Postprocedural disorders of nervous system

307

2.71

15.55

1.5

1.4

2.89

2.99

g/l

0.16

227

Haemolytic anaemias

117

3.94

15.55

1.6

1.3

2.34

2.65

g/l

0.44

Injuries to the knee and lower leg

977

3948

1.34

15.53

1.5

1.4

2.85

2.97

g/l

1.41

725

2833

Postprocedural endocrine and metabolic disorders, not elsewhere classified

122

549

2.25

15.50

1.8

1.3

2.87

3.00

g/l

0.29

397

Personality disorders, excluding more controls

215

1182

1.83

15.42

1.3

1.4

2.83

3.07

g/l

1.12

153

840

Covid-19 suspected case

204

1107

1.86

15.42

1.3

3.00

3.06

g/l

0.23

182

777

Disease of hard tissues of teeth, NOS

394

1296

1.60

15.41

1.4

1.3

3.02

3.00

g/l

0.09

268

912

Exophthalmic conditions

7.33

15.41

1.7

1.3

2.85

2.73

g/l

0.12

Other neurological diseases

557

2973

1.46

15.39

1.4

2.79

2.94

g/l

1.23

401

2136

Endocarditis

109

4.03

15.37

1.3

1.2

3.09

3.16

g/l

0.06

Disorders of mineral metabolism

332

2.63

15.34

1.3

2.67

2.99

g/l

0.77

242

Algoneurodystrophy

123

3.84

15.30

1.6

1.4

2.70

2.92

g/l

0.41

Substance use, excluding alcohol

191

1018

1.89

15.28

1.3

1.4

2.52

3.00

g/l

3.85

140

731

Acetic acid derivatives and related substances

205

552

1.93

15.22

1.5

1.3

2.84

3.11

g/l

1.31

145

391

Pleural plaque

249

2.88

15.19

1.3

2.95

3.08

g/l

0.23

188

Ulcerative colitis (strict definition, all Crohn cases excluded)

145

705

2.08

15.14

1.2

1.4

2.90

2.96

g/l

0.15

519

Cerebral cysts

218

3.03

15.11

1.8

1.3

2.93

g/l

0.00

163

Marginal zone B-cell lymphoma, including Hilmo

5.59

15.09

1.6

1.2

1.78

2.77

g/l

1.76

Small fibre neuropathy

111

3.98

15.04

1.7

1.3

2.75

2.89

g/l

0.18

Benign neoplasm: Colon, unspecified

198

1073

1.86

15.03

1.5

1.4

2.80

2.93

g/l

0.43

145

765

Autonomic disorders

4.67

15.03

1.4

1.3

2.59

2.79

g/l

0.35

Type 2 diabetes, definitions combined, including avohilmo

757

3167

1.39

15.02

1.4

2.91

2.97

g/l

0.40

527

2300

Carrier of infectious disease

4.21

15.02

1.6

1.3

2.73

2.87

g/l

0.14

Chorioretinal inflammation

4.19

14.99

1.5

1.3

3.16

2.76

g/l

0.51

Reactive arthropathies

336

2.59

14.98

1.4

3.08

3.06

g/l

0.04

236

Nephrotic syndrome

116

3.90

14.94

1.9

1.3

2.25

2.50

g/l

0.38

Retention of urine

255

1194

1.74

14.92

1.5

1.4

2.84

2.97

g/l

0.51

177

850

STROKE

418

1829

1.54

14.91

1.3

1.4

2.75

2.99

g/l

2.22

308

1310

Diabetes, insulin treatment (Kela reimbursement)

811

3540

1.37

14.88

1.4

2.88

2.94

g/l

0.37

563

2578

Ankylosing spondylitis

343

2.57

14.88

1.3

3.44

3.10

g/l

0.86

245

Disorders of muscles

397

2.45

14.82

1.3

3.02

2.93

g/l

0.19

281

Other disorders of skin and subcutaneous tissue, not elsewhere classified

127

592

2.17

14.80

1.8

1.4

2.86

2.92

g/l

0.14

426

Injuries to the abdomen, lower back, lumbar spine and pelvis

329

2028

1.61

14.79

1.3

1.4

2.92

2.93

g/l

0.04

240

1455

Generalized skin eruption due to drugs and medicaments

150

3.48

14.74

1.5

1.3

2.24

2.78

g/l

1.28

109

Etanercept

293

2.71

14.74

1.5

1.3

3.09

2.84

g/l

0.56

217

Faecal incontinence

270

2.77

14.73

1.4

1.3

2.53

2.87

g/l

0.70

191

Carpal tunnel syndrome

483

2838

1.48

14.69

1.5

1.4

2.93

2.96

g/l

0.17

363

2044

Other disorders of bone

178

941

1.91

14.63

1.5

1.3

2.85

2.94

g/l

0.25

135

687

Viral and other specified intestinal infections

191

1007

1.86

14.59

1.6

1.3

2.79

2.93

g/l

0.61

136

729

Acquired haemolytic anaemia

4.56

14.58

1.6

1.4

1.98

2.88

g/l

1.75

Disorders of optic nerve and visual pathways

413

2.41

14.55

1.6

1.4

2.70

2.90

g/l

0.51

303

Crohn disease (strict definition, require KELA, min 2 HDR)

278

2.74

14.55

1.2

1.4

3.85

3.00

g/l

2.59

199

Spondylolisthesis/Spondylolysis

146

722

2.04

14.54

1.7

1.3

2.70

3.04

g/l

1.62

108

517

Psoriatic arthropathies

407

2.41

14.52

1.3

1.4

2.98

3.10

g/l

0.28

289

Coeliac disease

116

527

2.23

14.44

1.7

1.4

2.87

2.86

g/l

0.01

383

Other and unspecified visual disturbances

106

464

2.31

14.43

1.6

1.3

3.08

2.90

g/l

0.51

328

Alcohol use disorder, Swedish definition

436

2647

1.50

14.41

1.3

1.4

2.97

3.01

g/l

0.13

275

1899

463

2795

1.49

14.38

1.3

1.4

2.95

3.00

g/l

0.21

293

2010

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.39

14.36

1.2

1.4

1.55

2.97

g/l

5.70

Chronic lymphocytic leukaemia

4.39

14.36

1.2

1.4

1.55

2.97

g/l

5.70

Chronic lymphocytic leukaemia, helper endpoint

4.39

14.36

1.2

1.4

1.55

2.97

g/l

5.70

Secondary uncertain malignant neoplasm

113

510

2.24

14.28

1.4

2.58

2.93

g/l

0.82

374

Viral warts

105

460

2.31

14.28

1.4

2.59

2.96

g/l

1.66

330

Crohn disease (strict definition, require KELA)

281

2.71

14.25

1.2

1.3

3.85

3.00

g/l

2.59

201

Coxarthrosis [arthrosis of hip](FG)

353

1537

1.59

14.23

1.3

2.88

2.99

g/l

0.57

280

1080

Postmenopausal osteoporosis with pathological fracture

179

3.17

14.13

1.3

1.4

1.94

2.82

g/l

4.84

133

Sacroiliitis, not elsewhere classified

164

3.29

14.12

1.3

1.4

3.21

2.99

g/l

0.32

115

Persons encountering health services for specific procedures, not carried out

376

2.45

14.12

1.4

2.91

3.04

g/l

0.24

271

Cardiac murmurs and other cardiac sounds

324

2.56

14.10

1.3

2.75

2.83

g/l

0.14

242

Other peripheral vascular diseases

317

2.59

14.09

1.3

1.4

2.86

2.97

g/l

0.24

234

486

2895

1.47

14.09

1.3

1.4

2.98

3.00

g/l

0.08

311

2074

Tonsillectomy and adenotomy

501

2387

1.47

14.06

1.4

1.3

2.74

3.00

g/l

3.15

389

1701

Diplopia

122

573

2.15

13.99

1.8

1.3

2.89

2.93

g/l

0.08

415

Other diseases of anus and rectum

222

1268

1.75

13.97

1.2

1.4

2.90

2.98

g/l

0.30

162

904

Unspecified kidney failure

324

2.56

13.96

1.3

2.72

3.07

g/l

0.74

240

Other bursopathies

110

498

2.23

13.81

1.5

1.3

2.96

g/l

0.01

347

Extreme obesity with alveolar hypoventilation

142

3.45

13.76

1.4

1.3

2.61

3.01

g/l

0.69

100

Otalgia

381

2.42

13.73

1.8

1.3

2.78

2.88

g/l

0.23

280

Neuralgia and neuritis, unspecified

172

3.19

13.73

1.4

1.3

2.51

2.87

g/l

0.98

123

Vascular disorders of the intestines

182

3.11

13.73

1.2

1.3

2.74

3.09

g/l

0.72

129

Cluster headache, strict, including avohilmo

209

2.97

13.71

1.3

2.72

3.01

g/l

0.71

146

Oesophagitis

157

3.30

13.70

1.4

1.2

2.75

2.96

g/l

0.34

109

Hyperlipidaemia, other/unspecified

283

1559

1.64

13.66

1.5

1.4

2.67

3.06

g/l

3.75

209

1118

Other external causes of accidental injury

655

2347

1.40

13.61

1.4

1.3

2.80

3.04

g/l

2.85

473

1707

Gout, strict definition

140

700

2.02

13.57

1.4

2.57

3.03

g/l

2.49

514

Disorders of calcium metabolism

232

2.84

13.55

1.3

1.4

2.79

3.02

g/l

0.36

172

Unspecified/other endometriosis

387

2.38

13.52

1.5

1.4

2.76

3.03

g/l

0.87

277

Erythema nodosum

4.01

13.50

1.7

1.4

2.70

2.84

g/l

0.17

Meningitis

195

3.03

13.48

1.5

1.3

2.60

3.06

g/l

1.77

143

Pyogenic arthritis

211

2.93

13.45

1.3

1.4

2.64

3.09

g/l

1.11

152

Coxarthrosis

334

1362

1.59

13.42

1.3

1.5

2.91

3.00

g/l

0.46

266

982

Other autoimmune haemolytic anaemias

6.55

13.40

1.8

1.3

1.75

2.93

g/l

1.77

Other noninfective disorders of lymphatic vessels and lymph nodes

116

3.70

13.35

1.5

1.3

2.86

2.84

g/l

0.02

Other enthesopathy of foot (+metatarsalgia)

392

2.37

13.34

1.6

1.3

2.79

2.91

g/l

0.19

278

Panic disorder

142

719

1.99

13.31

1.3

2.98

3.06

g/l

0.21

110

505

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

191

3.02

13.29

1.5

1.4

3.27

3.05

g/l

0.27

143

Falls/tendency to fall

877

3308

1.33

13.19

1.3

1.4

2.87

2.98

g/l

1.07

628

2382

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

276

1052

1.66

13.18

1.3

1.4

3.05

3.06

g/l

0.04

203

782

Acute lymphadenitis

247

2.76

13.17

1.9

1.3

2.76

2.90

g/l

0.25

184

Hypersensitivity pneumonitis due to organic dust

5.63

13.16

1.3

1.5

3.09

2.84

g/l

0.24

Cluster headache, wide,, including avohilmo

221

2.86

12.99

1.3

2.70

3.05

g/l

0.98

155

Childhood allergy (age < 16)

141

586

2.00

12.93

1.4

2.64

2.86

g/l

0.93

110

428

Hypothyroidism, strict autoimmune, 3 medication purchases required

644

3144

1.38

12.90

1.3

1.4

2.99

2.94

g/l

0.25

463

2311

Other and unspecified nerve root and plexus disorders, also in other diseases

179

988

1.83

12.90

1.5

1.3

2.91

3.04

g/l

0.40

108

701

Diseases of the myoneural junction and muscle

106

487

2.20

12.88

1.5

1.4

2.98

2.94

g/l

0.10

354

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

308

2.54

12.87

1.2

1.4

3.78

2.96

g/l

2.55

221

Raynaud syndrome

399

2.34

12.86

1.4

2.70

3.01

g/l

1.19

293

Phlebitis and thrombophlebitis (not including DVT)

183

1019

1.81

12.81

1.4

2.71

2.93

g/l

0.98

132

750

Open wound of lower leg

137

696

1.99

12.74

1.4

1.3

2.47

3.00

g/l

3.55

501

Menorrhagia

257

854

1.69

12.69

1.4

2.78

2.83

g/l

0.20

176

605

Lichen simplex chronicus and prurigo

224

2.81

12.66

1.2

1.4

2.91

2.98

g/l

0.12

166

Irregular menses

404

2040

1.49

12.66

1.5

1.4

2.78

2.95

g/l

1.59

299

1514

Benign neoplasm: Small intestine

135

3.40

12.65

1.2

1.4

3.01

2.77

g/l

0.38

Rosacea

125

617

2.05

12.62

1.4

3.43

2.89

g/l

1.77

437

Fall on same level

933

3811

1.31

12.58

1.3

1.4

2.82

2.98

g/l

2.01

680

2750

Other obstetric conditions, not elsewhere classified

280

1089

1.63

12.49

1.3

1.4

2.99

3.05

g/l

0.21

207

809

Cytomegalovirus infection, IBD co-morbidity

4.12

12.47

1.4

1.3

1.87

2.73

g/l

1.99

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

218

1269

1.71

12.46

1.2

1.3

2.69

3.07

g/l

2.65

153

910

Other and unspecified rosacea

411

2.29

12.46

1.4

3.40

2.92

g/l

1.15

295

Cardiomyopathy, other and unspecified

260

2.65

12.44

1.3

2.87

3.07

g/l

0.32

196

Benign neoplasm: Stomach

374

2.36

12.42

1.8

1.4

2.76

2.83

g/l

0.17

269

Psoriasis vulgaris

161

871

1.86

12.41

1.3

3.23

2.95

g/l

1.15

120

625

Viral warts, including avohilmo

198

1140

1.75

12.39

1.5

1.4

2.66

2.96

g/l

1.94

151

815

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

210

1066

1.73

12.34

1.3

2.69

2.97

g/l

1.89

163

773

External causes of morbidity and mortality

514

1797

1.44

12.34

1.4

1.3

2.85

3.04

g/l

1.74

373

1309

Diseases of pulp and periapical tissues, including avohilmo

820

3198

1.33

12.33

1.4

2.97

2.95

g/l

0.15

584

2314

Supplementary factors related to causes of morbidity and mortality classified elsewhere

262

1627

1.62

12.29

1.7

1.3

2.99

2.95

g/l

0.14

192

1161

Other coagulation defects

309

2.49

12.28

1.5

1.4

2.55

2.96

g/l

1.44

225

Benign neoplasm: Duodenum

4.06

12.27

1.2

1.3

2.98

2.84

g/l

0.16

Adenocarcinoma and ductal carcinoma of pancreas

104

3.72

12.25

1.2

1.4

3.40

2.87

g/l

1.40

Fentanyl

285

2.54

12.20

1.7

1.2

2.42

3.02

g/l

2.12

214

Systemic lupus erythematosus, unspecified

114

3.60

12.19

1.4

2.84

2.85

g/l

0.01

Disturbance of activity and attention

140

710

1.94

12.17

1.3

1.4

2.76

2.97

g/l

0.88

109

515

Disorders of vestibular function (Vertigo)

358

2326

1.51

12.14

1.3

1.4

2.71

2.91

g/l

1.57

251

1686

Cervicocranial syndrome

391

2.30

12.07

1.6

1.2

2.84

2.99

g/l

0.38

282

Rash and other nonspecific skin eruption

404

2.28

12.07

1.4

2.82

2.86

g/l

0.06

303

Erythema multiforme

4.30

12.06

1.2

1.3

2.65

2.82

g/l

0.15

Myelodysplastic syndrome, including Hilmo

4.27

12.03

1.3

1.4

2.94

2.97

g/l

0.02

Chronic tubulo-interstitial nephritis

110

3.61

12.03

1.3

1.4

3.34

2.99

g/l

0.64

Dermatophytosis

122

608

2.03

12.02

1.4

3.07

2.99

g/l

0.16

444

Lesion of ulnar nerve

127

643

1.99

11.97

1.5

1.3

2.97

3.09

g/l

0.34

459

Injuries to the ankle and foot

605

3789

1.37

11.93

1.4

2.93

2.94

g/l

0.06

460

2720

Scleritis and episcleritis

266

2.60

11.93

1.6

1.5

3.14

2.96

g/l

0.38

204

Post-traumatic stress disorder

362

2.35

11.93

1.3

3.23

3.03

g/l

0.43

251

Accidents

642

2347

1.37

11.92

1.4

1.3

2.83

3.04

g/l

2.27

468

1707

Other disorders of conjunctiva

117

576

2.05

11.92

1.5

1.3

2.67

2.92

g/l

0.97

413

Dental caries, including avohilmo

538

1952

1.42

11.91

1.4

2.89

2.94

g/l

0.28

368

1416

Chronic suppurative otitis media, including avohilmo

326

2.42

11.88

1.8

1.4

2.90

2.84

g/l

0.14

243

Metatarsalgia

363

2.34

11.85

1.6

1.3

2.82

2.89

g/l

0.09

254

Hernia of abdominal wall

350

2340

1.50

11.82

1.5

1.4

2.87

2.98

g/l

0.45

255

1682

Superficial injury of lower leg

222

1337

1.67

11.79

1.3

1.4

2.84

2.96

g/l

0.58

174

957

Synovial cyst of popliteal space [Baker]

227

2.72

11.79

1.3

2.93

2.90

g/l

0.03

162

Demyelinating diseases of the central nervous system

396

2.28

11.76

1.4

2.76

3.01

g/l

0.53

288

Oter anti-inflammatory and antirheumatic agents, non-steroids

155

445

1.92

11.74

1.4

1.3

3.04

3.15

g/l

0.27

116

317

Vitamin deficiency

173

3.00

11.71

1.5

1.3

2.57

2.99

g/l

1.05

126

Vitamin deficiency, wide

173

3.00

11.71

1.5

1.3

2.57

2.99

g/l

1.05

126

Ulcerative rectosigmoiditis

353

2.35

11.70

1.3

2.66

3.02

g/l

0.99

252

Abnormal involuntary movements

119

594

2.02

11.68

1.4

1.3

2.78

2.92

g/l

0.40

432

Cerebral palsy and other paralytic syndromes

104

494

2.13

11.67

1.5

1.4

2.77

2.95

g/l

0.51

364

Benign neoplasm: Pancreas

3.78

11.47

1.4

1.3

2.88

2.80

g/l

0.10

Dystonia

220

2.73

11.40

1.5

1.4

2.89

2.95

g/l

0.09

158

Cytomegaloviral disease

3.84

11.38

1.4

1.3

1.87

2.88

g/l

2.57

Fibroblastic disorders

159

881

1.82

11.36

1.4

1.3

2.98

2.99

g/l

0.02

114

627

Caries of dentine, including avohilmo

583

2160

1.38

11.35

1.4

2.78

2.96

g/l

1.68

403

1581

Hyperparathyroidism

129

661

1.94

11.35

1.5

1.3

2.52

2.86

g/l

1.63

468

Injury, poisoning and certain other consequences of external causes

418

1430

1.47

11.30

1.5

1.3

2.85

3.03

g/l

1.42

307

1012

Other CVD

142

761

1.88

11.29

1.4

1.3

2.93

2.94

g/l

0.02

558

Disorders of vitreous body

376

2445

1.47

11.29

1.4

2.87

2.91

g/l

0.20

288

1760

Hyperkinetic disorders

145

764

1.87

11.23

1.3

1.4

2.76

2.94

g/l

0.71

114

564

Tongue abnormality

222

2.70

11.20

1.6

1.5

2.85

2.91

g/l

0.10

166

Cytomegaloviral disease, including avohilmo

3.80

11.20

1.4

1.3

1.87

2.88

g/l

2.58

Disorders of vitreous body and globe

385

2504

1.46

11.19

1.4

2.84

2.91

g/l

0.41

297

1805

Allergic urticaria

354

2.32

11.18

1.3

1.4

2.99

2.93

g/l

0.13

257

Cramp and spasm

189

2.85

11.16

1.4

1.3

2.65

2.99

g/l

0.80

138

Other follicular disorders

342

2.34

11.16

1.4

3.42

2.97

g/l

1.17

241

Hyperkalaemia

178

2.90

11.13

1.6

1.4

2.51

3.03

g/l

1.67

135

Special screening examination for infectious and parasitic diseases

171

699

1.79

11.12

1.5

1.3

2.93

3.07

g/l

0.54

133

435

Cellulitis

186

1087

1.72

11.09

1.4

1.3

2.53

2.98

g/l

3.22

145

784

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

5.91

11.09

1.4

1.3

2.22

2.64

g/l

0.55

Disorders of lipoprotein metabolism and other lipidaemias

601

2687

1.36

11.08

1.5

1.4

2.79

3.03

g/l

2.92

453

1927

Injuries to the thorax

348

2355

1.48

11.06

1.5

1.4

2.90

2.98

g/l

0.36

266

1671

Injuries to the wrist and hand

814

4157

1.30

11.05

1.4

2.80

2.97

g/l

2.21

605

2990

Bullous disorders

191

2.82

10.93

1.4

2.98

2.90

g/l

0.11

141

Other retinal disorders

463

2500

1.41

10.90

1.4

2.85

2.94

g/l

0.49

327

1806

Postprocedural disorders of digestive system, not elsewhere classified

108

3.49

10.88

1.9

1.3

3.07

2.63

g/l

0.59

Disorders of continuity of bone

462

2.12

10.85

1.4

1.3

2.89

2.87

g/l

0.03

330

Umbilical hernia

212

1292

1.65

10.80

1.6

1.4

3.05

2.97

g/l

0.22

152

932

CR(E)ST syndrome

4.86

10.80

1.3

1.4

2.47

2.56

g/l

0.10

Malignant neoplasm of pancreas

209

2.71

10.79

1.2

1.5

3.24

3.02

g/l

0.56

154

Colectomy operation

128

675

1.91

10.75

1.4

1.3

3.15

2.88

g/l

0.85

487

Combined immunodeficiencies

8.34

10.74

1.4

1.2

1.74

2.86

g/l

1.91

Conductive and sensorineural hearing loss

583

2856

1.36

10.70

1.5

1.4

2.87

2.93

g/l

0.33

409

2077

Paracetamol or NSAID medication

120

296

2.06

10.70

1.3

2.88

3.13

g/l

0.79

228

Sensorineural hearing loss

546

2660

1.37

10.66

1.5

1.4

2.82

2.93

g/l

0.77

380

1931

Mouth breathing

317

2122

1.50

10.64

1.4

2.87

2.93

g/l

0.26

220

1542

Other/unspecified reactive arthropathies

282

2.45

10.60

1.4

3.15

3.01

g/l

0.22

202

Vasomotor rhinitis (mode)

270

2.48

10.58

1.9

1.4

2.82

2.88

g/l

0.11

196

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

4.08

10.56

1.4

2.34

2.88

g/l

0.70

Other congenital malformations

415

2.17

10.52

1.3

1.4

2.93

2.74

g/l

0.50

313

Other diseases of arteries and capillaries

332

2.31

10.52

1.7

1.4

2.66

3.06

g/l

1.18

243

Benign neoplasm of major salivary glands

370

2.24

10.52

1.7

1.4

2.74

2.95

g/l

0.59

273

Paralytic ileus

3.60

10.50

1.3

1.2

2.83

3.15

g/l

0.42

Abnormal findings on examination of urine, without diagnosis

157

2.98

10.50

1.4

1.3

2.67

2.85

g/l

0.35

115

Endometriosis

245

885

1.62

10.49

1.3

1.4

2.86

2.84

g/l

0.07

182

625

Fracture of rib(s), sternum and thoracic spine

229

1434

1.61

10.46

1.5

1.4

2.81

2.95

g/l

0.69

176

1012

Endometriosis of pelvic peritoneum

134

655

1.87

10.44

1.4

2.99

2.92

g/l

0.18

468

Neuromuscular dysfunction of bladder

346

2.28

10.42

1.3

2.65

2.97

g/l

0.71

259

Benign neoplasm: Caecum

430

2.14

10.41

1.6

1.4

2.64

2.94

g/l

1.08

311

Ulcer of lower limb, not elsewhere classified

110

558

1.99

10.36

1.3

1.4

2.63

2.95

g/l

0.86

406

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

142

3.07

10.36

1.5

1.3

3.36

3.10

g/l

0.25

110

Polyuria

171

996

1.73

10.36

1.4

2.99

2.95

g/l

0.08

131

715

conjunctival haemorrhage

273

2.45

10.34

1.6

1.3

2.74

2.88

g/l

0.31

202

Benign neoplasm: salivary glands, exclude unknown (D119)

335

2.30

10.32

1.7

1.4

2.83

2.99

g/l

0.37

245

Hypotension

117

607

1.94

10.31

1.3

3.03

2.95

g/l

0.15

442

Other/unspecified synovitis and tenosynovitis

438

2.12

10.31

1.5

1.3

2.65

2.95

g/l

1.17

311

Diseases of external ear

280

1844

1.53

10.26

1.4

2.85

2.90

g/l

0.19

210

1327

Other demyelinating diseases of the central nervous system

165

2.91

10.23

1.5

1.4

2.88

3.05

g/l

0.18

114

Other disorders starting during childhood or adolecense, excluding more controls

199

2.67

10.21

1.4

1.3

2.35

2.69

g/l

1.03

151

Chronic suppurative otitis media

233

2.56

10.19

1.8

1.3

2.89

2.91

g/l

0.03

169

Subacute thyroiditis

118

3.28

10.17

1.5

2.87

3.01

g/l

0.24

Nummular dermatitis

306

2.35

10.15

1.5

1.4

3.21

3.01

g/l

0.42

227

Calcific aortic valvular stenosis, diagnosis (helper)

181

1034

1.69

10.15

1.5

1.4

2.79

2.92

g/l

0.40

134

743

Operations 2 for CAVS

181

1034

1.69

10.15

1.5

1.4

2.79

2.92

g/l

0.40

134

743

Failure and rejection of transplanted organs and tissues

4.61

10.12

1.4

2.56

2.74

g/l

0.16

Procreative management

295

1613

1.51

10.11

1.5

1.4

2.57

2.88

g/l

2.85

199

1159

Other disorders of kidney and ureter

107

543

1.99

10.10

1.4

2.62

2.93

g/l

1.29

398

Viral meningitis

134

3.12

10.10

1.4

1.3

2.81

2.95

g/l

0.19

100

Other (not insulin) diabetes medications

740

3337

1.30

10.09

1.4

2.92

2.97

g/l

0.26

519

2420

Episcleritis

217

2.62

10.08

1.6

1.4

3.24

2.94

g/l

0.64

166

Artrosis, including avohilmo

622

2549

1.34

10.08

1.4

2.97

3.01

g/l

0.26

462

1797

Diseases of inner ear

402

2722

1.42

10.08

1.3

1.4

2.71

2.95

g/l

2.20

279

1967

Type of accident

238

1519

1.58

10.06

1.8

1.3

3.02

2.96

g/l

0.23

173

1082

Calcific aortic valvular stenosis, operated

181

1039

1.68

9.98

1.5

1.4

2.79

2.92

g/l

0.39

134

748

Calcific aortic valvular stenosis

181

1039

1.68

9.98

1.5

1.4

2.79

2.92

g/l

0.39

134

748

Calcific aortic valvular stenosis, including rheumatic fever

181

1038

1.68

9.97

1.5

1.4

2.79

2.93

g/l

0.42

134

746

Speech and linguistic disorders, excluding more controls

318

2.26

9.91

1.2

1.3

2.50

2.90

g/l

1.60

232

Cutaneous lupus erythematosus

3.98

9.91

1.2

1.3

3.15

2.83

g/l

0.37

Dipeptidyl peptidase 4 (DPP-4) inhibitors

387

2130

1.43

9.89

1.4

2.86

2.94

g/l

0.42

281

1539

Hordeolum and other deep inflammation of eyelid

243

2.50

9.86

1.6

1.4

2.83

2.99

g/l

0.30

176

Peritonsillar abscess

144

810

1.79

9.86

1.3

1.4

2.94

3.07

g/l

0.37

107

548

Fenamates

107

363

2.02

9.84

1.5

1.3

3.08

3.19

g/l

0.27

265

Viral meningitis, including avohilmo

147

2.98

9.81

1.4

1.3

2.71

2.93

g/l

0.36

109

Allergic purpura

3.50

9.79

1.3

2.49

2.83

g/l

0.53

Restless leg syndrome

122

655

1.88

9.76

1.7

1.3

2.71

2.93

g/l

0.83

473

Vitamin D deficiency

3.94

9.75

1.3

2.60

2.61

g/l

0.00

Viral encephalitis, not elsewhere classified/unspecified

3.94

9.75

1.4

2.17

2.88

g/l

1.13

Adhesive capsulitis of shoulder

123

662

1.87

9.74

1.4

1.3

2.99

2.95

g/l

0.09

472

Disorders of choroid and retina

594

3128

1.33

9.73

1.5

1.4

2.88

2.95

g/l

0.40

424

2259

Iron deficiency anaemia secondary to blood loss (chronic)

116

613

1.91

9.72

1.4

1.3

2.58

3.00

g/l

1.80

434

Elevated blood glucose level

319

2.28

9.68

1.9

1.3

2.82

2.93

g/l

0.22

227

Injuries to the head

879

4120

1.27

9.66

1.5

1.4

2.82

2.97

g/l

1.83

641

2973

Ankylosing spondylitis, ICD10

397

2.14

9.65

1.3

3.44

2.98

g/l

1.36

283

Anaemia in chronic diseases classified elsewhere

4.00

9.64

1.5

1.3

2.03

2.55

g/l

0.68

Unspecified haematuria

294

1604

1.50

9.63

1.6

1.4

2.98

2.95

g/l

0.09

225

1136

Achalasia of cardia

4.89

9.59

1.3

1.4

2.70

2.73

g/l

0.03

Other/unspecified cytomegaloviral diseases

3.89

9.57

1.4

1.3

1.87

2.84

g/l

2.07

Oesophageal varices

128

3.10

9.54

1.7

1.3

3.31

2.80

g/l

0.63

Problems related to lifestyle

452

2.05

9.53

1.3

2.92

3.10

g/l

0.37

310

Isolated proteinuria

113

3.26

9.51

1.4

1.3

2.65

2.90

g/l

0.43

Other specified and unspecified retinal disorders

113

3.24

9.49

1.5

1.2

2.98

2.86

g/l

0.14

Spontaneous rupture of synovium and tendon

278

2.36

9.48

1.7

1.3

2.78

2.86

g/l

0.12

200

Gingivitis and periodontal diseases

756

3026

1.29

9.47

1.4

2.93

2.97

g/l

0.28

562

2152

Adenocarcinoma of pancreas

3.74

9.47

1.2

1.3

3.43

2.82

g/l

1.43

Other diseases of gallbladder

108

3.28

9.46

1.3

2.49

2.98

g/l

1.19

Any death

454

2303

1.38

9.45

1.2

1.5

2.69

2.97

g/l

1.99

323

1634

Other noninflammatory disorders of vulva and perineum

407

2.11

9.43

1.4

2.86

2.92

g/l

0.12

291

Adult respiratory distress syndrome

7.14

9.42

1.0

1.3

2.26

2.69

g/l

0.32

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

368

2.16

9.41

1.3

1.4

2.35

2.73

g/l

1.30

277

Other disorders of eyelid

299

1915

1.48

9.40

1.5

1.4

2.71

2.89

g/l

1.17

223

1382

Chronic hepatitis NAS

4.83

9.38

1.2

2.98

2.80

g/l

0.11

Other and unspecified iridocyclitis

173

2.76

9.38

1.8

1.3

3.08

2.91

g/l

0.28

130

Hodgkin lymphoma, hilmo

3.47

9.37

1.6

1.3

2.20

2.95

g/l

1.15

Prurigo nodularis

4.02

9.36

1.1

1.4

2.46

3.09

g/l

1.19

Malignant neoplasm of other and unspecified parts of biliary tract

4.80

9.36

1.3

3.02

2.79

g/l

0.18

Polycystic ovarian syndrome, consortium definition

548

2340

1.35

9.35

1.4

2.76

2.92

g/l

1.71

401

1718

Smoking dependency

389

2.13

9.35

1.3

1.4

2.34

2.99

g/l

3.74

278

Haemorrhage, not elsewhere classified

3.38

9.33

1.4

1.2

2.42

3.13

g/l

1.36

Aortic aneurysm

151

858

1.73

9.32

1.5

1.4

2.92

3.06

g/l

0.46

623

Other or ill-defined heart diseases

185

2.68

9.29

1.5

1.2

2.96

3.13

g/l

0.29

130

Disorders of refraction and accommodation

244

1590

1.54

9.27

1.4

1.3

3.01

2.89

g/l

0.56

182

1157

Dental pulpitis, including avohilmo

737

3676

1.29

9.26

1.4

2.96

2.97

g/l

0.02

515

2662

Other localized connective tissue disorders

4.24

9.23

1.6

1.3

2.37

2.83

g/l

0.60

Mental and behavioural disorders due to tobacco

391

2.12

9.23

1.3

1.4

2.34

3.02

g/l

3.96

281

Other specified/unspecified bacterial intestinal infections

245

2.44

9.22

1.2

1.4

2.78

2.92

g/l

0.24

179

Viral hepatitis, IBD co-morbidity

110

3.21

9.17

1.1

1.3

3.17

3.47

g/l

0.34

Optic neuritis

181

2.70

9.17

1.5

1.4

2.69

2.94

g/l

0.43

131

Primary adrenocortical insufficiency

4.75

9.16

2.0

1.3

2.56

2.75

g/l

0.19

Kidney transplant status

222

2.52

9.15

1.7

1.3

2.36

2.88

g/l

1.12

161

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

240

1551

1.54

9.14

1.5

1.4

2.83

2.97

g/l

0.71

190

1128

Substance abuse

441

2995

1.37

9.13

1.3

1.4

2.79

3.01

g/l

1.73

305

2140

Special screening examination for other diseases and disorders

405

2.09

9.12

1.3

3.09

2.94

g/l

0.25

252

Atherosclerosis, excluding cerebral and coronary sclerosis

247

1267

1.54

9.11

1.6

1.4

2.69

2.94

g/l

1.42

188

903

Infective dermatitis

481

1.99

9.08

1.4

1.3

2.92

3.00

g/l

0.18

354

Other sleep disorders

454

2.02

9.06

1.4

2.90

2.97

g/l

0.16

331

Dialysis

154

2.84

9.05

1.3

2.22

2.86

g/l

1.57

111

Conduction disorders

194

962

1.62

9.04

1.4

1.3

2.91

2.97

g/l

0.17

129

703

Other and unspecified disorders of vitreous body

310

2092

1.46

9.03

1.4

2.89

2.88

g/l

0.06

242

1509

Tuberculosis, IBD comorbidity

188

2.63

9.01

2.2

1.3

2.65

2.86

g/l

0.35

138

Acute bronchiolitis

255

2.33

9.00

1.4

1.3

2.51

2.58

g/l

0.11

208

Colonic or urogenital fistula

208

1323

1.58

8.99

1.3

1.4

3.04

2.98

g/l

0.15

144

951

Osteonecrosis

236

2.45

8.97

1.4

1.3

2.31

2.91

g/l

1.40

170

Benign neoplasm: Descending colon

255

2.38

8.92

1.4

2.74

2.98

g/l

0.60

184

Benign neoplasm: Ascending colon

108

575

1.89

8.91

1.5

1.3

2.78

2.90

g/l

0.38

413

Tuberculosis, wide, including avohilmo

207

2.54

8.88

2.2

1.3

2.75

2.93

g/l

0.31

155

Superficial injury of abdomen, lower back and pelvis

132

749

1.78

8.85

1.2

1.3

2.71

2.97

g/l

1.20

549

Malignant neoplasm, including Hilmo

668

3004

1.30

8.85

1.3

1.4

2.76

3.02

g/l

3.17

467

2197

Malignant neoplasm, wide definition

669

3008

1.30

8.84

1.3

1.4

2.76

3.02

g/l

3.11

467

2200

Idiopathic gout

332

2.19

8.83

1.3

2.61

2.98

g/l

1.11

242

Mental and behavioural disorders due to psychoactive substance use

453

3063

1.36

8.82

1.3

1.4

2.78

3.01

g/l

1.93

309

2192

Perforation of tympanic membrane

378

2.11

8.82

1.3

1.4

3.09

2.95

g/l

0.27

277

Hypertensive heart and/or renal disease

168

735

1.68

8.77

1.4

2.84

2.97

g/l

0.28

122

509

Nonspecific lymphadenitis

251

2.38

8.77

1.4

1.3

2.96

2.90

g/l

0.09

191

Ganglion

153

908

1.69

8.73

1.5

1.4

2.88

2.96

g/l

0.25

118

650

Ulcer of oesophagus

197

2.57

8.73

1.3

1.2

3.07

3.06

g/l

0.00

141

Other keratitis

101

530

1.92

8.72

1.6

1.4

2.80

2.98

g/l

0.45

390

Myeloid leukaemia

3.61

8.72

1.4

1.3

2.82

2.97

g/l

0.12

Appendectomy

502

3594

1.33

8.67

1.3

1.4

2.92

2.97

g/l

0.25

353

2602

Pemphigoid

3.78

8.65

1.5

1.3

3.29

2.92

g/l

0.37

Other endocrine disorders

242

2.37

8.58

1.3

2.45

2.49

g/l

0.06

193

Lichen planus

100

526

1.92

8.57

1.8

1.3

3.08

2.85

g/l

0.48

379

Pleural plaque with presence of asbestos

211

2.49

8.55

1.3

1.2

3.08

2.97

g/l

0.15

158

Ulcerative proctitis

254

2.35

8.54

1.4

1.3

2.86

3.03

g/l

0.37

188

Hyperhidrosis

3.46

8.52

1.4

1.3

2.76

3.14

g/l

0.52

Atypical facial pain

188

2.59

8.51

1.6

1.4

3.02

3.00

g/l

0.03

140

Female infertility, cervical, vaginal, other or unspecified origin

193

769

1.61

8.46

1.4

2.89

g/l

0.01

147

550

Portal vein thrombosis

4.40

8.46

2.1

1.2

3.30

2.91

g/l

0.39

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

160

2.73

8.45

1.3

1.4

2.27

2.66

g/l

0.76

122

Cardiodefibrillation

226

1482

1.53

8.42

1.3

1.4

2.78

2.96

g/l

0.67

136

1069

Other disorders of central nervous system

4.78

8.42

1.4

2.22

2.70

g/l

0.45

Thyroiditis

313

2.20

8.41

1.5

2.88

2.94

g/l

0.13

230

Hallux valgus (acquired)

216

995

1.56

8.39

1.5

2.87

2.95

g/l

0.29

165

723

Nonischemic cardiomyopathy

346

2.13

8.35

1.2

1.4

3.21

2.92

g/l

0.61

253

Arthropathic psoriasis

525

1.90

8.31

1.3

1.4

2.97

g/l

0.00

380

Nail disorders

381

2.07

8.28

1.2

1.4

2.77

2.95

g/l

0.52

272

Infliximab

3.41

8.26

1.3

3.39

2.93

g/l

0.44

Other and unspecified coagulation defects

215

2.45

8.25

1.6

1.4

2.47

2.93

g/l

1.36

153

Other symptoms and signs involving cognitive functions and awareness

328

2058

1.42

8.25

1.5

1.4

2.83

2.92

g/l

0.42

235

1472

Olecranon bursitis

215

2.45

8.24

1.4

1.2

2.78

3.06

g/l

0.55

151

Squamous cell neoplasms and carcinomas of the skin

277

2.25

8.20

1.1

1.5

2.72

3.03

g/l

0.73

201

Other abnormal findings of blood chemistry

174

2.62

8.20

1.6

1.4

2.74

2.99

g/l

0.42

128

Non-allergic asthma

329

2.15

8.20

1.9

1.5

2.68

2.80

g/l

0.23

235

Other congenital malformations, including avohilmo

116

649

1.80

8.20

1.3

1.4

2.98

2.82

g/l

0.48

479

Abnormal blood-pressure reading, without diagnosis

140

2.82

8.18

1.7

1.4

2.77

2.94

g/l

0.23

104

Autoimmune hyperthyroidism

216

2.43

8.16

1.4

2.82

2.99

g/l

0.34

159

Seborrhoeic keratosis

180

1134

1.60

8.15

1.5

1.4

2.91

2.86

g/l

0.15

147

817

Other bullous disorders

3.29

8.12

1.3

2.81

2.87

g/l

0.07

Psoriatic arthropathies, ICD10

502

1.91

8.08

1.3

1.4

2.99

2.92

g/l

0.14

361

Inflammation of lacrimal passages (acute and unspecified)

4.21

8.04

1.7

1.2

3.17

2.88

g/l

0.29

Juvenile arthritis (FINNGEN)

182

2.56

8.01

1.3

1.4

2.57

2.75

g/l

0.28

135

Symptoms and signs involving emotional state

120

2.97

8.01

1.2

1.3

2.96

2.90

g/l

0.07

Juvenile rheumatoid arthirtis

3.49

7.99

1.3

1.4

2.43

3.09

g/l

1.40

Stenosis and insufficiency of lacrimal passages

340

2.11

7.95

1.3

2.89

2.81

g/l

0.13

244

Excessive attrition of teeth

483

3630

1.32

7.91

1.5

1.4

2.97

2.94

g/l

0.14

359

2640

Cardiomyopathies, Primary/intrinsic

443

1.96

7.88

1.4

2.96

3.13

g/l

0.49

328

Amyloidosis

3.84

7.83

1.4

1.3

1.68

3.00

g/l

3.21

Generalized anxiety disorder

136

806

1.70

7.82

1.3

3.02

3.05

g/l

0.05

104

566

Peripheral artery disease

261

1409

1.47

7.82

1.5

1.4

2.69

2.96

g/l

1.65

202

1001

Tuberculosis, wide

202

2.45

7.82

2.2

1.3

2.65

2.91

g/l

0.46

150

Female infertility

205

790

1.56

7.81

1.4

1.3

2.90

2.89

g/l

0.04

155

564

Other extrapyramidal and movement disorders in other diseases

183

1170

1.57

7.81

1.5

1.4

2.87

2.90

g/l

0.08

143

837

Pure hypercholesterolaemia

517

2499

1.32

7.79

1.4

2.82

3.03

g/l

2.05

393

1791

Other aneurysm

167

2.60

7.78

1.6

1.2

2.80

2.87

g/l

0.10

122

Phobic anxiety disorders

114

644

1.78

7.76

1.5

1.3

3.04

3.02

g/l

0.03

453

Barrett oesophagus

150

2.70

7.75

1.5

1.3

3.01

2.95

g/l

0.08

103

Later onset COPD

155

759

1.65

7.75

1.2

1.4

2.75

2.96

g/l

0.81

113

543

Diseases of pulp and periapical tissues and dental caries

457

1745

1.35

7.72

1.4

1.3

2.89

2.94

g/l

0.24

315

1265

Allergic contact dermatitis

105

582

1.82

7.69

1.4

1.3

2.94

g/l

0.01

416

Other diseases of blood and blood-forming organs

241

2.31

7.68

1.3

2.96

2.92

g/l

0.04

173

Diseases of peritoneum

406

1.99

7.67

1.5

1.4

3.07

2.95

g/l

0.17

296

Desensitization to allergens

267

2.24

7.66

1.4

2.75

2.84

g/l

0.19

190

Vulvovaginal ulceration/inflammation in other diseases

319

2.12

7.65

1.5

1.4

3.08

2.99

g/l

0.18

235

Iron deficiency

140

2.76

7.64

1.3

3.04

2.90

g/l

0.19

105

Angina pectoris

354

1695

1.39

7.64

1.5

1.4

2.84

2.97

g/l

0.70

245

1202

Fracture of lumbar spine and pelvis

152

933

1.63

7.61

1.3

1.4

2.98

2.88

g/l

0.26

108

666

Dislocation, sprain and strain of joints and ligaments of knee

476

3276

1.32

7.59

1.4

2.94

3.00

g/l

0.37

344

2356

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

356

2.04

7.55

1.1

1.4

2.59

3.00

g/l

1.37

258

Other obstructive and reflux uropathy

141

2.73

7.52

1.2

1.3

3.31

2.90

g/l

0.66

105

Other psoriatic arthropathies

487

1.89

7.48

1.3

1.4

2.99

2.92

g/l

0.13

353

Other specified and unspecified disorders of eyelid

4.50

7.48

2.0

1.3

2.10

3.11

g/l

1.94

Hypertensive Heart Disease

148

682

1.65

7.45

1.4

2.93

2.98

g/l

0.09

105

470

Acne

520

1.85

7.45

1.3

3.34

2.91

g/l

1.58

376

Other/unspecified enthesopathies, not elsewhere classified

296

2.15

7.43

1.9

1.3

2.88

2.87

g/l

0.03

214

Glaucoma

376

2353

1.36

7.43

1.4

2.80

2.93

g/l

0.77

255

1713

Trigeminal neuralgia

226

2.33

7.42

1.8

1.4

2.71

2.91

g/l

0.37

168

Pacemaker

218

1358

1.50

7.41

1.3

1.4

2.84

2.92

g/l

0.24

141

974

Acute myeloid leukaemia and myelodysplastic syndromes

3.79

7.38

1.5

1.2

2.30

2.77

g/l

0.70

Unspecified misadventure during surgical and medical care

208

2.38

7.37

1.5

1.3

3.41

2.93

g/l

0.79

151

Vascular diseases of the intestine

104

3.02

7.36

1.1

1.2

2.42

2.90

g/l

0.80

Benign paroxysmal vertigo

209

1395

1.51

7.35

1.3

1.4

2.65

2.89

g/l

1.49

144

1008

Atrophic disorders of skin

121

709

1.72

7.34

1.5

1.4

2.76

2.82

g/l

0.15

507

Disorders resulting from impaired renal tubular function

132

2.77

7.32

1.3

1.93

2.89

g/l

3.36

Disorders of plasma-protein metabolism, not elsewhere classified

7.66

7.30

1.5

1.3

2.30

3.01

g/l

—

Other and unspecified follicular disorders

161

2.58

7.29

1.6

1.3

3.45

3.01

g/l

0.64

113

Testicular dysfunction

173

2.52

7.28

1.3

1.2

2.89

3.20

g/l

0.40

121

Acute peritonitis

228

2.31

7.27

1.5

1.3

3.04

2.98

g/l

0.06

166

Complications following infusion, transfusion and therapeutic injection

4.39

7.26

1.7

1.2

2.56

2.94

g/l

0.35

Diabetes insipidus

4.65

7.26

2.1

1.3

2.77

2.84

g/l

—

Follicular lymphoma, hilmo

144

2.68

7.25

1.6

1.4

1.82

2.88

g/l

3.17

107

Lateral epicondylitis

542

1.82

7.25

1.5

1.3

2.71

2.99

g/l

1.06

379

Cardiomyopathy (excluding other)

464

1.89

7.22

1.4

1.3

2.97

3.16

g/l

0.55

343

256

1600

1.44

7.22

1.5

1.4

2.79

2.88

g/l

0.37

193

1140

Otitis externa

182

1185

1.54

7.21

1.4

1.3

2.86

2.93

g/l

0.22

145

856

Other epidermal thickening

156

2.60

7.21

1.4

2.56

2.92

g/l

0.85

119

Anogenital herpesviral [herpes simplex] infection, including avohilmo

551

1.81

7.19

1.4

2.95

3.03

g/l

0.21

396

Oral lichen planus

3.17

7.17

2.0

1.3

3.05

2.92

g/l

0.13

Gluteal tendinitis

145

2.65

7.15

1.3

1.4

2.23

2.89

g/l

2.94

108

Eustachian salpingitis and obstruction

398

1.95

7.05

1.6

1.3

2.99

3.17

g/l

0.34

284

Acute epiglottitis

4.28

7.05

1.7

1.3

3.61

2.65

g/l

—

Testicular hypofunction

158

2.57

7.05

1.3

1.2

2.90

3.22

g/l

0.37

112

Scar conditions and fibrosis of skin

158

2.57

7.04

1.2

1.4

2.75

2.97

g/l

0.37

115

Nonpyogenic thrombosis of intracranial venous system

4.52

7.03

1.3

3.58

2.99

g/l

0.52

Myocardial infarction

294

1461

1.41

7.02

1.4

2.83

3.01

g/l

0.99

213

1024

Morphin

3.91

7.00

1.6

1.2

3.65

3.19

g/l

0.49

Other disorders of optic [2nd] nerve and visual pathways

252

2.21

6.95

1.7

1.3

2.66

2.87

g/l

0.36

188

Unspecific neurodegenerative disorder

105

1227

0.58

6.95

1.2

1.4

2.80

2.90

g/l

0.25

872

Paralytic strabismus

252

2.20

6.95

1.6

1.4

2.95

2.99

g/l

0.05

185

Impingement syndrome of shoulder

154

974

1.59

6.94

1.4

2.75

2.95

g/l

0.75

123

697

Intracranial injury

435

3091

1.31

6.93

1.5

1.4

2.77

2.96

g/l

1.76

316

2225

Decubitus ulcer and pressure area

171

2.48

6.92

1.6

1.2

2.72

2.86

g/l

0.19

127

Unspecified fall

377

2768

1.34

6.92

1.5

1.4

2.84

2.91

g/l

0.34

262

2017

Other contact dermatitis

305

2.08

6.91

1.6

1.4

3.01

2.96

g/l

0.09

228

Noninflammatory disorders of female genital tract

271

946

1.44

6.89

1.5

1.3

2.86

g/l

0.03

193

673

Intestinal adhesions without obstruction

279

2.13

6.88

1.7

1.4

2.75

3.09

g/l

0.78

203

Appendicitis, broad definition

553

3904

1.27

6.88

1.4

2.88

2.99

g/l

0.89

382

2827

Acute nasopharyngitis (common cold)

475

1.85

6.87

1.3

1.4

2.85

3.10

g/l

0.65

317

Other shoulder lesions

367

1.98

6.86

1.3

2.87

3.00

g/l

0.15

261

Contact with and exposure to communicable diseases

253

1771

1.43

6.82

1.4

2.92

2.98

g/l

0.18

137

1305

Golimumab

161

2.53

6.79

1.2

1.3

3.32

3.01

g/l

0.41

123

Fracture at wrist and hand level

270

1917

1.41

6.78

1.3

1.4

2.86

2.99

g/l

0.59

183

1369

Disorders of adult personality and behaviour

229

1584

1.45

6.77

1.3

1.4

2.80

3.02

g/l

1.02

165

1135

Other embolism and thrombosis

525

1.80

6.77

1.7

1.3

3.14

2.87

g/l

0.65

388

Abnormal findings in nipple discharge synovial fluid wound secretions

3.98

6.76

1.5

1.3

2.48

2.71

g/l

0.20

Diseases of appendix

556

3923

1.27

6.75

1.4

2.87

2.99

g/l

0.97

385

2842

Skin changes due to chronic exposure to nonionizing radiation

237

1490

1.44

6.74

1.5

1.4

2.80

2.89

g/l

0.33

176

1053

Other specified and unspecified disorders of eye and adnexa

138

2.65

6.74

1.2

1.4

2.44

2.84

g/l

0.80

105

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

302

2.07

6.71

1.6

1.4

2.64

2.93

g/l

0.64

221

Duodenal ulcer

322

2.03

6.70

1.2

1.3

3.65

2.88

g/l

1.34

235

Acute appendicitis, no complications

423

3214

1.31

6.70

1.4

2.89

3.00

g/l

0.74

292

2330

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

109

638

1.72

6.68

1.4

2.31

2.93

g/l

2.61

463

Fracture of foot, except ankle

195

1311

1.49

6.68

1.4

1.3

2.77

2.96

g/l

1.04

148

937

Benign neoplasm: Parotid gland

296

2.08

6.67

1.5

1.4

2.92

2.96

g/l

0.06

218

Personality disorders

215

1475

1.46

6.65

1.3

1.4

2.83

3.01

g/l

0.78

153

1053

Other disorders of patella

122

737

1.66

6.64

1.2

1.4

3.13

3.00

g/l

0.40

521

150

2.55

6.64

1.2

3.22

2.90

g/l

0.47

112

Hidradenitis suppurativa

169

2.46

6.63

1.3

1.4

3.48

2.99

g/l

0.83

120

Malignant neoplasm

632

2952

1.26

6.61

1.3

1.4

2.72

3.02

g/l

3.76

435

2163

Benign neoplasm of mouth and pharynx

464

1.85

6.61

1.4

1.3

2.55

2.98

g/l

1.74

333

Localized scleroderma [morphea]

4.24

6.59

1.4

1.3

2.44

2.67

g/l

0.22

Other/unspecified enthesopathies of lower limb, excluding foot

271

2.12

6.58

1.2

1.3

3.27

3.02

g/l

0.41

199

Malignant neoplasm

630

2944

1.26

6.57

1.3

1.4

2.70

3.02

g/l

4.12

434

2157

Other juvenile arthritis

176

2.42

6.55

1.3

1.4

2.61

2.88

g/l

0.41

128

Other and unspecified acquired haemolytic anaemias

6.39

6.54

1.9

1.3

1.61

2.81

g/l

—

Acne vulgaris

387

1.92

6.53

1.2

1.3

3.46

2.90

g/l

1.62

273

MS-disease / Multiple Sclerosis

327

2.01

6.47

1.4

2.50

3.03

g/l

1.70

241

Thoracic aortic aneurysm

102

592

1.73

6.46

1.6

1.4

3.05

g/l

0.00

432

Injuries to the shoulder and upper arm

637

3955

1.24

6.43

1.4

2.97

2.94

g/l

0.17

464

2841

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

281

2.08

6.43

1.4

1.3

2.36

2.63

g/l

0.81

219

Plantar fascial fibromatosis

369

1.94

6.42

1.4

1.3

3.03

2.96

g/l

0.08

262

Corneal ulcer

142

899

1.59

6.42

1.6

1.3

2.96

g/l

0.00

649

DVT of lower extremities

127

783

1.63

6.40

1.4

1.3

3.10

2.86

g/l

0.66

572

Haemorrhage in early pregnancy

212

1420

1.46

6.37

1.2

1.5

2.68

2.93

g/l

1.30

159

1054

Occupational exposure to risk-factors

119

2.73

6.37

1.7

1.2

3.45

2.96

g/l

0.64

Major coronary heart disease event excluding revascularizations

367

1813

1.34

6.37

1.3

1.4

2.85

2.97

g/l

0.65

268

1274

Disorders of lacrimal system and orbit in diseases classified elsewhere

3.14

6.35

1.3

2.98

2.83

g/l

0.13

Pneumonitis due to solids and liquids

255

2.13

6.35

1.3

1.2

2.58

2.83

g/l

0.50

192

Superficial injury of wrist and hand

171

1132

1.52

6.34

1.4

2.64

2.97

g/l

2.08

133

818

Benign neoplasm: Rectum

125

770

1.63

6.33

1.5

1.4

2.66

2.97

g/l

1.40

103

555

Unspecified nephritic syndrome

3.22

6.33

1.6

1.3

2.64

2.81

g/l

0.22

Hypertrophic disorders of skin

236

2.18

6.33

1.3

1.4

3.03

3.04

g/l

0.01

171

Alzheimer disease, including avohilmo

1007

0.56

6.32

1.4

2.92

2.90

g/l

0.03

712

Endocrine disorders, other/unspecified

3.40

6.32

1.2

1.3

4.65

2.91

g/l

—

Recurrent dislocation of patella

198

2.30

6.29

1.1

1.4

2.73

3.00

g/l

0.48

140

Hypercalcemia

149

2.52

6.29

1.2

1.4

2.47

2.95

g/l

0.85

109

Other hearing loss

174

1120

1.51

6.28

1.5

1.4

2.76

2.89

g/l

0.46

115

796

Actinic keratosis

227

1444

1.43

6.26

1.5

1.4

2.80

2.89

g/l

0.36

168

1021

Impetigo

205

2.27

6.26

1.4

1.3

2.49

2.80

g/l

0.70

159

Other abnormal uterine and vaginal bleeding

155

716

1.56

6.22

1.3

1.4

2.97

2.78

g/l

0.60

109

504

Other and unspecified diseases of blood and blood-forming organs

3.10

6.22

1.4

1.3

3.20

2.83

g/l

0.28

Radial styloid tenosynovitis [de Quervain]

199

2.28

6.22

1.7

1.4

2.89

2.96

g/l

0.13

148

Myocardial infarction, strict

268

1359

1.40

6.21

1.4

2.81

3.01

g/l

1.17

198

947

Thyrotoxicosis, other and/or unspecified

146

938

1.56

6.21

1.3

1.4

2.91

2.88

g/l

0.09

107

673

Extrapyramidal and movement disorders

261

1879

1.39

6.20

1.6

1.4

2.79

2.92

g/l

0.64

191

1359

Alopecia areata

104

2.84

6.19

1.4

3.08

2.86

g/l

0.26

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

233

1648

1.42

6.15

1.2

1.4

2.99

3.00

g/l

0.02

168

1192

Glucagon-like peptide-1 (GLP-1) analogues

233

1648

1.42

6.15

1.2

1.4

2.99

3.00

g/l

0.02

168

1192

Ingrowing nail

226

2.19

6.14

1.2

1.3

2.92

2.95

g/l

0.05

164

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

229

1615

1.42

6.14

1.2

1.4

2.88

3.02

g/l

0.60

175

1163

Amyloidosis, other/unspecified

3.82

6.12

1.4

1.3

1.64

3.08

g/l

2.66

Allergic colitis

116

2.72

6.11

1.4

2.31

2.52

g/l

0.34

Alcoholic liver disease

390

1.89

6.11

1.2

1.4

3.67

2.95

g/l

1.47

288

Use of pramipexole

150

974

1.55

6.09

1.4

2.63

2.90

g/l

1.14

106

700

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

222

1560

1.43

6.08

1.3

1.4

3.01

2.97

g/l

0.12

160

1111

Lichen simplex chronicus

105

2.80

6.07

1.3

3.36

3.00

g/l

0.51

Abscess of anal and rectal regions

349

1.94

6.05

1.3

3.25

3.10

g/l

0.23

248

Epilepsy

204

1408

1.45

6.04

1.3

1.4

2.64

2.89

g/l

1.13

159

1040

Other dialysis

117

2.69

6.02

1.2

1.3

2.43

2.78

g/l

0.52

Arthropathies in other diseases classified elsewhere

112

2.71

5.94

1.3

1.4

2.83

3.15

g/l

0.31

Disorders of psychological development

102

562

1.69

5.90

1.3

1.4

2.53

2.88

g/l

1.42

407

Autoimmune thyroiditis

3.35

5.89

1.2

1.3

2.99

2.98

g/l

0.01

Benign neoplasm: Rectum, anus and anal canal

135

863

1.57

5.89

1.4

2.66

2.94

g/l

1.33

108

624

Other disorders of bladder

460

1.79

5.88

1.3

3.32

2.97

g/l

0.75

338

Degenerative diseases of the nervous system

1050

0.58

5.87

1.2

1.4

2.87

2.92

g/l

0.09

747

Artificial opening status

186

2.28

5.82

1.5

2.85

3.03

g/l

0.30

142

Superficial injury of hip and thigh

101

603

1.68

5.80

1.4

1.3

3.00

2.89

g/l

0.26

429

Benign neoplasm: Sigmoid colon

128

812

1.58

5.79

1.6

1.4

2.66

2.95

g/l

1.39

588

Type 1 diabetes

184

1260

1.46

5.77

1.4

1.3

2.87

2.97

g/l

0.30

129

916

Mature T/NK-cell lymphomas, hilmo

4.00

5.75

1.3

2.80

2.51

g/l

—

Adjustment and management of implanted device

108

658

1.65

5.75

1.1

1.4

2.86

3.01

g/l

0.38

478

Diabetic maculopathy, excluding more controls

427

1.82

5.75

1.4

2.86

3.07

g/l

0.45

305

Acute posthaemorrhagic anaemia

2.94

5.74

1.3

3.24

2.73

g/l

0.49

Bell's palsy

508

1.74

5.74

1.4

1.3

2.33

2.99

g/l

3.93

361

Convalescence

200

2.22

5.74

1.5

2.97

2.99

g/l

0.02

144

Trigger finger

584

1.69

5.69

1.4

1.3

2.96

2.89

g/l

0.14

417

Acute appendicitis

512

3799

1.25

5.68

1.4

2.87

3.00

g/l

1.01

357

2749

Abnormalities of gait and mobility

458

1.78

5.67

1.4

1.3

2.59

2.93

g/l

0.98

339

Statin medication

511

2282

1.26

5.65

1.4

2.88

3.04

g/l

1.32

370

1597

Endometriosis of rectovaginal septum and vagina

288

2.00

5.65

1.6

1.4

2.55

2.95

g/l

1.18

205

Urethritis and urethral syndrome

3.23

5.62

1.4

2.44

2.91

g/l

0.87

Thyrotoxicosis

182

1254

1.46

5.59

1.5

1.4

2.96

2.85

g/l

0.41

133

896

Other and unspecified aplastic anaemias

4.74

5.54

1.5

1.3

4.30

2.32

g/l

—

Other and unspecified psoriasis

263

2.03

5.53

1.2

1.4

2.99

2.98

g/l

0.02

196

Excessive vomiting in pregnancy

382

1.85

5.53

1.4

1.5

2.91

2.95

g/l

0.07

281

Endometriosis ASRM stages 1,2

137

893

1.54

5.53

1.4

2.99

2.93

g/l

0.16

645

Heterophoria

375

1.86

5.52

1.6

1.4

3.26

2.79

g/l

1.08

268

Bruxism

2.95

5.50

1.4

3.50

2.93

g/l

0.62

Spasmodic torticollis

123

2.56

5.48

1.7

1.4

2.56

2.85

g/l

0.47

Strabismus

200

1404

1.43

5.48

1.7

1.4

2.97

2.85

g/l

0.41

141

1019

AV-block

501

1.68

5.47

1.3

1.4

3.20

3.05

g/l

0.27

367

Lichen ruber planus, wide definition including periferal and oral lichen planus

161

1089

1.49

5.45

1.7

1.4

3.04

2.90

g/l

0.42

120

785

Glaucoma suspect

238

1727

1.38

5.44

1.4

2.77

2.89

g/l

0.52

158

1253

Crohn disease (strict definition, all UC cases excluded)

218

2.13

5.43

1.1

1.3

3.91

2.87

g/l

1.87

156

Infections with a predominantly sexual mode of transmission, including avohilmo

306

2109

1.33

5.43

1.3

1.4

2.85

3.04

g/l

1.29

224

1513

Otitis externa, unspecified

555

1.69

5.41

1.3

1.4

2.92

g/l

0.01

411

Ventral hernia

157

1059

1.49

5.39

1.4

2.84

2.89

g/l

0.10

117

764

Female genital prolapse

185

703

1.47

5.38

1.8

1.3

2.73

2.79

g/l

0.16

130

502

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

143

947

1.52

5.37

1.4

2.85

2.93

g/l

0.19

102

682

Speech and linguistic disorders

446

1.75

5.37

1.4

1.3

2.41

2.72

g/l

1.18

335

Drug-induced neutropenia

287

1.97

5.36

1.5

1.4

2.59

2.91

g/l

0.50

211

Alcohol abuse, main dg, excluding more controls

106

656

1.62

5.35

1.3

1.4

2.98

3.11

g/l

0.30

461

Other disorders starting during childhood or adolescence

278

1.98

5.31

1.4

2.35

2.49

g/l

0.34

218

Other erythematous conditions

125

2.51

5.31

1.3

1.4

2.67

2.81

g/l

0.19

Benign neoplasm of other and unspecified endocrine glands

100

612

1.64

5.29

1.4

1.3

2.93

2.90

g/l

0.05

447

Other and unspecified glaucoma

207

2.14

5.29

1.5

1.3

2.48

2.86

g/l

0.70

152

Tubulo-interstitial nephritis, not specified as acute or chronic

214

2.12

5.26

1.3

1.4

3.08

2.90

g/l

0.24

160

Injuries to the neck

175

1213

1.45

5.24

1.4

2.82

3.00

g/l

0.74

134

863

Striking against or struck by other objects

257

1899

1.36

5.23

1.4

2.68

2.96

g/l

1.95

175

1364

Dermatophytosis, including avohilmo

469

3679

1.25

5.23

1.4

2.95

2.96

g/l

0.05

338

2630

Valvular operations

492

1.72

5.23

1.5

1.4

2.87

3.08

g/l

0.45

368

Pure hyperglyceridaemia

2.92

5.22

1.4

2.93

2.99

g/l

0.06

Papilloedema, unspecified

2.92

5.22

1.4

1.3

3.12

2.66

g/l

0.57

Oesophageal obstruction

2.78

5.22

1.2

3.16

2.96

g/l

0.18

Erosion of teeth , including avohilmo

209

1497

1.40

5.21

1.3

1.4

2.68

2.96

g/l

1.69

150

1076

Familial hypercholesterolemia

561

1.67

5.20

1.6

1.4

2.54

2.92

g/l

1.63

404

Presence of cardiac and vascular implants and grafts

251

1353

1.37

5.19

1.5

1.4

2.81

3.02

g/l

1.21

190

987

Congenital malformations of the urinary system

256

2.01

5.19

1.2

1.3

3.04

2.84

g/l

0.26

190

Disorders of tooth development and eruption

109

553

1.61

5.17

1.4

1.3

2.74

3.03

g/l

0.96

398

Other hammer toe(s) (acquired)

100

558

1.64

5.15

1.6

1.5

2.97

2.89

g/l

0.18

405

Tuberculosis

164

2.27

5.14

2.2

1.3

2.71

2.88

g/l

0.22

123

Persistent mood disorders

135

892

1.52

5.14

1.3

1.4

2.78

2.92

g/l

0.49

106

623

Artificial joint operation, meniscal resection

627

3297

1.22

5.14

1.4

2.93

2.95

g/l

0.09

447

2369

Poisoning by drugs, medicaments and biological substances

181

1268

1.43

5.13

1.3

1.4

2.72

3.02

g/l

1.40

128

912

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

327

1.88

5.13

1.3

2.45

3.12

g/l

1.80

228

Other condition

111

703

1.59

5.12

1.8

1.3

3.21

2.96

g/l

0.83

508

Malignant neoplasm of eye, brain and central nervous system

146

2.35

5.09

1.4

2.59

2.91

g/l

0.49

110

Mantle cell lymphoma, including Hilmo

4.55

5.09

1.8

1.3

2.13

2.84

g/l

—

Calculus of kidney and ureter

195

1387

1.41

5.07

1.4

3.15

3.00

g/l

0.47

138

1002

Alzheimer disease

849

0.57

5.06

1.2

1.4

2.79

2.90

g/l

0.22

607

Right bundle-branch block

116

2.53

5.05

1.1

1.2

2.51

3.19

g/l

1.71

Biguanides

677

3389

1.21

5.05

1.4

2.90

2.96

g/l

0.33

483

2444

Propionic acid derivatives

182

630

1.46

5.03

1.4

1.3

2.69

3.04

g/l

1.97

135

458

Anti-inflammatory and antirheumatic products, non-steroids

182

630

1.46

5.03

1.3

2.74

3.04

g/l

1.52

134

458

Oral lichen planus, including avohilmo , including avohilmo

294

1.92

5.02

1.5

2.83

2.91

g/l

0.13

210

Amenorrhoea

294

1.92

5.01

1.8

1.5

2.56

3.09

g/l

1.81

213

Other and unspecified epidermal thickening

2.67

5.01

1.3

2.47

2.89

g/l

0.86

Specific development disorders of scholastic skills

234

2.03

5.00

1.4

1.3

2.25

2.76

g/l

1.51

175

Sleep disorders, other/unspecified

160

2.28

5.00

1.2

1.4

3.11

2.81

g/l

0.35

115

Other and unspecified myopathies

309

1.89

4.97

1.4

1.3

2.86

2.97

g/l

0.20

229

Lesion of lateral popliteal nerve

180

2.19

4.95

1.5

1.3

3.08

2.99

g/l

0.10

126

Maternal care for other conditions predominantly related to pregnancy

162

1091

1.45

4.94

1.2

1.4

2.84

3.02

g/l

0.76

117

814

Perioral dermatitis

2.70

4.94

1.5

1.3

3.43

2.97

g/l

0.55

Pleural plaque without asbestos

2.69

4.92

1.4

1.2

2.58

2.68

g/l

0.13

Spondylopathies in diseases classified elsewhere

4.66

4.90

1.2

1.3

2.42

2.57

g/l

—

Neovascular glaucoma

124

2.44

4.89

1.5

1.3

2.77

2.81

g/l

0.04

Abrasion of teeth

266

2002

1.33

4.88

1.3

1.4

2.96

2.94

g/l

0.08

197

1447

Vitamin B12 deficiency anaemia

318

1.87

4.88

1.3

1.4

3.32

2.98

g/l

0.60

233

Other maternal disorders predominantly related to pregnancy

409

2021

1.27

4.86

1.3

1.4

2.95

2.89

g/l

0.28

296

1498

Other female pelvic inflammatory diseases

112

720

1.56

4.86

1.3

1.4

2.78

2.83

g/l

0.12

518

Other problems related to primary support group, including family circumstances

586

1.62

4.85

1.4

2.68

2.85

g/l

0.56

436

Hypocalcemia

2.87

4.84

1.4

1.3

3.04

2.88

g/l

0.12

Ptosis of eyelid

414

1.75

4.83

1.8

1.3

2.42

2.90

g/l

2.25

298

Diseases of male genital organs

347

1347

1.30

4.80

1.4

2.92

3.04

g/l

0.60

258

946

Congenital malformations of the urinary system, including avohilmo

271

1.94

4.78

1.2

1.3

3.01

2.85

g/l

0.22

202

Malignant neoplasm of digestive organs, including Hilmo

272

1505

1.33

4.77

1.4

1.5

3.04

3.01

g/l

0.09

183

1105

Suppurative otitis media, unspecified

2.91

4.77

1.7

1.4

3.28

3.05

g/l

0.16

Tobacco use

223

2.04

4.77

1.3

2.76

3.05

g/l

0.50

158

Flat foot [pes planus] (acquired)

364

1.80

4.77

1.3

1.6

3.35

2.89

g/l

0.60

267

Specific personality disorders

180

1279

1.41

4.75

1.3

1.4

2.83

3.00

g/l

0.63

134

914

Other and unspecified nail disorders

2.83

4.74

1.3

2.58

2.90

g/l

0.49

Osteomyelitis

224

2.03

4.71

1.5

1.2

2.71

2.94

g/l

0.38

165

Tinnitus

160

1115

1.44

4.70

1.4

2.99

2.97

g/l

0.07

120

801

Any dementia

106

1129

0.65

4.70

1.2

1.4

2.83

2.91

g/l

0.17

803

Idiopathic urticaria

2.68

4.68

1.3

2.67

2.81

g/l

0.22

Chronic Coagulation defects

2.68

4.68

1.7

1.3

2.72

2.67

g/l

0.04

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

374

1.78

4.67

1.3

1.4

2.73

2.95

g/l

0.50

270

Other nonscarring hair loss

4.40

4.67

1.1

1.4

2.93

3.12

g/l

—

Other disorders of the musculoskeletal system and connective tissue

104

665

1.57

4.64

1.5

1.4

2.59

2.91

g/l

1.16

485

Achilles tendinitis

412

1.73

4.63

1.7

1.3

2.80

3.07

g/l

0.87

300

Poisoning by medicine

163

1144

1.43

4.62

1.3

1.4

2.72

2.99

g/l

1.21

112

816

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

218

1607

1.36

4.62

1.2

1.4

2.69

3.01

g/l

2.08

153

1161

Artificial joint re-operation

226

2.01

4.60

1.3

1.5

3.39

2.92

g/l

0.84

170

Any event in cancer register

668

3260

1.20

4.60

1.3

1.4

2.77

3.01

g/l

2.94

467

2394

Excessive earwax

440

3217

1.24

4.60

1.5

1.4

2.88

2.93

g/l

0.24

301

2339

Benign neoplasm: Pituitary gland, craniopharyngeal duct

206

2.06

4.59

1.4

1.3

3.04

2.90

g/l

0.15

152

Glaucoma secondary to other eye disorders

128

2.37

4.59

1.5

1.3

2.77

2.92

g/l

0.17

Carcinoma in situ of skin of other and unspecified parts of face

240

1.97

4.58

1.3

2.77

2.74

g/l

0.04

187

Gonarthrosis,primary

592

2955

1.21

4.54

1.4

2.95

2.94

g/l

0.03

440

2123

Graves ophthalmopathy, strict

2.76

4.54

1.3

1.4

2.71

2.76

g/l

0.06

Mixed conductive and sensorineural hearing loss

452

1.69

4.54

1.4

1.3

2.88

2.91

g/l

0.06

324

Infections with a predominantly sexual mode of transmission

228

1694

1.35

4.52

1.4

2.87

3.02

g/l

0.69

170

1198

Other and unspecified injuries of lower leg

356

1.78

4.52

1.4

1.3

2.80

3.05

g/l

0.64

251

Acne, including avohilmo

170

972

1.42

4.51

1.3

3.21

2.94

g/l

1.22

132

709

Hyperaldosteronism

2.68

4.51

1.6

1.2

2.94

2.98

g/l

0.04

Convergence insufficiency and excess

3.48

4.49

1.2

1.3

2.91

2.99

g/l

—

Arterial embolism and thrombosis

161

2.19

4.49

1.3

1.2

2.30

2.89

g/l

1.48

123

Medial epicondylitis

130

2.33

4.44

1.4

3.08

2.98

g/l

0.09

Other chondrocalcinosis

4.15

4.44

1.6

1.4

2.46

3.05

g/l

0.80

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

129

846

1.49

4.44

1.2

1.4

2.72

2.83

g/l

0.29

101

637

Injuries to the hip and thigh

314

2193

1.29

4.44

1.4

2.92

g/l

0.02

245

1566

Sudden idiopathic hearing loss

395

1.73

4.44

1.9

1.3

2.94

2.91

g/l

0.04

289

Visual impairment including blindness (binocular or monocular)

223

1.99

4.40

1.3

2.78

2.86

g/l

0.11

161

Dementia, including avohilmo

148

1437

0.70

4.38

1.2

1.4

2.82

2.87

g/l

0.13

101

1018

Seronegative juvenile rheumatoid arthritis

2.78

4.38

1.3

1.1

2.26

2.67

g/l

0.73

Cauda equina syndrome

3.27

4.37

1.2

1.4

2.65

2.78

g/l

—

Thyrotropin deficiency

3.42

4.36

1.5

1.3

2.52

2.73

g/l

—

Discitis, unspecified

3.25

4.36

1.4

1.2

2.90

3.05

g/l

—

Schizophrenia

798

0.52

4.36

1.1

1.4

2.44

3.05

g/l

1.95

565

Type 1 diabetes, wide definition, subgroup 1

140

966

1.45

4.35

1.4

1.3

2.84

2.96

g/l

0.36

104

736

Bacterial, viral and other infectious agents, including avohilmo

413

1.71

4.33

1.4

2.75

2.97

g/l

0.54

289

Superficial injury of ankle and foot

637

1.56

4.33

1.5

1.3

2.68

2.94

g/l

0.85

463

Contusion of toe(s) without damage to nail

101

2.51

4.31

1.4

1.2

2.80

2.84

g/l

0.04

Degeneration of macula and posterior pole

278

1647

1.31

4.31

1.4

2.81

2.88

g/l

0.31

205

1195

Use of anticholinesterases

1045

0.63

4.31

1.3

1.4

2.69

2.88

g/l

0.58

745

N06DA Anticholinesterases

1045

0.63

4.31

1.3

1.4

2.69

2.88

g/l

0.58

745

Obsessive-compulsive disorder

274

1.87

4.30

1.5

1.3

3.00

2.99

g/l

0.01

188

Thyrotoxicosis with diffuse goitre

638

1.56

4.30

1.5

1.3

2.86

2.88

g/l

0.05

461

Myopia

103

670

1.55

4.30

1.3

1.4

3.12

2.96

g/l

0.44

477

Tuberculosis of other organs, strict, including avohilmo

2.99

4.30

1.9

1.3

2.61

3.03

g/l

0.69

Lichen planus, including avohilmo

131

896

1.47

4.29

1.8

1.4

3.13

2.89

g/l

0.67

635

Agoraphobia

126

2.33

4.28

1.3

1.4

3.17

3.01

g/l

0.24

Anogenital herpesviral [herpes simplex] infection

297

1.83

4.25

1.5

1.4

2.93

3.05

g/l

0.24

216

Other specified/unspecified dorsopathies

2.58

4.23

1.6

1.4

3.26

2.99

g/l

0.22

D07AA Corticosteroids, weak (group I)

118

792

1.49

4.22

1.5

1.4

2.89

2.87

g/l

0.06

591

Mantle cell lymphoma

4.93

4.22

1.8

1.2

2.29

2.85

g/l

—

Urolithiasis

204

1512

1.35

4.21

1.4

3.14

3.01

g/l

0.42

141

1089

KRA_PSY_EATING, excluding more controls

317

1.79

4.18

1.3

2.70

2.99

g/l

0.76

225

Scoliosis

313

1.80

4.18

1.3

2.63

2.93

g/l

0.69

231

Event of undetermined intent

292

1.83

4.16

1.2

1.3

3.25

2.90

g/l

0.61

211

Other disorders of nervous system

249

1.90

4.16

1.3

1.5

2.48

2.97

g/l

1.40

186

Acute gastritis

235

1.93

4.15

1.5

1.3

2.71

2.83

g/l

0.22

171

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

133

892

1.45

4.15

1.2

1.4

2.74

2.85

g/l

0.26

103

667

Cerebrovascular diseases

477

2714

1.22

4.14

1.3

1.4

2.82

2.92

g/l

0.64

353

1930

Other specified and unspecified personality disorders

411

1.69

4.14

1.3

1.4

2.90

2.96

g/l

0.09

293

Leisure time condition

130

895

1.46

4.14

1.8

1.3

2.81

2.93

g/l

0.33

640

Speech therapy

170

1228

1.39

4.14

1.6

1.4

2.72

2.90

g/l

0.82

157

874

Unspecified privation

465

1.64

4.12

1.6

1.4

2.69

2.98

g/l

0.60

339

Necrosis of pulp, including avohilmo

429

3461

1.23

4.11

1.4

2.84

2.99

g/l

1.04

296

2514

Other and unspecified disorders of skin and subcutaneous tissue

222

1.95

4.11

1.6

1.4

2.64

2.98

g/l

0.75

163

Transport accidents

332

2188

1.27

4.11

1.5

1.3

3.00

3.07

g/l

0.31

243

1594

Respiratory tuberculosis

148

2.18

4.09

2.3

1.3

2.61

2.82

g/l

0.28

110

Respiratory tuberculosis, confirmed and not-confirmed

148

2.18

4.09

2.3

1.3

2.61

2.82

g/l

0.28

110

Other disorders of bone density and structure

2.66

4.08

1.3

3.15

2.79

g/l

0.48

Viral conjunctivitis, including avohilmo

155

2.15

4.07

1.5

1.3

2.75

3.07

g/l

0.39

118

Osteonecrosis due to drugs

3.39

4.07

1.5

1.3

1.55

3.08

g/l

—

Deep endometriosis

406

1.69

4.05

1.5

1.4

2.57

2.91

g/l

1.21

297

Dementia

136

1323

0.70

4.05

1.2

1.4

2.72

2.89

g/l

0.53

940

Dislocation, sprain and strain of joint and ligaments of hip

123

2.30

4.05

1.3

2.92

2.69

g/l

0.30

Ankylosing spondylitis, strict definition

189

2.03

4.05

1.2

1.3

3.77

3.04

g/l

1.11

136

Disorder of the sleep-wake schedule

2.80

4.04

1.5

1.3

2.79

2.68

g/l

0.09

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

169

2.09

4.02

1.3

1.4

3.14

2.93

g/l

0.35

119

Open wound of ankle and foot

492

1.62

4.00

1.3

2.98

3.02

g/l

0.06

350

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

317

2174

1.27

4.00

1.5

1.4

3.04

2.89

g/l

0.87

242

1599

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

105

2.41

4.00

1.3

1.5

2.50

3.07

g/l

1.22

Injury of muscle and tendon at forearm level

2.86

3.98

1.3

3.57

2.76

g/l

0.60

Molar incisor enamel hypoplasia

215

1.93

3.95

1.4

1.99

2.46

g/l

1.33

175

Tooth eruption problems

115

753

1.48

3.95

1.4

2.81

2.90

g/l

0.25

561

Cyst of kidney

254

1.86

3.94

1.5

1.3

2.96

3.00

g/l

0.05

183

Follicular cysts of skin and subcutaneous tissue

127

880

1.45

3.93

1.4

1.3

2.80

2.94

g/l

0.39

625

Exposure to other and unspecified inanimate mechanical forces

357

1.72

3.93

1.4

1.3

2.79

2.99

g/l

0.61

258

Inflammatory disease of uterus

102

677

1.51

3.92

1.4

2.67

2.94

g/l

0.94

486

Status epilepticus

106

2.38

3.91

1.4

1.3

2.38

2.86

g/l

0.78

Use of memantine

756

0.58

3.90

1.4

2.62

2.89

g/l

0.68

552

Use of other anti-dementia drugs

756

0.58

3.90

1.4

2.62

2.89

g/l

0.68

552

Oral lichen planus and hypothyroidism or thyroxine medication

2.81

3.88

1.7

1.3

2.06

2.80

g/l

2.21

Early lumbar disc prolapse, operated

427

1.65

3.86

1.2

1.3

3.04

3.19

g/l

0.30

290

Visual field defects

307

1.77

3.85

1.5

1.3

2.78

2.95

g/l

0.30

221

Injury of nerves at forearm level

3.12

3.83

1.3

1.4

2.78

2.75

g/l

—

Hypertrophic scar

214

1.93

3.82

1.4

2.77

2.97

g/l

0.32

156

Other superficial mycoses

2.63

3.82

1.6

1.3

2.92

2.91

g/l

0.01

Chronic mastoiditis

2.63

3.82

2.2

1.2

2.91

2.86

g/l

0.06

Other facial nerve disorders

2.45

3.82

1.6

1.3

2.75

2.76

g/l

0.01

Other disorders of binocular movement

2.57

3.82

1.4

1.3

2.84

2.87

g/l

0.04

Other disorders of veins

273

2104

1.28

3.82

1.3

1.4

2.90

2.92

g/l

0.04

190

1541

Other misadventures during surgical and medical care

2.57

3.82

1.4

1.3

2.87

2.80

g/l

0.04

Dissection of aorta

2.45

3.81

1.8

1.3

2.62

2.80

g/l

0.15

Pain associated with micturition

523

1.58

3.78

1.4

2.74

2.88

g/l

0.34

381

Hyperfunction of pituitary gland

201

1.96

3.78

1.4

1.3

2.31

3.04

g/l

3.40

144

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

287

2237

1.27

3.76

1.4

3.03

2.93

g/l

0.44

225

1605

Respiratory conditions due to other external agents

2.95

3.75

1.6

1.3

2.10

2.94

g/l

1.18

Tuberculosis of other organs

2.95

3.75

2.1

1.3

2.51

3.15

g/l

1.14

Other peripheral vertigo

362

1.70

3.75

1.5

1.4

2.72

2.89

g/l

0.33

267

Graves ophthalmopathy

2.43

3.75

1.3

1.4

2.69

2.83

g/l

0.20

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

134

2.19

3.74

2.1

1.3

3.39

2.89

g/l

0.65

Disorder of lipoprotein metabolism, unspecified

493

1.59

3.74

1.3

1.4

3.07

3.01

g/l

0.11

352

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

112

766

1.47

3.73

1.2

1.4

2.91

2.97

g/l

0.13

562

Other specified disorders of muscle

2.59

3.73

1.5

1.2

3.31

2.89

g/l

0.48

Presbycusis

388

1.66

3.71

1.6

1.2

2.35

2.94

g/l

2.34

280

Mental and behavioural disorders due to sedatives or hypnotics

296

1.77

3.71

1.3

1.4

2.58

3.08

g/l

1.34

214

Tuberculosis of other organs, strict

2.82

3.70

2.0

1.3

2.51

3.03

g/l

0.91

Herpesviral keratitis and keratoconjunctivitis

148

2.11

3.69

1.6

1.3

3.41

2.89

g/l

0.55

111

Diabetic retinopathy, excluding more controls

175

715

1.37

3.69

1.4

1.5

2.93

2.97

g/l

0.11

112

484

Chromosomal abnormalities, not elsewhere classified

122

2.25

3.68

1.4

1.3

2.16

2.46

g/l

0.37

Dilated cardiomyopathy

464

1.60

3.68

1.4

1.3

3.08

2.99

g/l

0.21

337

Benign neoplasm of eye and adnexa

433

1.63

3.68

1.7

1.4

2.80

2.92

g/l

0.19

321

Left hemicolectomy

2.72

3.67

1.4

1.2

2.72

2.86

g/l

0.09

Benign lipomatous neoplasm of other sites/unspecified

297

1.76

3.66

1.2

1.4

2.83

2.91

g/l

0.08

219

Hypertrophy of breast in women and men

141

1010

1.40

3.66

1.4

1.3

2.87

2.90

g/l

0.08

727

Other symptoms and signs involving the urinary system

418

1.64

3.66

1.5

1.3

2.86

3.05

g/l

0.37

301

Spirochaetal infections, other/unspecified

380

1.67

3.65

1.3

1.4

2.79

2.96

g/l

0.37

270

Mental and behavioural disorders due to alcohol

341

2624

1.24

3.65

1.3

1.4

2.92

3.03

g/l

0.44

223

1865

Caries of enamel

708

3982

1.16

3.65

1.4

2.94

g/l

0.01

562

2822

Dislocation, sprain and strain of joints and ligaments of head

176

2.01

3.65

1.5

1.3

2.66

2.84

g/l

0.21

127

Dissociative [conversion] disorders

149

2.10

3.64

1.2

1.3

2.93

3.14

g/l

0.34

101

Benign neoplasm of middle ear and respiratory system

283

1.78

3.64

1.8

1.3

3.28

2.97

g/l

0.59

202

Other and unspecified nonscarring hair loss

4.11

3.63

1.1

1.4

3.16

3.15

g/l

—

Myocardial infarction, without ST-elevation

218

1505

1.31

3.62

1.4

2.89

2.94

g/l

0.18

173

1064

Dislocation, sprain and strain of joints and ligaments at neck level

116

804

1.45

3.62

1.5

1.4

2.90

2.97

g/l

0.21

570

Left ventricular outflow tract obstruction (LVOTO), broad definition

498

1.58

3.61

1.6

1.3

2.85

2.94

g/l

0.13

369

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

143

2.12

3.60

1.6

1.3

3.50

2.92

g/l

1.16

107

Hemiplegia

163

2.04

3.60

1.3

2.67

2.97

g/l

0.41

118

Any dementia, excluding more controls

1000

0.68

3.60

1.2

1.4

2.83

2.96

g/l

0.28

708

Other acquired deformities of musculoskeletal system and connective tissue

177

2.00

3.59

1.9

1.3

2.53

3.01

g/l

0.94

122

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

143

2.11

3.59

1.6

1.2

3.77

3.08

g/l

0.67

108

Examination and encounter for administrative purposes

270

1.79

3.56

1.2

2.99

2.95

g/l

0.06

164

Alzheimer’s disease, strict definition

707

0.59

3.54

1.1

1.4

3.00

2.87

g/l

0.20

513

Delirium, not induced by alcohol and other psychoactive substances

413

1.63

3.54

1.4

1.3

2.73

2.98

g/l

0.43

300

Other disorders of glucose regulation and pancreatic internal secretion

338

1.70

3.53

1.7

1.3

2.82

2.94

g/l

0.27

242

Medicines for HER+ breast cancer

137

1757

0.72

3.51

1.2

1.4

2.75

2.81

g/l

0.15

1293

Sequelae of injuries, of poisoning and of other consequences of external causes

163

1206

1.36

3.49

1.4

1.3

2.83

2.98

g/l

0.42

113

864

Primary open-angle glaucoma

173

1241

1.34

3.49

1.4

2.81

2.86

g/l

0.13

113

889

Female infertility, associated with anovulation

332

1.70

3.48

1.5

1.4

3.04

3.11

g/l

0.10

239

Chalazion

511

1.55

3.46

1.7

1.3

3.15

2.95

g/l

0.29

366

Palmar fascial fibromatosis [Dupuytren]

503

1.56

3.46

1.4

1.3

2.98

2.96

g/l

0.03

356

Unstable angina pectoris

189

1119

1.33

3.45

1.4

2.93

3.01

g/l

0.23

148

771

Chondrocostal junction syndrome [Tietze]

139

2.11

3.44

1.5

1.3

2.90

2.75

g/l

0.21

100

Malignant neoplasm of thyroid gland, including Hilmo

311

1.72

3.43

1.7

1.4

2.73

2.82

g/l

0.12

225

Kyphosis

3.58

3.42

1.2

1.3

3.02

2.90

g/l

—

Persons encountering health services in circumstances related to reproduction

426

2368

1.21

3.40

1.3

1.4

2.84

2.90

g/l

0.30

307

1719

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

408

2622

1.21

3.40

1.4

2.87

2.93

g/l

0.30

285

1950

Bacterial, viral and other infectious agents

388

1.63

3.40

1.4

1.3

2.84

3.02

g/l

0.40

270

Embedded teeth, including avohilmo

427

1.60

3.39

1.4

2.85

2.96

g/l

0.25

309

Use of donepezil

629

0.54

3.39

1.2

1.4

2.62

2.87

g/l

0.48

463

Injury of unspecified body region

298

1.72

3.35

1.5

1.3

2.35

2.90

g/l

1.53

222

Campylobacter enteritis

2.34

3.35

1.3

3.01

2.76

g/l

0.27

Sixth [abducent] nerve palsy

121

2.17

3.33

1.6

1.3

2.65

2.87

g/l

0.24

Malignant neoplasm of endocrine gland, including Hilmo

352

1.66

3.32

1.6

1.4

2.71

2.84

g/l

0.18

250

Injuries to unspecified part of trunk, limb or body region

438

1.58

3.30

1.6

1.3

2.39

3.00

g/l

2.59

323

Cholesteatoma of middle ear

162

1.99

3.30

2.2

1.3

2.78

2.89

g/l

0.10

118

Endometriosis of ovary

105

685

1.45

3.29

1.3

2.99

2.82

g/l

0.44

484

Hypertrophy of tongue papillae

2.83

3.28

1.6

1.3

3.05

2.83

g/l

—

Cardiac arrest

148

1.96

3.28

1.1

1.3

2.50

3.24

g/l

1.27

104

Malignant neoplasm of breast, ER-positive, including Hilmo

118

1226

0.71

3.27

1.2

1.4

2.80

2.92

g/l

0.31

908

Complications of other internal prosthetic devices, implants and grafts

122

2.15

3.26

1.2

1.3

2.69

2.84

g/l

0.15

Other noninflammatory disorders of vagina

316

1.69

3.25

1.3

3.06

2.93

g/l

0.21

228

Malignant neoplasm of breast, HER-positive

118

1225

0.71

3.24

1.2

1.4

2.80

2.92

g/l

0.32

907

Carcinoma in situ of skin of upper limb, including shoulder

2.53

3.22

1.4

1.3

2.36

2.67

g/l

0.37

Primary open-angle glaucoma, strict

142

1040

1.37

3.22

1.4

2.76

2.84

g/l

0.21

739

Other secondary gonarthrosis

199

1.87

3.21

1.3

1.4

3.49

2.95

g/l

0.43

146

Benign neoplasm: Rectosigmoid junction

130

2.10

3.19

1.1

1.3

2.74

3.00

g/l

0.37

Scabies

214

1.84

3.19

1.7

1.3

3.28

2.96

g/l

0.41

155

Postmenopausal bleeding

152

582

1.37

3.18

1.3

2.87

2.70

g/l

0.56

109

413

LSIL lesion of the vagina

2.77

3.17

1.4

1.3

2.95

2.93

g/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

251

1.77

3.17

1.3

1.4

2.76

2.99

g/l

0.42

185

Malignant neoplasm of breast

167

1422

0.76

3.16

1.2

1.4

2.79

2.91

g/l

0.42

112

1057

Prolonged pregnancy

733

0.61

3.15

1.2

1.4

3.02

3.12

g/l

0.23

544

Atopic conjunctivitis

179

1.92

3.15

1.5

1.3

2.80

2.88

g/l

0.12

138

Other strabismus

155

1154

1.34

3.15

1.6

1.4

3.03

2.85

g/l

0.50

108

834

Seborrhoeic dermatitis

412

1.59

3.14

1.3

2.85

2.99

g/l

0.27

311

Wet age-related macular degeneration

519

1.51

3.14

1.4

2.74

2.90

g/l

0.33

393

Mixed and other personality disorders

381

1.61

3.14

1.5

1.4

2.84

2.99

g/l

0.22

277

Chondropathies

107

753

1.43

3.14

1.6

1.4

2.91

2.93

g/l

0.04

538

Malignant neoplasm of breast, HER2-negative

167

1420

0.76

3.13

1.2

1.4

2.79

2.91

g/l

0.41

112

1055

Normotensive glaucoma

282

1.71

3.12

1.5

1.3

2.75

2.90

g/l

0.23

211

Abdominal aortic aneurysm (AAA)

272

1.72

3.11

1.5

1.2

2.66

3.01

g/l

1.05

206

Sequelae of injuries of neck and trunk

105

2.21

3.10

1.6

1.3

2.87

2.85

g/l

0.01

Myelodysplastic syndrome

3.72

3.10

1.4

1.3

2.26

2.45

g/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

238

1.78

3.10

2.2

1.5

2.55

2.87

g/l

0.54

174

Effects of foreign body entering through natural orifice

167

1266

1.32

3.09

1.3

1.4

2.82

3.00

g/l

0.66

113

908

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

253

1.75

3.08

1.4

2.51

2.99

g/l

1.07

189

Amiodarone users

360

1.62

3.07

1.2

1.4

2.96

g/l

0.00

263

Suicide or other Intentional self-harm

169

1285

1.32

3.06

1.3

1.4

2.78

2.98

g/l

0.80

119

924

Residual foreign body in soft tissue

188

1.87

3.06

1.4

1.3

2.88

2.93

g/l

0.10

132

Melanocytic naevi

216

1697

1.28

3.05

1.4

2.67

2.97

g/l

1.92

170

1225

Gonarthrosis, primary, with knee surgery

349

2242

1.21

3.04

1.4

2.90

2.91

g/l

0.02

253

1618

Benign neoplasm of meninges

408

1.58

3.03

1.7

1.4

2.64

2.81

g/l

0.40

293

Salpingitis and oophoritis

117

842

1.40

3.03

1.4

2.39

2.87

g/l

3.38

610

Benign neoplasm: Cerebral meninges

369

1.61

3.03

1.7

1.4

2.67

2.84

g/l

0.33

268

Injuries to the elbow and forearm

507

3713

1.17

3.02

1.4

2.86

2.92

g/l

0.29

369

2698

Pilonidal cyst

401

1.58

3.01

1.4

1.3

3.43

3.08

g/l

0.82

285

Glaucoma-related operations

175

1.90

3.00

1.4

1.3

2.82

2.84

g/l

0.03

131

Psoriasis (vulgaris), strict definition

120

2.10

2.99

1.1

1.3

2.97

2.98

g/l

0.01

Amputation

316

1.65

2.99

1.4

1.2

2.85

3.04

g/l

0.26

228

Meralgia paraesthetica

127

2.07

2.98

1.5

1.4

3.00

2.96

g/l

0.04

Unspecified event, undetermined intent

2.26

2.98

1.4

1.3

3.60

2.78

g/l

0.78

Disorders of breast

333

2418

1.21

2.97

1.5

1.4

2.84

2.88

g/l

0.17

247

1765

Congenital malformations of genital organs

487

1.52

2.97

1.2

1.4

2.56

2.82

g/l

0.85

371

Corns and callosities

249

1.74

2.96

1.2

1.4

3.16

3.07

g/l

0.09

182

Melanoma in situ

148

1.98

2.95

1.4

2.99

2.87

g/l

0.10

109

Other benign neoplasms of connective and other soft tissue

411

1.57

2.95

1.5

1.4

2.55

2.93

g/l

1.15

297

Other disorders of pigmentation

162

1.93

2.95

1.4

2.76

3.06

g/l

0.48

117

Primary gonarthrosis, bilateral

311

2134

1.22

2.95

1.3

1.4

2.94

2.93

g/l

0.06

240

1543

Sequelae of other external causes

220

1.78

2.93

1.7

1.3

2.59

2.97

g/l

0.80

160

Gestational [pregnancy-induced] hypertension

174

1336

1.30

2.91

1.6

1.4

3.12

2.97

g/l

0.55

132

973

2.24

2.91

1.2

1.3

3.19

3.10

g/l

0.07

Other diseases of spinal cord

2.23

2.91

1.3

2.70

2.74

g/l

0.03

Solid cancers, including Hilmo

587

2954

1.16

2.90

1.3

1.4

2.87

3.02

g/l

1.21

405

2161

Monoamine oxidase A inhibitors

477

1.52

2.89

1.2

1.3

2.73

3.01

g/l

0.84

336

Malignant neoplasm of breast, including Hilmo

174

1444

0.77

2.89

1.2

1.4

2.81

2.91

g/l

0.36

119

1071

Malignant neoplasm of breast, HER2-negative, including Hilmo

174

1444

0.77

2.89

1.2

1.4

2.81

2.91

g/l

0.36

119

1071

Malignant neoplasm of digestive organs

228

1383

1.26

2.89

1.4

3.04

3.00

g/l

0.10

149

1014

L01XX Other antineoplastic agents

185

1.85

2.87

1.2

1.4

2.36

2.86

g/l

0.79

138

150

972

1.33

2.84

1.3

1.4

2.83

2.90

g/l

0.21

105

697

Cystic kidney disease

116

2.09

2.84

1.3

3.06

2.77

g/l

0.27

Fall on same level involving ice and snow

398

3359

1.19

2.83

1.6

1.4

2.92

2.94

g/l

0.07

289

2443

Malignant neoplasm of thyroid gland

283

1.67

2.83

1.7

1.4

2.75

2.84

g/l

0.10

206

Other puerperal infections

392

1.57

2.82

1.4

2.92

2.96

g/l

0.07

287

Astigmatism

298

1.65

2.82

1.3

1.4

2.63

2.75

g/l

0.19

220

Hydronephrosis

432

1.53

2.81

1.4

1.3

2.90

3.05

g/l

0.31

320

Other and unspecified primary disorders of muscles

3.67

2.81

2.1

1.3

2.94

2.69

g/l

—

Other and unspecified trigeminal disorders

2.68

2.81

1.1

1.5

3.24

2.85

g/l

—

Acute nephritic syndrome

2.49

2.80

1.6

1.3

2.54

2.88

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

401

1.55

2.79

1.3

2.74

2.96

g/l

0.59

295

Benign neoplasm of ovary

103

737

1.40

2.79

1.2

1.5

2.60

2.80

g/l

0.73

527

Other and unspecified local infections of skin and subcutaneous tissue

425

1.54

2.79

1.5

1.3

2.58

2.92

g/l

0.77

318

Speech disturbances, not elsewhere classified

307

1.64

2.79

1.3

2.55

2.95

g/l

1.26

225

Superficial injury of head

154

1172

1.32

2.78

1.6

1.3

2.62

2.86

g/l

1.07

127

839

Carbimazole or st.post thyroidectomy, condition for graves disease

139

1044

1.34

2.78

1.7

1.4

2.80

2.89

g/l

0.30

743

Emotional disorders starting during childhood or adolecense, excluding more controls

174

1.85

2.78

1.4

1.3

2.07

2.90

g/l

3.39

128

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

119

873

1.37

2.78

1.3

1.4

2.89

3.00

g/l

0.26

617

Malignant neoplasm, without specification of site, including Hilmo

117

2.06

2.76

1.7

1.4

3.38

3.02

g/l

0.23

Contact with other hot fluids

131

2.00

2.76

1.3

2.51

2.70

g/l

0.26

Certain conditions originating in the perinatal period

391

1.53

2.76

1.3

2.43

2.77

g/l

0.96

304

Viral haemorrhagic fevers, not elsewhere classified/unspecified

316

1.62

2.75

1.4

1.3

2.74

3.04

g/l

0.78

226

Dysplasia of cervi uteri

141

742

1.34

2.75

1.4

2.75

2.89

g/l

0.49

102

531

Respiratory tuberculosis, not confirmed, including avohilmo

104

2.13

2.75

2.8

1.3

2.65

2.76

g/l

0.11

Sub-endpoint used in defining T1D endpoints

185

1424

1.28

2.74

1.4

1.3

2.82

2.95

g/l

0.40

132

1035

Uterine polyps

165

736

1.31

2.72

1.3

2.87

2.81

g/l

0.16

121

522

Other congenital malformations of skin

167

1.87

2.72

1.3

3.10

2.76

g/l

0.66

127

Peripheral arterial reconstruction

582

1.45

2.72

1.4

2.54

3.01

g/l

1.69

425

Acidosis

2.45

2.72

1.1

1.2

2.25

3.00

g/l

—

Varicose veins

368

2333

1.19

2.71

1.5

1.4

2.83

2.91

g/l

0.36

254

1707

Muscle strain

2.16

2.71

1.2

1.4

2.95

3.09

g/l

0.08

Social phobias

388

1.55

2.71

1.5

1.3

2.99

3.08

g/l

0.18

269

Adenomyosis (Endometriosis of uterus)

541

1.46

2.70

1.2

1.4

2.74

2.80

g/l

0.13

390

Congenital malformations of the circulatory system

106

745

1.39

2.69

1.6

1.4

2.60

2.81

g/l

0.68

560

L02BG Aromatase inhibitors

110

1474

0.73

2.68

1.2

1.4

2.70

2.76

g/l

0.16

1071

Mental and behavioural disorders due to opioids

161

1.88

2.67

1.5

1.3

2.55

2.96

g/l

0.54

112

Malignant neoplasm of endocrine gland

311

1.62

2.67

1.7

1.4

2.75

2.82

g/l

0.08

225

Specific development disorders of speech and language

277

1.65

2.67

1.4

1.3

2.43

2.62

g/l

0.47

212

Entropion and trichiasis of eyelid

227

1.73

2.66

1.5

1.3

2.70

2.84

g/l

0.25

165

Embedded and impacted teeth

196

1255

1.27

2.66

1.4

2.97

2.95

g/l

0.07

157

900

Alzheimer’s disease (Late onset)

637

0.63

2.66

1.1

1.4

2.80

2.87

g/l

0.11

462

Other benign neoplasms of skin

233

1882

1.24

2.65

1.6

1.4

3.07

2.89

g/l

0.78

176

1344

Behavioural disorders, excluding more controls

2.35

2.64

1.3

2.20

2.87

g/l

—

Infective bursitis

2.23

2.64

1.2

1.3

3.18

3.10

g/l

0.06

Personal history of other diseases and conditions

575

1.44

2.64

1.5

1.4

2.47

2.89

g/l

1.86

440

Alcohol abuse, main dg

106

772

1.38

2.61

1.3

1.4

2.98

2.94

g/l

0.08

551

100

2.12

2.60

2.1

1.3

3.49

3.02

g/l

0.68

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

285

1581

1.22

2.60

1.7

1.4

2.75

2.99

g/l

1.72

211

1166

Other local infections of skin and subcutaneous tissue

457

1.50

2.59

1.5

1.3

2.55

2.93

g/l

0.98

339

Allergic contact dermatitis due to drugs in contact with skin

2.32

2.59

1.3

2.94

2.68

g/l

—

Isolated proteinuria with specified morphological lesion

3.11

2.58

3.1

1.4

3.08

2.89

g/l

—

Other menopausal disorders

162

693

1.31

2.57

1.8

1.3

2.93

2.82

g/l

0.39

118

493

Pustular psoriasis

185

1.80

2.57

1.2

1.5

3.80

2.89

g/l

1.15

134

Other specified disorders of kidney and ureter

114

2.04

2.57

1.5

1.3

2.76

2.89

g/l

0.15

Hypertrophic cardiomyopathy

149

1.89

2.57

1.4

1.3

2.23

2.81

g/l

1.44

108

Disturbances of smell and taste

149

1.89

2.56

1.3

1.5

3.07

2.99

g/l

0.06

104

Familial hypercholesterolemia, with ischemic heart disease

268

1.65

2.56

1.4

1.3

2.68

3.13

g/l

1.15

200

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

125

768

1.34

2.55

1.2

1.4

2.60

2.95

g/l

1.32

549

Malignant neoplasm of small intestine, including Hilmo

2.15

2.55

1.1

1.5

2.90

g/l

0.00

Crossbite

362

1.53

2.55

1.3

1.4

2.29

2.69

g/l

1.33

289

Papillary adenocarcinoma of thyroid gland

208

1.74

2.54

1.9

1.4

2.78

2.86

g/l

0.07

149

All dysplastic lesions of the vagina

101

2.10

2.54

1.5

1.4

2.87

2.95

g/l

0.08

Pregnancy hypertension

275

2027

1.21

2.54

1.5

1.4

3.04

2.91

g/l

0.63

209

1488

Congenital malformations of eye, ear, face and neck

300

1.61

2.53

1.3

3.02

2.84

g/l

0.28

222

Stroke, excluding SAH

351

2132

1.19

2.53

1.2

1.4

2.88

2.90

g/l

0.07

260

1508

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

147

1131

1.30

2.52

1.2

1.4

2.91

3.03

g/l

0.37

103

811

Superficial injury of forearm

501

1.46

2.52

1.5

1.4

2.74

2.92

g/l

0.39

367

Hypoglycaemia, other or unspecified

254

1.66

2.52

1.9

1.3

2.81

2.85

g/l

0.08

181

Vertical strabismus

129

1.96

2.51

1.3

3.45

2.86

g/l

0.50

100

Oligomenorrhoea

136

1.93

2.51

1.8

1.4

2.73

3.04

g/l

0.48

103

Female infertility, tubal origin

209

1.73

2.50

1.2

1.4

3.03

3.02

g/l

0.02

157

Peripheral artery operations in Hilmo

420

1.50

2.50

1.5

1.3

2.67

3.05

g/l

0.78

309

Contraceptive management

294

1704

1.21

2.49

1.3

1.4

2.91

2.95

g/l

0.13

214

1241

Congenital ovarian cysts

202

1.75

2.49

1.2

1.4

2.71

2.97

g/l

0.44

149

Open wound of wrist and hand

308

2488

1.20

2.49

1.3

1.4

2.83

3.06

g/l

1.74

233

1769

Benign neoplasm of bone and articular cartilage

397

1.52

2.48

2.0

1.4

2.90

2.97

g/l

0.13

285

Other malignant neoplasms of skin (=non-melanoma skin cancer)

271

1513

1.22

2.48

1.6

1.4

2.78

2.99

g/l

1.32

201

1110

Respiratory tuberculosis, not confirmed

102

2.07

2.47

2.9

1.3

2.54

2.77

g/l

0.28

Other noninflammatory disorders of uterus, except cervix

120

595

1.35

2.47

1.5

1.3

2.84

2.74

g/l

0.26

425

Other degenerative diseases of the nervous system

147

822

1.31

2.47

1.4

2.78

3.03

g/l

0.83

107

582

Somnolence, stupor and coma

144

1.89

2.46

1.4

2.01

2.91

g/l

3.36

109

Cystic kidney disease, including avohilmo

123

1.97

2.46

1.3

3.06

2.82

g/l

0.22

Other symptoms and signs involving general sensations and perceptions

137

1.91

2.46

1.2

1.3

2.65

2.84

g/l

0.22

Essential (haemorrhagic) thrombocythaemia

123

1.97

2.46

1.2

1.4

2.86

2.85

g/l

0.00

Secondary polycythaemia

2.26

2.45

1.4

1.3

2.35

2.90

g/l

—

Other arterial embolism and thrombosis

2.26

2.45

1.4

1.2

2.12

2.92

g/l

1.34

Impacted teeth

145

958

1.30

2.44

1.3

3.05

2.95

g/l

0.30

118

687

Transient ischemic attack

300

1994

1.20

2.42

1.4

2.79

2.91

g/l

0.59

219

1423

Impotence

219

1.70

2.41

1.4

1.3

2.97

3.15

g/l

0.25

150

Benign neoplasm: Long bones of lower limb

131

1.93

2.41

1.8

1.4

2.48

2.79

g/l

0.52

Dementia in Alzheimer disease

477

0.59

2.41

1.1

1.3

2.95

2.89

g/l

0.05

347

Aortic valve malfunction, age under 60 years

449

1.48

2.40

1.6

1.3

3.06

2.96

g/l

0.12

330

Pustulosis palmaris et plantaris

160

1.83

2.40

1.1

1.5

3.85

2.97

g/l

1.02

120

Use of antiglaucoma preparations and miotics

227

1.68

2.39

1.3

2.86

2.83

g/l

0.04

171

104

715

1.36

2.39

1.3

1.4

2.80

2.88

g/l

0.18

517

Other renal tubulo-interstitial diseases

2.23

2.38

1.1

1.3

2.75

2.93

g/l

0.11

Medical abortion

418

1937

1.17

2.38

1.3

1.4

2.85

2.89

g/l

0.20

309

1417

Other and unspecified mood [affective] disorders

313

1.57

2.38

1.2

1.4

2.84

2.93

g/l

0.13

222

Postprocedural musculoskeletal disorders, not elsewhere classified

274

1.62

2.37

1.4

1.5

2.53

3.00

g/l

1.09

201

Alcohol use disorder, ICD-based

263

2180

1.21

2.37

1.2

1.4

2.93

3.04

g/l

0.40

169

1561

Hallux rigidus

525

1.43

2.35

1.4

1.6

3.02

2.95

g/l

0.18

384

Other disorders of breast

668

1.38

2.35

1.4

3.13

2.85

g/l

0.69

476

Type 1 diabetes, wide definition

143

1107

1.29

2.35

1.4

2.82

2.97

g/l

0.43

106

815

Psychotic depression

221

1.68

2.34

1.2

1.5

3.28

2.95

g/l

0.42

155

Open wound of forearm

427

1.48

2.34

1.3

2.89

2.97

g/l

0.12

308

Drug-induced systemic lupus erythematosus

3.30

2.33

1.4

3.36

3.04

g/l

—

Background retinopathy and retinal vascular changes

2.33

2.32

1.5

1.2

2.54

2.87

g/l

—

Inflammatory diseases of prostate (prostatitis)

510

1.44

2.32

1.2

1.4

3.11

3.15

g/l

0.07

359

Benign neoplasm: Skin of eyelid, including canthus

661

1.38

2.32

1.7

1.4

3.25

2.86

g/l

1.10

474

Emotionally unstable personality disorder

628

1.39

2.31

1.4

2.64

2.99

g/l

1.11

449

Heart failure and hypertrophic cardiomyopathy

2.40

2.30

1.4

1.3

2.16

2.71

g/l

—

Melanocytic naevi, other sites/unspecified

372

1.51

2.30

1.6

1.4

2.98

2.96

g/l

0.03

264

Ménière disease

364

1.52

2.29

1.5

1.4

2.53

2.89

g/l

0.96

261

Disorders of speech understanding and production

196

1.71

2.28

1.5

1.3

2.39

2.52

g/l

0.25

160

Brain meningioma, including Hilmo

185

1.74

2.28

1.6

1.5

2.40

2.81

g/l

0.78

132

Benign neoplasm: Tongue

2.08

2.28

1.6

1.3

2.51

2.94

g/l

0.64

Presence of other devices

129

975

1.30

2.27

1.3

1.4

2.83

2.94

g/l

0.34

107

726

Major anomalies of jaw size

113

1.97

2.26

1.3

3.14

2.73

g/l

0.63

Pediculosis, acariasis and other infestations

278

1.59

2.26

1.6

1.3

3.34

2.92

g/l

0.64

200

Benign thyroid growths and nodules

186

1389

1.25

2.25

1.8

1.4

2.87

2.83

g/l

0.11

137

1005

Myeloproliferative diseases

294

1.57

2.24

1.2

1.4

2.62

2.95

g/l

0.64

215

Maltreatment syndromes

232

1.65

2.23

1.2

1.4

3.22

2.99

g/l

0.31

171

Emotional disorders and disorders of social functioning with onset specific to childhood

242

1.63

2.23

1.4

2.11

2.70

g/l

2.44

185

Impacted cerumen

448

1.46

2.23

1.4

1.3

2.80

2.94

g/l

0.25

329

Malignant neoplasm of liver and intrahepatic bile ducts

2.11

2.23

1.3

1.2

4.58

3.06

g/l

—

Urethral stricture

179

1.74

2.22

1.2

3.39

3.03

g/l

0.37

134

Oral leukoplakia, including avohilmo

2.06

2.22

1.3

2.68

2.79

g/l

0.06

Other diseases of peritoneum

157

1.80

2.22

1.4

3.13

2.94

g/l

0.18

119

Benign neoplasm: Adrenal gland

319

1.54

2.21

1.2

1.4

2.90

2.94

g/l

0.07

231

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

115

873

1.32

2.21

1.3

1.4

2.75

2.90

g/l

0.55

638

Benign neoplasm: Skin, unspecified

150

1.81

2.21

1.2

1.4

2.81

2.97

g/l

0.15

107

Degenerative macular diseases

400

1.48

2.20

1.5

1.3

2.69

2.91

g/l

0.55

295

Polyp of the female genital tract

170

762

1.27

2.19

1.3

2.90

2.81

g/l

0.27

126

540

Blepharochalasis

163

1297

1.26

2.19

1.4

1.3

2.93

2.85

g/l

0.24

118

932

Non-small cell lung cancer, adenocarcinoma

180

1.73

2.19

1.1

1.4

2.77

3.06

g/l

0.52

132

Endometriosis diagnosis and infertility diagnosis occurring together

559

1.40

2.18

1.4

3.14

2.98

g/l

0.36

398

Other congenital malformations of circulatory system

2.04

2.17

2.8

1.3

3.24

2.86

g/l

0.45

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

151

1.80

2.17

1.4

1.3

2.58

2.92

g/l

0.77

113

Recurrent dislocation and subluxation of joint

289

1.56

2.16

1.2

1.4

2.67

3.13

g/l

1.34

197

Endometriosis ASRM stages 3,4

142

1114

1.28

2.15

1.4

2.80

2.88

g/l

0.23

112

794

Other predominantly sexually transmitted diseases, not elsewhere classified

121

930

1.31

2.15

1.3

1.4

2.96

3.03

g/l

0.15

661

Additional codes for the location of defect, injury or illness

227

1.64

2.15

1.6

1.3

2.85

3.00

g/l

0.21

164

Ischaemic Stroke, excluding all haemorrhages

320

2000

1.18

2.14

1.3

1.4

2.91

g/l

0.03

232

1425

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.40

2.13

1.1

1.4

3.27

2.90

g/l

—

Varicella [chickenpox]

220

1.65

2.13

1.2

1.3

2.59

2.83

g/l

0.32

157

Hypertrophy of breast

117

897

1.31

2.12

1.5

1.4

2.88

2.89

g/l

0.02

647

IgA nephropathy (IgA glomerulonephritis)

2.07

2.12

1.7

1.3

2.47

3.00

g/l

0.76

Malignant neoplasm of skin, including Hilmo

316

1796

1.18

2.11

1.6

1.4

2.75

3.01

g/l

2.11

233

1322

Hyperprolactinaemia

145

1.81

2.11

1.4

2.55

3.01

g/l

1.44

102

Lesion of femoral nerve

3.26

2.11

1.1

1.4

4.28

2.91

g/l

—

Nontoxic multinodular goitre

104

785

1.33

2.10

1.5

1.4

2.72

2.81

g/l

0.27

568

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

292

1.55

2.08

1.4

1.3

2.49

2.96

g/l

1.33

212

Coxarthrosis, primary

349

2488

1.17

2.08

1.3

1.4

2.87

2.91

g/l

0.13

285

1772

Glucosamine medication

254

1695

1.20

2.07

1.3

1.4

2.83

2.86

g/l

0.07

183

1222

Mental and behavioural disorders due to alcohol, excluding acute intoxication

278

2329

1.18

2.07

1.2

1.4

2.89

3.03

g/l

0.60

179

1676

Superficial injury of thorax

693

1.35

2.06

1.6

1.3

2.81

2.97

g/l

0.35

508

Benign neoplasm: Skin of trunk

161

1.75

2.06

2.2

1.3

3.07

2.93

g/l

0.16

124

Hypertensive Renal Disease

1.99

2.05

1.7

1.3

2.42

2.72

g/l

0.28

Autism spe, excluding more controls

1.99

2.05

1.5

1.4

2.65

2.86

g/l

0.19

UC patients in KELA-register (code 208), prior to 1994

154

1.77

2.04

1.6

1.4

2.77

2.95

g/l

0.23

114

Vestibular neuronitis

358

1.49

2.04

1.3

1.4

3.16

2.95

g/l

0.34

264

Vitreous haemorrhage

399

1.46

2.04

1.4

3.10

2.98

g/l

0.18

294

Malignant neoplasm of bronchus and lung, including Hilmo

105

663

1.32

2.04

1.2

1.5

2.56

2.97

g/l

1.64

481

Motor disorders, excluding more controls

2.14

2.03

1.7

1.2

1.80

2.45

g/l

1.48

Other vitreous opacities

147

1.78

2.03

1.4

2.55

2.90

g/l

0.74

109

Diabetic nephropathy, excluding more controls

543

1.35

2.02

1.4

1.5

2.84

2.94

g/l

0.20

364

Other abnormal findings in urine

2.53

2.02

1.5

1.4

2.57

3.08

g/l

—

Stroke, including SAH

372

2307

1.16

2.01

1.3

1.4

2.85

2.91

g/l

0.31

278

1632

Unspecified urinary incontinence

327

1.50

2.00

1.4

2.70

2.76

g/l

0.07

230

Short stature starting before birth

2.68

1.98

1.4

1.2

1.86

2.05

g/l

—

Malignant neoplasm of brain

119

1.86

1.97

1.3

1.2

2.75

2.94

g/l

0.17

Bitten or struck by other mammals

571

1.37

1.95

1.4

2.81

2.95

g/l

0.31

410

Injury of muscle and tendon at shoulder and upper arm level

215

1788

1.20

1.95

1.4

2.90

2.99

g/l

0.31

153

1283

Primary hyperparathyroidism

437

1.42

1.94

1.7

1.4

2.57

2.84

g/l

0.70

308

Injury of muscle and tendon at hip and thigh level

496

1.40

1.93

1.3

1.4

2.97

2.93

g/l

0.06

360

Use of glatiramer acetate

2.14

1.93

1.3

1.4

3.31

3.02

g/l

—

Amputation of toe

234

1.59

1.93

1.4

1.2

2.73

3.05

g/l

0.49

169

Status post-ami

118

694

1.29

1.92

1.3

1.4

3.05

3.07

g/l

0.04

103

485

Chronic periodontitis, including avohilmo

673

3863

1.11

1.91

1.4

2.91

2.97

g/l

0.44

508

2747

Calcific tendinitis of shoulder

211

1.62

1.91

1.2

1.4

3.30

2.89

g/l

0.57

147

Arterial embolism and thrombosis of lower extremity artery

1.93

1.90

1.2

2.48

2.85

g/l

0.43

Other infective otitis externa

235

1.58

1.90

1.2

1.4

2.74

3.00

g/l

0.51

172

Pedestrian injured in transport accident

275

1.53

1.89

1.3

1.4

3.16

3.02

g/l

0.16

200

Malignant neoplasm of oral cavity, including Hilmo

143

1.76

1.89

1.2

1.3

3.13

3.07

g/l

0.05

106

Hydatidiform mole

0.00

1.89

0.0

1.5

—

3.04

—

False labour

205

1050

1.21

1.89

1.3

1.4

3.07

3.03

g/l

0.12

140

782

Biomechanical lesions, not elsewhere classified

174

1.68

1.86

1.2

1.4

2.57

2.97

g/l

0.53

126

In situ neoplasms

236

1989

1.19

1.86

1.3

1.4

2.77

2.91

g/l

0.74

164

1439

Foreign body in respiratory tract

205

1.62

1.86

1.5

1.4

3.05

2.81

g/l

0.24

154

L02BA Anti-estrogens

755

0.70

1.85

1.1

1.5

2.75

2.85

g/l

0.16

541

Brain meningioma

182

1.66

1.85

1.7

1.5

2.45

2.80

g/l

0.61

130

Atlantoaxial subluxation

3.59

1.85

1.2

1.5

2.37

2.90

g/l

—

Other and unspecified injuries of ankle and foot

167

1.69

1.84

2.0

1.3

2.85

g/l

0.01

118

Foreign body on external eye

707

1.32

1.84

1.2

1.3

2.76

3.02

g/l

0.85

504

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

100

768

1.31

1.83

1.4

2.76

2.88

g/l

0.39

569

Benign lipomatous neoplasm

174

1429

1.22

1.82

1.3

1.4

2.90

2.94

g/l

0.09

115

1035

Cysts of oral region, not elsewhere classified

238

1.56

1.81

1.7

1.4

3.06

3.04

g/l

0.03

173

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

168

1.68

1.81

1.5

1.3

3.11

3.13

g/l

0.01

128

Unspecified dementia

271

0.53

1.81

1.0

1.3

3.01

2.91

g/l

0.08

211

!Aliquae complicationes praecoces traumatis

168

1.68

1.81

1.4

1.3

2.59

2.98

g/l

0.73

120

Early complications of trauma

168

1.68

1.81

1.4

1.3

2.59

2.98

g/l

0.73

120

Dronedarone medication

1.93

1.81

1.3

1.1

2.86

3.04

g/l

0.21

Melanocytic naevi of lower limb, including hip

176

1.66

1.80

1.5

1.3

2.41

2.98

g/l

1.41

126

Insulin, fast-acting (human)

632

1.33

1.79

1.3

3.00

3.04

g/l

0.08

445

Primary coxarthrosis, bilateral

152

1233

1.24

1.79

1.4

2.64

2.88

g/l

0.95

124

871

Fracture of skull and facial bones

134

1072

1.25

1.79

1.5

1.3

2.83

2.98

g/l

0.42

757

Postmenopausal atrophic vaginitis

140

607

1.26

1.79

1.6

1.3

2.74

2.73

g/l

0.02

114

432

Myeloproliferative diseases (CML excluded)

263

1.53

1.78

1.2

1.4

2.70

2.92

g/l

0.39

192

Universal erythroderma, KELA reimbursement

2.37

1.78

1.1

1.4

2.82

2.75

g/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

337

1.46

1.77

1.2

1.4

2.73

3.09

g/l

1.02

228

Malignant neoplasm of small intestine

2.11

1.76

1.1

1.5

2.33

2.87

g/l

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

216

1.58

1.76

1.6

1.4

3.63

2.98

g/l

0.61

160

Injury of muscle and tendon at wrist and hand level

634

1.33

1.76

1.4

2.59

3.07

g/l

1.94

459

Other superficial mycoses, including avohilmo

514

1.37

1.75

1.2

1.4

2.60

2.98

g/l

1.61

375

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

330

1.46

1.74

1.4

2.57

2.97

g/l

1.10

239

Other/unspecified disorders of vestibular function

147

1.71

1.74

1.1

1.4

2.94

2.86

g/l

0.07

110

Preterm labour and delivery

161

1319

1.22

1.73

1.4

2.99

2.86

g/l

0.34

109

977

Perineal laceration during delivery

770

0.74

1.72

1.7

1.4

3.05

2.97

g/l

0.17

564

Other appendicitis

364

1.43

1.72

1.2

1.4

3.03

2.96

g/l

0.10

259

Other otitis externa (chronic)

282

1.50

1.71

1.4

2.45

2.96

g/l

1.37

209

Open wound of abdomen, lower back and pelvis

118

1.79

1.70

1.2

2.72

2.96

g/l

0.18

Periodontitis

670

3869

1.10

1.70

1.4

2.92

2.97

g/l

0.36

507

2751

Other specified/unspecified hearing loss

324

1.46

1.69

1.6

1.3

2.87

3.02

g/l

0.26

234

Contusion of ankle

172

1.64

1.67

1.6

1.3

2.66

2.88

g/l

0.30

125

Other acquired deformities of ankle and foot

3.20

1.67

1.2

1.6

3.51

3.32

g/l

—

Cerebral aneurysm, nonruptured

375

1.42

1.67

1.4

2.68

2.88

g/l

0.40

269

Haemangioma, any site

375

1.42

1.67

1.7

1.4

2.90

2.92

g/l

0.03

271

Malignant neoplasm of skin

291

1701

1.16

1.65

1.6

1.4

2.74

3.01

g/l

2.01

216

1254

Hepatocellular carcinoma, including Hilmo

1.94

1.65

1.4

1.2

3.67

3.20

g/l

—

Contact with heat and hot substances

237

1.53

1.62

1.3

2.75

2.87

g/l

0.15

175

Other eating disorders

229

1.53

1.62

1.3

1.4

2.97

2.85

g/l

0.17

161

Diffuse brain injury

1.85

1.62

1.1

1.3

2.76

3.17

g/l

—

Graves disease, strict definition

480

1.36

1.60

1.4

2.82

2.95

g/l

0.30

350

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.96

1.60

1.5

1.4

2.86

2.78

g/l

—

Congenital malformations of the nervous system

106

1.81

1.59

1.2

1.3

2.65

2.51

g/l

0.13

Left bundle-branch block

238

1.52

1.59

1.3

3.13

3.11

g/l

0.03

172

Superficial injury of shoulder and upper arm

558

1.33

1.59

1.6

1.4

2.90

3.06

g/l

0.36

406

Other disorders of Eustachian tube

106

1.80

1.59

1.3

2.09

2.96

g/l

1.94

Basal cell carcinoma, including Hilmo

263

1532

1.16

1.58

1.7

1.4

2.73

2.99

g/l

1.84

196

1127

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

396

1.39

1.58

1.2

1.5

3.28

2.94

g/l

0.80

290

Peripheral retinal degeneration

1.83

1.57

1.4

1.3

2.79

2.98

g/l

—

Solid cancers

544

2872

1.11

1.57

1.3

1.4

2.85

3.02

g/l

1.38

374

2098

Intentional self-harm by sharp object

114

1.77

1.57

1.3

2.50

2.88

g/l

0.53

Conduct disorder

1.86

1.56

1.3

2.19

2.75

g/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

199

1.56

1.55

1.5

1.4

3.39

2.93

g/l

0.77

147

L01XE Protein kinase inhibitors

176

1.60

1.55

1.4

1.3

2.57

2.90

g/l

0.46

130

Other conjunctival vascular disorders and cysts

1.94

1.55

1.7

1.3

2.74

g/l

—

Melanocytic naevi of trunk

596

1.31

1.54

1.2

1.4

2.89

2.94

g/l

0.10

437

Fitting and adjustment of other devices

195

1450

1.19

1.54

1.4

2.84

2.97

g/l

0.52

168

1036

Other congenital malformations of skin, including avohilmo

373

1.40

1.54

1.3

2.94

2.95

g/l

0.03

270

Glaucoma, exfoliation

281

1.46

1.54

1.4

1.3

3.12

2.85

g/l

0.35

214

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

399

1.38

1.52

1.2

1.4

3.28

3.01

g/l

0.57

280

Hydrocele

433

1.37

1.52

1.3

1.4

2.63

3.16

g/l

1.60

308

Carcinoma in situ of skin

282

1.46

1.52

1.4

2.96

2.91

g/l

0.05

205

Congenital lens malformations

2.92

1.52

1.2

1.5

2.32

2.22

g/l

—

Retinal detachments and breaks

195

1652

1.18

1.51

1.6

1.4

2.86

2.95

g/l

0.35

147

1204

L02BB Anti-androgens

296

0.57

1.51

2.8

1.2

3.23

3.03

g/l

—

219

Lichen sclerosus et atrophicus

485

1.34

1.51

1.6

1.4

2.84

2.86

g/l

0.02

341

Varicella [chickenpox], including avohilmo

266

1.47

1.51

1.2

1.4

2.73

2.80

g/l

0.07

199

Lesion of sciatic nerve

108

1.77

1.50

1.3

1.2

3.28

2.84

g/l

0.33

Disorders of synovium and tendon in diseases classified elsewhere

2.08

1.49

1.4

1.3

2.80

2.83

g/l

—

Family history of other conditions

2.02

1.49

1.2

1.3

2.49

2.85

g/l

—

Contusion of other and unspecified parts of foot

234

1.50

1.49

1.2

1.3

2.65

2.89

g/l

0.47

163

Acute alcohol intoxication, ICD10

125

1017

1.23

1.49

1.4

2.85

2.98

g/l

0.37

738

Malignant neoplasm of respiratory system and intrathoracic organs

101

664

1.26

1.48

1.2

1.5

2.71

2.94

g/l

0.59

482

Varicose veins of other sites

251

1.48

1.47

1.2

1.3

3.22

3.08

g/l

0.15

181

malignant neoplasm of male genital organs

730

0.79

1.46

1.3

1.5

3.28

3.20

g/l

0.16

533

Sequelae of infectious and parasitic diseases, including avohilmo

301

1.43

1.46

1.5

1.4

2.81

3.00

g/l

0.28

215

Use of interferon beta-1a

102

1.78

1.45

1.3

1.4

2.58

2.98

g/l

0.40

Haemangioma and lymphangioma, any site

420

1.36

1.45

1.6

1.4

2.99

2.90

g/l

0.15

306

Other and unspecified disorders of adult personality and behaviour

2.77

1.44

1.2

1.5

1.88

3.13

g/l

—

Conductive hearing loss, unspecified

336

1.40

1.43

1.3

3.07

2.96

g/l

0.14

244

Benign neoplasm of urinary organs

164

1.59

1.43

1.2

1.3

2.38

2.94

g/l

1.16

120

Anomalies of dental arch relationship, including avohilmo

135

1005

1.22

1.43

1.4

3.09

2.87

g/l

0.69

101

731

Car occupant injured in other and unspecified transport accidents

118

960

1.23

1.42

1.6

1.4

2.91

2.98

g/l

0.21

687

Fracture of lower leg, including ankle

349

3043

1.13

1.42

1.5

1.4

2.86

2.95

g/l

0.39

260

2185

Overexertion and strenuous or repetitive movements

457

1.34

1.40

1.2

1.4

2.54

3.01

g/l

1.71

330

Single spontaneous delivery

179

1117

0.84

1.40

1.4

2.84

2.75

g/l

0.31

113

858

Sequelae of infectious and parasitic diseases

296

1.42

1.39

1.5

1.4

2.74

3.01

g/l

0.43

213

Injury of eye and orbit

721

1.27

1.39

1.2

1.3

3.16

3.00

g/l

0.32

512

Other salmonella infections, including avohilmo

150

1.61

1.38

1.6

1.3

2.86

2.89

g/l

0.04

108

Non-small cell lung cancer, adenocarcinoma, helper endpoint

206

1.51

1.37

1.1

1.4

2.77

2.91

g/l

0.22

158

Exposure to other and unspecified forces of nature

2.65

1.37

1.8

1.2

2.67

3.07

g/l

—

Hypermetropia

348

1.38

1.36

1.5

1.4

2.85

2.66

g/l

0.34

267

Early lumbar disc prolapse operation

556

1.30

1.35

1.2

1.4

3.10

3.05

g/l

0.08

387

Other salmonella infections

112

1.71

1.35

1.4

1.3

2.99

2.82

g/l

0.17

Foreign body in ear

1.88

1.35

1.4

1.3

2.23

2.77

g/l

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

240

1.47

1.35

1.6

1.4

2.79

3.03

g/l

0.33

173

Benign neoplasm: Brain, supratentorial

2.06

1.33

1.5

1.4

2.89

2.80

g/l

0.06

Outcome of delivery

535

0.77

1.33

1.2

1.4

2.89

2.97

g/l

0.18

399

Mental disorders, not otherwise specified

384

1.36

1.33

1.3

1.4

3.14

2.93

g/l

0.34

276

Alzheimer’s disease (Late onset), excluding more controls

327

0.69

1.33

1.1

1.6

2.89

2.91

g/l

0.02

224

Malignant neoplasm of prostate

688

0.80

1.32

1.3

1.5

3.31

3.19

g/l

0.24

507

Scabies, including avohilmo

100

807

1.24

1.32

1.6

1.4

2.97

2.91

g/l

0.14

586

Complications predominantly related to the puerperium

165

1399

1.18

1.32

1.5

1.4

2.82

2.96

g/l

0.59

127

1022

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

168

1.56

1.31

1.3

1.4

2.89

2.94

g/l

0.05

125

Bicipital tendinitis

176

1.54

1.31

1.3

2.94

3.04

g/l

0.12

125

Wide developmental disorders, excluding more controls

141

1.60

1.30

1.4

1.3

2.36

2.70

g/l

0.43

105

Enterobiasis

2.83

1.29

1.8

1.1

2.43

2.90

g/l

—

Basal cell carcinoma

246

1463

1.15

1.29

1.7

1.4

2.78

2.99

g/l

1.28

183

1070

Pediculosis, acariasis and other infestations, including avohilmo

117

963

1.22

1.29

1.5

1.4

2.96

2.93

g/l

0.08

700

Malignant neoplasm of brain, including Hilmo

169

1.55

1.29

1.3

1.4

2.52

2.96

g/l

0.60

128

Acute alcohol intoxication

148

1247

1.19

1.28

1.4

2.92

2.99

g/l

0.18

100

901

Undefined dementia

248

0.59

1.28

1.0

1.3

3.01

2.93

g/l

0.06

189

Ovarian dysfunction

353

1.36

1.27

1.4

1.5

2.93

3.06

g/l

0.26

255

329

0.64

1.27

1.1

1.3

3.70

2.89

g/l

0.72

243

Alzheimer disease, excluding more controls

412

0.74

1.26

1.2

1.5

2.88

g/l

0.00

282

Diabetic retinopathy

207

1108

1.16

1.26

1.4

2.96

2.93

g/l

0.08

134

776

Parkinson's disease

552

0.72

1.25

1.7

1.3

2.29

2.96

g/l

2.36

404

Disorder of external ear, unspecified

123

1.64

1.24

1.6

1.4

3.50

2.97

g/l

0.50

Behavioural disorders

100

1.71

1.24

1.3

1.2

2.20

2.72

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

398

1.34

1.24

1.2

1.4

3.37

2.85

g/l

0.91

280

Diabetic nephropathy

724

1.24

1.4

1.5

2.84

2.93

g/l

0.18

495

Other congenital malformations of the digestive system, including avohilmo

260

1.42

1.23

1.6

1.3

2.43

2.51

g/l

0.15

205

Sequelae of other and unspecified infectious and parasitic diseases

237

1.44

1.22

1.6

1.4

2.70

3.05

g/l

0.54

170

Fracture of neck

204

1.48

1.22

1.0

1.3

2.28

3.02

g/l

1.24

148

Impacted maxillary molar

288

1.39

1.21

1.5

1.4

3.25

2.92

g/l

0.50

200

Benign neoplasm: Skin of other and unspecified parts of face

400

1.33

1.20

1.5

1.4

2.99

2.88

g/l

0.18

296

Retinal vascular occlusion

400

1.33

1.20

1.2

1.3

2.86

2.92

g/l

0.09

288

Bursitis of shoulder

1.84

1.19

1.5

1.4

2.79

2.94

g/l

—

Injury of muscle and tendon at lower leg level

728

1.24

1.19

1.8

1.3

2.93

3.10

g/l

0.38

523

Intermittent heterotropia

280

1.40

1.19

1.4

2.75

g/l

0.00

210

Congenital malformations of great arteries

138

1.58

1.19

1.7

1.4

2.25

2.27

g/l

0.02

116

Malignant neoplasm of head and neck

289

1.39

1.19

1.2

1.4

2.85

3.04

g/l

0.26

210

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

332

1.36

1.18

1.2

1.4

3.46

3.02

g/l

1.02

236

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

358

1.34

1.18

1.1

1.4

2.56

2.97

g/l

0.75

263

Benign mammary dysplasia

604

1.26

1.18

1.5

1.4

2.63

2.82

g/l

0.48

422

Organic, including symptomatic, mental disorders

216

1736

0.87

1.17

1.2

1.4

2.78

2.91

g/l

0.43

149

1234

Other congenital malformations of the digestive system

213

1.45

1.17

1.6

1.3

2.40

2.47

g/l

0.12

166

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

0.00

1.16

0.0

1.3

—

2.88

—

Benign neoplasm of thyroid gland

118

1.62

1.15

2.4

1.3

2.96

2.83

g/l

0.13

Infectious mononucleosis

412

1.31

1.15

2.1

1.4

2.76

3.03

g/l

0.72

294

Infectious mononucleosis, including avohilmo

412

1.31

1.15

2.1

1.4

2.76

3.03

g/l

0.72

294

Foreign body entering into or through eye or natural orifice

360

1.34

1.15

1.3

2.53

2.89

g/l

0.91

264

Congenital malformations of heart and great arteries

649

1.24

1.14

1.3

1.4

2.42

2.76

g/l

1.13

488

Sequelae of injuries of upper limb

465

1.29

1.14

1.2

1.4

2.63

2.97

g/l

0.81

339

Focal brain injury

191

1.47

1.13

1.5

1.3

3.23

3.05

g/l

0.18

138

Malignant neoplasm of urinary organs, including Hilmo

413

1.31

1.13

1.1

1.4

2.58

3.00

g/l

0.91

307

LSIL lesion of the cervix uteri, vagina or vulva

734

1.23

1.12

1.4

2.80

2.96

g/l

0.46

522

Motorcycle rider injured in other and unspecified transport accidents

267

1.39

1.12

1.4

1.2

3.02

3.03

g/l

0.00

191

Obstructed labour due to maternal pelvic abnormality

716

1.23

1.12

1.3

1.4

2.83

2.80

g/l

0.06

520

Unspecified maternal hypertension

1.98

1.12

1.1

1.4

3.52

2.93

g/l

—

Laparoscopic right hemicolectomy

192

1.46

1.11

1.3

3.29

2.95

g/l

0.43

144

Sequelae of injuries of head

217

1.43

1.11

1.5

1.3

2.67

2.98

g/l

0.34

152

Premature rupture of membranes

837

0.82

1.11

1.3

1.4

3.00

3.07

g/l

0.14

622

Pregnancy with abortive outcome

413

1953

1.10

1.11

1.4

2.82

2.89

g/l

0.35

296

1429

Malignant neoplasm of head and neck, including Hilmo

362

1.33

1.11

1.2

1.5

2.81

2.99

g/l

0.29

268

Parkinson's disease, strict definition

493

0.73

1.11

1.8

1.3

2.32

2.92

g/l

1.94

357

Amblyopia ex anopsia

176

1.48

1.10

1.2

1.3

3.48

2.50

g/l

1.62

135

Retinal vascular disorders

406

1.31

1.10

1.2

1.3

2.86

2.92

g/l

0.09

294

Non-small cell lung cancer, including Hilmo

513

1.26

1.10

1.1

1.5

2.89

2.95

g/l

0.09

378

Congenital cataract

2.42

1.10

1.0

1.5

2.33

2.22

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

337

1.34

1.10

1.2

1.4

3.46

2.95

g/l

1.23

249

Orchitis and epididymitis

363

1.33

1.09

1.3

1.4

3.26

3.12

g/l

0.18

256

Retinal haemorrhage

1.74

1.09

1.4

1.3

2.35

2.77

g/l

—

Coxarthrosis, primary, with hip surgery

249

2050

1.13

1.09

1.3

1.4

2.85

2.90

g/l

0.15

200

1457

Diabetic maculopathy

551

1.25

1.09

1.5

2.80

2.88

g/l

0.13

382

Bipolar affective disorders

113

947

1.20

1.08

1.4

1.3

2.85

3.04

g/l

0.59

663

Benign neoplasm: Choroid

244

1.40

1.07

1.2

1.5

2.80

2.93

g/l

0.16

181

Parkinson's disease, including avohilmo

581

0.76

1.07

1.6

1.3

2.29

2.97

g/l

2.80

425

Macular pucker

622

1.24

1.06

1.7

1.4

2.93

2.91

g/l

0.04

445

Malignant melanoma of skin

489

0.73

1.06

1.4

2.22

2.92

g/l

1.94

358

Malignant neoplasm of prostate, including Hilmo

704

0.83

1.05

1.3

1.5

3.32

3.19

g/l

0.30

518

Other and unspecified mononeuropathies of lower limb

1.68

1.04

1.2

1.3

3.97

2.85

g/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.85

1.03

1.5

1.4

2.62

2.42

g/l

—

Other and unspecified mononeuropathies, also in other diseases

1.64

1.03

1.4

1.3

2.49

2.88

g/l

0.67

Eating disorders

525

1.26

1.03

1.3

1.4

2.77

2.96

g/l

0.41

383

Exposure to other and unspecified animate mechanical forces

138

1.53

1.03

1.4

1.3

2.84

2.87

g/l

0.03

105

Pedal cyclist injured in noncollision transport accidents

598

0.77

1.01

1.4

2.88

2.97

g/l

0.13

433

Myocardial infarction, with ST-elevation

626

1.23

1.01

1.2

1.4

2.63

3.06

g/l

2.05

459

Fracture of forearm

354

2893

1.10

1.00

1.3

1.4

2.88

2.87

g/l

0.01

258

2095

Non-small cell lung cancer

347

1.31

1.00

1.2

1.4

2.59

3.02

g/l

1.11

256

Other lesions of median nerve

1.72

0.99

1.1

1.3

1.48

2.79

g/l

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

0.00

0.98

0.0

1.3

—

2.75

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

311

2070

1.11

0.98

1.4

2.89

2.92

g/l

0.16

229

1539

Nontoxic goitre/thyroid nodule

158

1375

1.15

0.98

1.8

1.4

2.84

2.79

g/l

0.18

118

982

Specific developmental disorder of motor function

1.62

0.98

1.7

1.3

1.80

2.24

g/l

1.06

Assault

684

1.22

0.97

1.2

1.4

3.03

2.99

g/l

0.07

478

Use of disulfiram, acamprosate or naltrexone

415

1.28

0.97

1.4

1.3

2.57

3.10

g/l

1.60

291

Malignant neoplasm of mesothelium and soft tissue

124

1.54

0.97

1.5

1.4

3.25

2.95

g/l

0.25

Benign neoplasm: Kidney

116

1.56

0.96

1.2

1.4

2.57

2.89

g/l

0.36

Malignant neoplasm of bronchus and lung

571

1.22

0.96

1.2

1.5

2.68

2.96

g/l

0.82

422

Erectile dysfunction

284

1.34

0.96

1.8

1.2

3.31

2.98

g/l

0.42

208

Anorexia (incl.atypical)

258

1.36

0.96

1.1

1.4

2.87

2.90

g/l

0.04

180

malignant neoplasm of male genital organs, including Hilmo

105

748

0.84

0.96

1.3

1.5

3.33

3.19

g/l

0.34

543

Malignant neoplasm of stomach, including Hilmo

157

1.47

0.96

1.4

1.3

3.37

3.05

g/l

0.31

118

Primary ovarian failure

1.70

0.95

1.3

2.44

2.97

g/l

—

Short Achilles tendon (acquired)

1.70

0.95

1.5

1.4

3.01

3.02

g/l

—

Focal epilepsy

120

1025

1.17

0.95

1.3

1.4

2.74

2.89

g/l

0.31

744

Fracture of femur

122

940

1.17

0.94

1.4

2.75

2.89

g/l

0.44

670

Sequelae of cerebrovascular disease

178

1336

1.14

0.94

1.3

1.4

2.94

2.90

g/l

0.09

133

940

Primary angle-closure glaucoma

125

1.53

0.94

1.7

1.4

2.61

3.01

g/l

0.77

Meningococcal infection

2.25

0.94

1.2

1.1

3.38

2.62

g/l

—

Meningococcal infection, including avohilmo

2.25

0.94

1.2

1.1

3.38

2.62

g/l

—

Periodontal disease, other/unspecified

101

1.59

0.94

1.4

2.88

2.76

g/l

0.07

Other ill-defined and unspecified causes of mortality

277

1.34

0.93

1.2

3.27

3.01

g/l

0.33

206

Motor disorders

101

1.59

0.92

1.7

1.3

1.80

2.21

g/l

1.00

Eating disorder

454

1.26

0.91

1.3

1.4

2.70

2.94

g/l

0.62

334

Delivery, wide proxy

146

891

0.87

0.91

1.4

3.03

2.80

g/l

0.83

101

671

Pedestrian injured in collision with pedal cycle

102

1.58

0.90

1.4

1.3

3.19

2.89

g/l

0.38

Long labour

114

1127

0.86

0.90

1.3

1.4

3.06

2.96

g/l

0.26

836

Delivery

188

1120

0.88

0.90

1.5

1.4

2.97

2.75

g/l

0.92

122

860

Malignant neoplasm of stomach

135

1.49

0.89

1.4

3.59

3.08

g/l

0.51

104

Diabetic neuropathy

508

1.24

0.88

1.5

1.4

2.62

2.96

g/l

0.77

347

Crushed, pushed or stepped on by crowd or human stampede

377

1.28

0.88

1.2

1.3

2.67

2.96

g/l

0.76

272

Carcinoma in situ of breast, intraductal

358

0.72

0.87

1.3

1.4

3.20

2.76

g/l

1.30

253

Open bite

299

1.31

0.86

1.3

1.4

3.27

2.76

g/l

0.87

227

Focal epilepsy, strict definition

109

934

1.17

0.86

1.3

2.72

2.90

g/l

0.36

679

Retinoschisis and retinal cysts

1.68

0.85

2.7

1.3

3.00

2.73

g/l

—

Inguinal hernia

338

2057

1.09

0.85

1.3

1.4

3.05

2.98

g/l

0.29

242

1441

Toxic effects of substances chiefly nonmedicinal as to source

550

1.22

0.85

1.3

2.96

2.93

g/l

0.05

398

Emotional disorders starting during childhood or adolescence

245

1.34

0.84

1.4

2.07

2.76

g/l

2.76

193

Thiazolidinediones

433

1.25

0.84

1.3

1.4

2.40

2.87

g/l

1.91

313

Contact with machinery

478

1.24

0.84

1.2

1.3

2.71

3.05

g/l

0.82

342

Open wound of head

333

2870

1.09

0.84

1.5

1.4

2.70

2.98

g/l

2.05

224

2040

Hyperplasia of prostate

181

903

1.13

0.83

1.5

1.4

2.99

3.16

g/l

0.56

138

643

Schizophrenia or delusion

149

1691

0.88

0.83

1.1

1.4

2.68

2.98

g/l

1.46

1199

Scissor bite

164

0.60

0.83

1.5

2.42

2.50

g/l

—

134

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

1.71

0.83

1.5

1.3

2.62

2.42

g/l

—

Hereditary corneal dystrophies

113

1.51

0.82

1.2

1.5

2.70

2.97

g/l

0.22

Schizophrenia, schizotypal and delusional disorders

150

1699

0.88

0.82

1.1

1.4

2.66

2.97

g/l

1.49

1205

Redundant prepuce, phimosis and paraphimosis

117

997

1.16

0.81

1.2

1.4

3.03

3.05

g/l

0.03

698

Aneurysms, operations, SAH

699

1.19

0.81

1.4

2.87

2.86

g/l

0.03

495

Spontaneous abortion

282

1720

1.10

0.81

1.3

1.4

2.85

2.92

g/l

0.37

210

1270

Malignant neoplasm of bladder, including Hilmo

359

1.27

0.81

1.5

1.4

2.82

3.09

g/l

0.36

273

Vascular syndromes of brain in cerebrovascular disorders

130

1.47

0.81

1.3

1.2

3.50

2.79

g/l

0.68

Fall on and from stairs and steps

149

1314

1.14

0.81

1.5

1.3

2.94

2.91

g/l

0.07

104

946

Sequelae of injuries of lower limb

436

1.24

0.80

1.5

1.4

2.93

3.01

g/l

0.09

319

All dysplastic lesions of the cervix uteri, vagina or vulva

178

1548

1.12

0.80

1.4

2.85

3.00

g/l

0.62

134

1130

Other fall from one level to another

135

1183

1.14

0.80

1.3

1.4

2.73

2.95

g/l

0.94

106

863

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.79

0.0

1.3

—

2.82

—

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.5

—

2.83

—

Epidural haemorrhage

0.00

0.78

0.0

1.3

—

3.13

—

Exposure to other and unspecified man-made environmental factors

1.63

0.78

1.1

1.3

2.90

2.96

g/l

0.04

Nontoxic single thyroid nodule

286

1.30

0.78

2.0

1.4

3.17

2.86

g/l

0.53

209

Granulomatous disorders of skin and subcutaneous tissue

1.56

0.78

1.7

1.2

3.66

2.95

g/l

—

Male infertility

199

1.36

0.78

1.3

3.45

3.14

g/l

0.30

132

Foreign body or object entering through skin

269

1.31

0.77

1.4

1.3

2.87

2.89

g/l

0.03

195

Diabetic retinopathy, strict definition

722

1.17

0.77

1.4

1.5

2.96

2.91

g/l

0.09

494

Polycystic ovarian syndrome, broad definition

548

1.21

0.76

1.4

3.13

3.05

g/l

0.14

406

Juvenile osteochondrosis

132

1.45

0.76

1.7

1.4

2.88

2.66

g/l

0.27

100

Autism

132

1.45

0.76

1.5

1.4

2.65

2.86

g/l

0.20

Fracture of shoulder and upper arm

206

1858

1.11

0.75

1.5

1.4

2.90

g/l

0.01

155

1336

Typhoid and paratyphoid fevers, including avohilmo

2.11

0.75

1.4

1.3

2.48

3.13

g/l

—

Pedal cyclist injured in collision with pedestrian or animal

2.10

0.75

1.4

1.3

3.67

2.74

g/l

—

Other disorders of cornea

405

1.24

0.74

1.2

1.4

2.97

2.85

g/l

0.20

299

Autism spe

133

1.44

0.74

1.5

1.4

2.65

2.83

g/l

0.16

102

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.85

0.73

1.0

1.3

2.40

2.88

g/l

—

Traumatic subdural haemorrhage

421

1.22

0.73

1.5

1.4

2.84

3.03

g/l

0.30

301

Medical treatment for female infertility

130

1135

1.14

0.73

1.4

2.94

3.04

g/l

0.31

103

822

Other congenital malformations of heart

1.81

0.73

1.6

1.2

1.23

2.57

g/l

—

Colitis due to radiation

2.01

0.73

1.4

1.3

2.94

3.00

g/l

—

Aggressive periodontitis

1.59

0.72

1.2

1.3

3.39

2.93

g/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

380

1.24

0.71

1.3

1.4

2.69

2.92

g/l

0.68

274

Migraine with aura, drug-induced

1.76

0.71

2.7

1.4

3.30

2.76

g/l

—

Unspecified parasitic disease, including avohilmo

1.94

0.71

1.0

1.2

3.70

2.65

g/l

—

Thyrotoxicosis with toxic single thyroid nodule

1.94

0.71

1.8

1.5

4.17

2.93

g/l

—

Puerperal sepsis

581

1.19

0.71

1.7

1.4

2.81

2.86

g/l

0.11

415

Other disorders of the genitourinary system

517

1.20

0.70

1.5

1.4

3.01

2.75

g/l

0.51

369

Tooth agenesis EXCLUDE clefts and syndromes

205

0.68

0.70

1.5

1.4

1.90

2.76

g/l

—

159

Viral agents as the cause of diseases classified to other chapters, including avohilmo

101

1.49

0.70

1.3

2.45

2.80

g/l

—

Helminthiases

1.56

0.70

1.4

1.3

2.46

2.75

g/l

—

Pregnancy, childbirth and the puerperium

125

741

0.88

0.70

1.3

1.5

3.05

2.83

g/l

0.64

554

Other spirochaetal diseases, including avohilmo

203

1843

1.10

0.69

1.4

2.86

2.92

g/l

0.22

168

1326

Other spirochaetal diseases

201

1824

1.10

0.69

1.4

2.85

2.91

g/l

0.24

167

1310

Focal epilepsy, mode (most common among epilepsy diagnosis)

102

888

1.15

0.69

1.3

1.4

2.82

2.91

g/l

0.16

643

Lesion of plantar nerve

230

1.31

0.69

1.9

1.4

2.89

2.95

g/l

0.08

167

Mandibular retrognathia

318

1.26

0.69

1.5

1.4

2.70

2.92

g/l

0.44

234

Undescended testis, unilateral

1.68

0.69

1.0

1.4

2.13

2.20

g/l

—

Polycystic ovarian syndrome

248

1.29

0.68

1.3

1.4

2.97

3.01

g/l

0.07

172

Abscess of Bartholin gland

110

1.46

0.68

1.1

1.3

3.19

2.98

g/l

0.18

Alcohol dependence

144

1285

1.12

0.68

1.1

1.4

2.88

3.04

g/l

0.43

935

Femoral hernia

127

1.42

0.68

1.3

2.88

2.84

g/l

—

Prepatellar bursitis

153

1.38

0.67

1.1

1.3

3.30

2.93

g/l

0.51

110

Intracerebral haemorrhage

420

1.22

0.66

1.2

1.3

3.02

2.97

g/l

0.07

301

Generalized epilepsy, mode (most common among epilepsy diagnosis)

128

1.41

0.66

1.4

1.3

2.62

2.78

g/l

0.22

Ill-defined and unknown causes of mortality

304

1.25

0.65

1.2

3.25

2.98

g/l

0.38

227

Maternal care for other known or suspected fetal problems

150

842

1.12

0.64

1.3

1.4

3.11

3.07

g/l

0.11

104

633

Assault by bodily force

395

1.22

0.64

1.3

3.01

3.02

g/l

0.02

278

Foreign body in alimentary tract

207

1.31

0.63

1.4

1.3

2.90

2.91

g/l

0.01

151

Retinal breaks without detachment

737

1.16

0.63

1.7

1.4

3.01

2.95

g/l

0.12

540

Malignant melanoma of skin, including Hilmo

590

0.83

0.63

1.3

1.4

2.47

2.95

g/l

1.30

428

Burn and corrosion of head and neck

1.53

0.63

1.2

1.3

2.37

2.86

g/l

0.94

Single delivery by forceps and vacuum extractor

527

0.86

0.62

1.3

1.5

3.08

2.95

g/l

0.26

415

Open wound of shoulder and upper arm

1.56

0.62

1.2

1.3

3.38

2.83

g/l

—

Persistent delusional disorders

290

0.76

0.61

1.0

1.4

2.85

3.08

g/l

0.22

208

Viral hepatitis

325

1.23

0.61

1.1

1.3

3.15

3.13

g/l

0.02

228

Impacted maxillary canine

1.58

0.61

1.4

1.2

2.36

2.75

g/l

—

Malignant neoplasm of kidney, except renal pelvis

316

1.24

0.60

1.1

1.4

2.55

2.95

g/l

0.74

231

Pathological resorption of teeth

157

1.34

0.59

1.1

1.2

2.73

2.82

g/l

0.09

116

LSIL lesion of the cervix uteri

593

1.17

0.59

1.3

1.4

2.81

2.95

g/l

0.33

424

Burn and corrosion of trunk

114

1.41

0.59

1.2

1.3

3.31

2.86

g/l

—

Other disorders of breast and lactation associated with childbirth

1.57

0.59

1.3

1.82

2.97

g/l

—

Viral hepatitis, including avohilmo

345

1.22

0.58

1.1

1.3

3.16

3.11

g/l

0.05

240

Mental and behavioural disorders due to cannabinoids

123

1.39

0.58

1.2

1.3

2.67

2.99

g/l

—

Tibial collateral bursitis [Pellegrini-Stieda]

1.72

0.58

1.0

1.4

3.04

2.91

g/l

—

Complications of the puerperium, not elsewhere classified

193

1.30

0.57

1.3

1.4

3.18

3.00

g/l

0.21

140

Other chromosome abnormalities, not elsewhere classified

1.69

0.57

1.5

1.3

1.97

2.19

g/l

—

Struck by thrown, projected or falling objec

229

1.27

0.57

1.2

1.3

2.74

3.01

g/l

0.36

159

Clear cell adenocarcinoma of kidney

150

1.34

0.56

1.0

1.4

2.99

3.15

g/l

0.13

113

Malignant neoplasm of breast, HER-negative

856

0.87

0.55

1.3

1.5

2.71

2.89

g/l

0.52

624

1.59

0.54

1.8

1.3

2.38

2.80

g/l

—

Other and unspecified corneal deformities and disorders

116

1.38

0.54

1.2

1.4

2.68

3.03

g/l

—

Torticollis

1.51

0.54

1.1

1.3

2.67

2.88

g/l

—

Left ventricular outflow tract obstruction, narrow definition

222

1.26

0.54

1.4

1.3

2.05

2.75

g/l

1.59

158

Transient global amnesia

361

0.80

0.53

2.2

1.3

2.66

2.90

g/l

0.45

262

Periapical abscess

287

2684

1.07

0.53

1.4

2.76

2.96

g/l

1.32

205

1958

Maternal care for known or suspected fetal abnormality and damage

743

0.88

0.53

1.3

1.4

2.84

3.11

g/l

0.80

551

Infections of genitourinary tract in pregnancy

442

1.18

0.52

1.4

1.5

3.05

2.89

g/l

0.35

320

Combinations of oral blood glucose lowering drugs

142

1292

1.10

0.52

1.4

3.12

3.00

g/l

0.27

926

Type 1 diabetes, strict (exclude DM2)

497

1.17

0.51

1.2

1.4

3.05

2.88

g/l

0.27

367

Type 1 diabetes, definitions combined

497

1.17

0.51

1.2

1.4

3.05

2.89

g/l

0.24

368

Sulfonylureas

120

1056

0.90

0.51

1.1

1.4

2.60

2.90

g/l

1.05

740

Contact with nonpowered hand tool

170

1.30

0.51

1.4

1.3

3.15

3.11

g/l

0.04

117

Generalized epilepsy

179

1.29

0.51

1.3

2.89

2.87

g/l

0.02

133

Congenital malformations of cardiac septa

331

1.20

0.51

1.3

1.4

2.61

2.59

g/l

0.02

260

Other abnormal products of conception

199

1205

1.08

0.51

1.5

1.4

3.02

3.00

g/l

0.06

140

896

Coronary artery bypass grafting

641

1.12

0.50

1.7

1.4

2.80

3.12

g/l

1.30

446

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

379

0.82

0.50

1.5

1.4

2.35

2.97

g/l

1.85

273

Injury of other and unspecified intrathoracic organs

234

1.24

0.49

1.3

3.37

2.97

g/l

0.54

168

Obstructed labour due to malposition and malpresentation of fetus

112

1146

0.90

0.48

1.4

3.13

2.95

g/l

0.58

848

Toxic effect of contact with venomous animals

181

1.27

0.48

1.2

1.3

2.93

2.91

g/l

0.01

132

Malignant neoplasm of bladder

172

1.28

0.47

1.4

1.2

2.51

3.13

g/l

0.56

133

Ectopic pregnancy

880

1.12

0.47

1.4

2.75

2.88

g/l

0.36

640

All dysplastic lesions of the cervix uteri

153

1385

1.09

0.46

1.4

2.86

3.02

g/l

0.67

111

1018

Slow fetal growth and fetal malnutrition

1.40

0.45

2.4

1.3

1.56

2.22

g/l

—

Other viral hepatitis

283

1.20

0.45

1.1

1.3

2.97

3.12

g/l

0.18

202

Maternal care for known or suspected malpresentation of fetus

737

0.90

0.44

1.4

2.78

3.08

g/l

1.12

552

Malignant neoplasm of breast, ER-negative, including Hilmo

914

0.90

0.43

1.2

1.4

2.75

2.89

g/l

0.39

670

Tarsal tunnel syndrome

1.62

0.43

1.0

1.3

3.60

2.85

g/l

—

Presbyopia

405

1.16

0.43

1.4

3.44

2.95

g/l

0.95

290

Other osteochondropathies

313

1.18

0.42

1.5

1.3

2.61

2.91

g/l

0.38

220

Chronic periodontitis, complicated

331

3061

1.05

0.42

1.4

2.81

2.93

g/l

0.67

246

2188

Lyme disease, including avohilmo

194

1812

1.07

0.42

1.4

2.84

2.91

g/l

0.27

163

1304

Lyme disease

194

1812

1.07

0.42

1.4

2.84

2.91

g/l

0.27

163

1304

Pedal cyclist injured in transport accident

107

1173

0.91

0.41

1.5

1.3

3.20

2.94

g/l

0.76

847

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.41

0.0

1.1

—

2.94

—

Seminoma of testis, including Hilmo

1.52

0.41

1.0

1.2

3.32

3.21

g/l

—

Other and unspecified vascular occlusions

295

1.19

0.41

1.3

2.69

2.90

g/l

0.34

225

Inflammatory disorders of breast

286

1.19

0.41

1.8

1.4

2.80

2.89

g/l

0.13

207

Malignant neoplasm of hypopharynx

0.00

0.41

0.0

1.1

—

2.26

—

Retained placenta and membranes, without haemorrhage

586

1.13

0.40

1.3

1.4

2.71

2.83

g/l

0.23

418

Other blood glucose lowering drugs, excl. Insulins

634

1.12

0.40

1.3

1.4

2.93

2.85

g/l

0.12

449

Calculus of lower urinary tract

168

1.25

0.40

1.8

1.2

2.68

2.93

g/l

0.21

123

Malignant neoplasm of rectum, including Hilmo

465

0.86

0.40

1.4

2.41

2.99

g/l

1.67

336

Inflammatory disease of cervix uteri

241

1.21

0.40

1.1

1.3

3.04

2.86

g/l

0.28

180

Spirochaetal infections, other/unspecified, including avohilmo

195

1826

1.07

0.40

1.4

2.84

2.91

g/l

0.27

164

1310

Abnormal spermatozoa

493

1.14

0.39

1.3

1.4

3.15

2.98

g/l

0.28

363

Other viral hepatitis, including avohilmo

306

1.18

0.39

1.1

1.3

3.00

3.10

g/l

0.13

216

Other disorders of iris and ciliary body

1.34

0.39

1.2

1.3

2.73

2.81

g/l

—

Benign leiomyoma with endometriosis

674

1.11

0.38

1.3

1.5

2.70

2.82

g/l

0.24

478

Other mental disorders due to brain damage and dysfunction and to physical disease

419

1.15

0.38

1.4

3.06

2.91

g/l

0.16

305

Cervical polyps

401

1.15

0.38

1.4

2.45

2.82

g/l

1.05

296

Convergent concomitant strabismus

280

1.18

0.37

1.5

1.4

2.50

2.86

g/l

0.65

208

Frostbite

1.36

0.37

1.4

2.68

2.79

g/l

—

Contact with sharp glass

161

1.25

0.37

1.2

1.3

2.85

2.96

g/l

0.09

115

HSIL lesion of the cervix uteri

1008

0.91

0.37

1.4

2.94

3.02

g/l

0.21

733

Pre-eclampsia or poor fetal growth

175

1631

1.07

0.37

1.4

3.09

2.96

g/l

0.47

126

1199

Follow-up examination after treatment for malignant neoplasms

281

1.18

0.36

1.2

2.69

2.91

g/l

0.24

168

Right hemicolectomy

180

1.22

0.36

1.2

3.60

2.95

g/l

0.87

132

Retinal detachment with retinal break

526

1.12

0.35

1.5

1.4

2.90

2.95

g/l

0.09

384

Malignant neoplasm of ovary

179

0.78

0.35

1.3

1.5

2.32

2.74

g/l

—

130

Manic episode

1.32

0.35

1.3

3.77

2.86

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

363

0.85

0.35

1.5

1.4

2.35

2.97

g/l

1.86

264

Malignant neoplasm of urinary organs

348

1.15

0.34

1.1

1.4

2.76

2.97

g/l

0.25

256

Congenital malformations of aortic and mitral valves

181

1.22

0.34

1.4

1.3

2.01

2.78

g/l

1.49

130

Nontraumatic intracranial haemmorrhage

786

1.09

0.33

1.3

1.4

3.02

2.88

g/l

0.33

564

Malignant neoplasm of testis

1.28

0.32

1.2

1.3

2.79

3.25

g/l

—

Bulimia nervosa (incl. atypical)

146

1.24

0.32

1.3

1.4

2.75

2.87

g/l

0.11

Type 1 diabetes, strict definition, subgroup 1

378

1.14

0.32

1.2

1.3

2.76

2.84

g/l

0.13

289

Supervision of normal pregnancy

111

683

0.93

0.31

1.2

1.4

2.91

2.97

g/l

0.13

514

Leiomyoma of uterus

368

1982

1.04

0.31

1.5

1.4

2.80

2.88

g/l

0.39

261

1463

Malignant neoplasm of testis, including Hilmo

1.32

0.31

1.1

1.3

2.75

3.25

g/l

—

Open wound of thorax

1.30

0.30

2.0

1.2

4.09

3.09

g/l

—

Postpartum haemorrhage due to retained placenta

641

0.90

0.30

1.2

1.4

3.01

3.04

g/l

0.05

457

Carcinoma in situ of cervix uteri

504

0.89

0.29

1.4

1.5

2.71

2.93

g/l

0.57

364

Other and unspecified injuries of head

297

1.15

0.29

1.2

1.3

3.06

2.93

g/l

0.19

214

Diabetes mellitus in pregnancy

193

1162

1.06

0.29

1.2

1.4

3.16

3.06

g/l

0.36

141

872

Embolic stroke

130

1.23

0.28

1.3

1.2

3.26

2.87

g/l

0.32

Other and unspecified nonorganic psychotic disorders

1033

0.93

0.28

1.2

1.4

2.69

3.02

g/l

1.13

720

Malignant neoplasm of rectum

365

0.88

0.28

1.5

1.4

2.36

2.98

g/l

1.72

264

Inguinal or femoral hernia, bilateral

412

1.12

0.28

1.2

1.4

3.23

2.95

g/l

0.47

302

Acute and transient psychotic disorders

575

0.90

0.28

1.2

1.4

2.89

3.03

g/l

0.22

408

Kela-code for severe mental illness

187

1966

0.95

0.27

1.2

1.4

2.84

2.97

g/l

0.49

133

1394

Other disorders of amniotic fluid and membranes

715

0.92

0.27

1.8

1.4

2.71

3.09

g/l

1.04

528

Septal defects

321

1.13

0.27

1.2

1.4

2.76

2.51

g/l

0.40

260

Carcinoma in situ of colon

1.27

0.26

1.3

3.09

2.94

g/l

—

Pervasive developmental disorders excl. Autism + Asperger

1.30

0.26

1.0

1.2

1.90

2.36

g/l

—

Parkinson's disease, excluding more controls

411

0.89

0.26

1.7

1.5

2.29

3.01

g/l

2.53

288

Burns and corrosions of external body surface, specified by site

549

1.09

0.25

1.5

1.3

2.73

2.94

g/l

0.47

399

Malignant melanoma

626

1.09

0.25

1.3

1.4

2.66

2.94

g/l

0.59

458

Gestational diabetes (for exclusion)

206

1483

0.95

0.25

1.2

1.4

3.12

2.99

g/l

0.54

152

1105

Malignant melanoma, including Hilmo

713

1.08

0.25

1.3

1.4

2.69

2.96

g/l

0.60

517

Postpartum care and examination

457

0.92

0.25

1.3

1.4

2.91

3.00

g/l

0.17

339

Schizophrenia or delusion, excluding more controls

149

1395

1.05

0.25

1.1

1.4

2.68

3.06

g/l

2.02

986

Wide developmental disorders

197

1.16

0.25

1.4

2.36

2.58

g/l

0.25

158

Maternal care related to the fetus and amniotic cavity and possible delivery problems

265

1492

1.04

0.24

1.4

2.89

2.95

g/l

0.24

201

1113

Malignant neoplasm of ovary, including Hilmo

234

0.85

0.24

1.2

1.5

2.23

2.76

g/l

0.47

167

Dislocation, sprain and strain of joints and ligaments of elbow

302

1.13

0.24

1.8

1.4

3.03

2.86

g/l

0.23

224

Malignant neoplasm of corpus uteri, including Hilmo

321

1.12

0.24

1.2

1.5

2.80

2.70

g/l

0.11

223

Other assisted single delivery

0.72

0.24

1.2

1.5

3.41

2.83

g/l

—

Other obstructed labour

350

1.12

0.24

1.2

1.4

2.86

g/l

0.00

252

HSIL lesion of the cervix uteri, vagina or vulva

103

1096

0.94

0.24

1.4

2.84

3.02

g/l

0.58

794

Use of galantamine

201

0.85

0.23

1.3

3.28

2.85

g/l

0.35

149

Antenatal screening

119

706

0.94

0.23

1.2

1.4

3.17

2.96

g/l

0.76

528

Other sexually transmitted chlamydial diseases

303

1.12

0.23

1.3

1.4

2.87

3.14

g/l

0.49

205

Unspecified lump in breast

726

1.08

0.23

1.6

1.4

2.51

2.84

g/l

1.19

512

Parkinson's disease, strict definition, excluding more controls

374

0.90

0.23

1.8

1.4

2.32

2.96

g/l

2.03

258

Otosclerosis

294

1.12

0.23

1.1

1.5

2.94

2.84

g/l

0.15

215

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.29

0.23

1.8

1.2

3.12

3.06

g/l

—

Inguinal hernia, bilateral

409

1.10

0.22

1.2

1.3

3.15

2.94

g/l

0.32

301

Dementia in other diseases classified elsewhere

153

1.18

0.22

1.2

2.77

2.89

g/l

—

114

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

641

1.08

0.22

1.2

1.4

3.00

2.94

g/l

0.11

467

Ependymoma

0.00

0.21

0.0

1.2

—

2.95

—

1.19

0.21

1.4

1.1

1.71

2.86

g/l

—

Mental and behavioural disorders of puerperium, not classified elsewhere

1.19

0.21

1.8

1.2

3.12

g/l

—

Chondrosarcoma

0.00

0.21

0.0

1.2

—

2.85

—

Syndactyly, including avohilmo

0.00

0.21

0.0

1.2

—

3.29

—

Sequelae of transport accidents

0.00

0.20

0.0

1.4

—

3.72

—

Postpartum hemorraghe, parous women as controls

141

1125

1.05

0.20

1.3

3.01

g/l

0.01

106

812

Maternal care for cervical incompetence

144

0.83

0.20

1.3

1.4

2.59

2.98

g/l

—

110

Colorectal adenocarcinoma

768

0.94

0.19

1.7

1.4

2.74

2.99

g/l

0.62

551

Contact with other sharp object(s)

333

0.90

0.19

1.2

1.3

2.19

2.99

g/l

3.11

239

Chronic viral hepatitis

228

0.88

0.19

1.1

1.3

2.90

3.14

g/l

0.18

158

Other disorders of penis

444

1.08

0.18

1.7

1.4

2.88

3.00

g/l

0.20

325

Pregnancy examination and test

528

1.06

0.17

1.7

1.4

2.93

2.95

g/l

0.05

398

Injury of nerves at wrist and hand level

138

1.16

0.17

1.3

1.96

3.06

g/l

—

Postpartum haemorrhage due to anatomy

517

0.93

0.17

1.3

2.91

3.08

g/l

0.32

369

Serous carcinoma of ovary, including Hilmo

110

1.18

0.17

1.2

1.6

2.30

2.85

g/l

—

Non-small cell lung cancer, squamous

110

1.18

0.17

1.4

1.2

2.62

3.13

g/l

—

Abnormalities of forces of labour

537

0.93

0.17

1.2

1.4

2.78

2.95

g/l

0.37

389

Spermatocele

282

1.10

0.16

1.5

1.4

2.69

3.06

g/l

0.61

198

Colorectal cancer

937

0.95

0.16

1.6

1.5

2.79

2.99

g/l

0.57

672

Antepartum haemorrhage, not elsewhere classified

453

0.93

0.16

1.4

2.61

3.05

g/l

1.23

339

Crowding of teeth, including avohilmo

418

1.07

0.16

1.2

1.4

2.74

2.75

g/l

0.01

318

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.16

0.15

1.1

1.2

2.47

2.78

g/l

—

487

1.07

0.15

1.2

1.4

2.88

3.09

g/l

0.40

346

malignant neoplasm of female genital organs

622

0.94

0.15

1.2

1.5

2.63

2.85

g/l

0.37

445

Traumatic amputation of wrist and hand

150

1.13

0.14

1.5

1.3

2.65

3.14

g/l

0.40

104

Multiple delivery

419

0.93

0.14

1.6

1.4

3.51

2.71

g/l

1.22

337

Other and/or unspecified nontoxic goitre

315

0.92

0.13

3.1

1.3

3.14

2.81

g/l

0.62

228

Unspecified mental disorder

229

2232

1.03

0.13

1.2

1.4

2.88

2.99

g/l

0.39

165

1596

Complications of labour and delivery

362

1970

1.02

0.13

1.4

3.00

2.84

g/l

0.98

260

1445

Failed induction of labour

296

1.08

0.13

1.5

1.4

2.83

2.98

g/l

0.23

218

Colorectal cancer, including Hilmo

106

1026

0.96

0.13

1.5

2.84

3.00

g/l

0.45

747

Colon adenocarcinoma, helper endpoint

458

0.94

0.13

1.9

1.3

2.98

2.92

g/l

0.07

335

Other complications of labour and delivery, not elsewhere classified

565

1.05

0.12

1.2

1.4

3.02

2.99

g/l

0.06

420

Abnormal findings on antenatal screening of mother

427

0.94

0.12

1.5

2.77

3.01

g/l

0.32

323

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

100

1007

0.96

0.12

1.3

1.4

2.59

2.98

g/l

1.94

729

Carcinoma in situ of other and unspecified digestive organs

152

1.12

0.12

1.2

1.3

3.36

3.00

g/l

0.45

109

Use of levodopa decarboxylase inhibitor

477

0.94

0.12

2.0

1.3

2.20

2.93

g/l

2.98

346

severe traumatic brain injury, does not include concussion

937

1.04

0.10

1.4

2.84

3.00

g/l

0.37

678

Burns and corrosions

721

1.04

0.10

1.4

1.3

2.58

2.94

g/l

1.24

514

Prominent ears

1.14

0.10

1.4

1.2

2.77

2.84

g/l

—

Maternal care for known or suspected abnormality of pelvic organs

141

927

1.03

0.09

1.3

1.4

2.97

3.06

g/l

0.22

690

Mental and behavioural disorders associated with the puerperium

1.06

0.09

1.8

1.4

3.12

2.81

g/l

—

Malignant neoplasm of rectosigmoid junction

1.06

0.09

1.2

1.3

1.89

2.83

g/l

—

Other congenital malformations of male genital organs, including avohilmo

1.04

0.09

1.0

1.5

2.22

2.24

g/l

—

Bicuspidal aortic valve syndrome

145

1.10

0.09

1.4

1.3

2.25

2.85

g/l

—

105

Benign neoplasm of breast

523

0.96

0.09

1.4

2.40

2.87

g/l

1.20

374

Deep bite that required surgery

1.07

0.08

1.5

1.3

3.03

2.86

g/l

—

Liveborn infants according to place of birth

1.03

0.08

1.0

1.2

2.37

2.24

g/l

—

Polyhydramnios

214

1.08

0.08

1.4

3.12

3.01

g/l

0.09

155

Placenta praevia

224

1.07

0.08

1.4

3.21

3.06

g/l

0.11

163

Type1 diabetes, definitions combined, early onset

351

1.05

0.07

1.2

1.3

2.83

2.77

g/l

0.09

261

LeFortI or BSSO operation

176

1.08

0.07

1.3

1.4

2.69

3.01

g/l

0.60

126

Hypertrichosis

0.86

0.06

1.3

1.4

2.62

2.95

g/l

—

Other disorders of prostate

0.86

0.06

2.0

1.2

3.28

3.19

g/l

—

Supervision of high-risk pregnancy

114

670

1.02

0.06

1.5

1.4

3.14

2.97

g/l

0.50

502

Labour and delivery complicated by fetal stress [distress]

137

874

1.02

0.06

1.3

1.4

3.20

2.99

g/l

0.69

101

650

Single delivery by caesarean section

113

631

1.02

0.06

1.4

1.5

3.32

2.90

g/l

1.84

499

malignant neoplasm of female genital organs, including Hilmo

714

0.97

0.06

1.2

1.4

2.70

2.85

g/l

0.27

512

Use of rivastigmine

465

0.96

0.06

1.4

1.3

2.50

2.89

g/l

1.15

338

Gonococcal infection

119

1.09

0.06

1.5

2.25

2.96

g/l

—

Malignant neoplasm of colon

563

1.03

0.05

1.7

1.4

3.11

2.96

g/l

0.27

404

Pre-eclampsia

106

1040

1.02

0.05

1.6

1.4

3.05

2.90

g/l

0.43

747

Acute appendicitis, with complications

909

0.98

0.05

1.4

2.77

3.04

g/l

0.87

667

Fall on and from ladder

297

1.04

0.05

1.4

1.2

2.94

3.00

g/l

0.05

219

Deep bite

556

1.03

0.05

1.3

1.4

2.85

2.75

g/l

0.27

420

Other sexually transmitted chlamydial diseases, including avohilmo

495

0.97

0.05

1.3

1.4

2.81

3.09

g/l

0.70

342

Macular hole

189

1.06

0.04

1.4

1.5

2.28

2.81

g/l

1.12

145

Hydrocephalus

239

1.05

0.04

2.1

1.3

2.43

2.79

g/l

0.46

185

Alcohol withdrawal state with delirium

281

0.96

0.04

1.1

1.3

2.57

3.11

g/l

1.16

205

Malignant neoplasm of corpus uteri

279

1.04

0.04

1.1

1.5

2.92

2.71

g/l

0.20

198

Poor fetal growth

676

1.02

0.04

1.3

1.4

3.30

2.99

g/l

0.64

503

Pedal cyclist injured in collision with motor vehicle

122

1.07

0.02

2.1

1.3

3.21

2.96

g/l

—

Gonococcal infection, including avohilmo

132

1.06

0.02

1.4

1.6

2.25

2.96

g/l

—

Postpartum haemorrhage

141

1174

0.99

0.02

1.3

1.4

3.01

2.95

g/l

0.17

106

872

Family history of malignant neoplasm

540

1.02

0.02

1.2

1.4

2.57

2.94

g/l

0.86

397

Type 1 diabetes, strict definition

430

1.02

0.02

1.2

1.3

2.74

2.86

g/l

0.22

320

Pre-eclampsia or eclampsia

113

1120

1.01

0.01

1.5

1.4

3.04

2.89

g/l

0.41

808

Myocardial infarction, unclassifiable

659

0.99

0.01

1.3

1.4

2.91

2.99

g/l

0.15

477

Vascular dementia

238

0.97

0.01

1.4

1.2

2.60

2.87

g/l

0.27

180

Memory loss

307

0.98

0.01

1.5

1.4

2.58

2.87

g/l

0.47

228

Divergent concomitant strabismus

337

0.98

0.01

1.8

1.4

3.03

2.93

g/l

0.09

242

Subarachnoid haemorrhage

377

0.98

0.01

1.4

3.01

2.92

g/l

0.13

269

Multiple gestation

463

1.02

0.01

1.5

1.4

3.18

3.06

g/l

0.22

338

Thyrotoxicosis with toxic multinodular goitre

216

0.97

0.00

1.9

1.5

2.85

2.94

g/l

0.05

157

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

246

0.98

0.00

1.5

1.4

3.09

2.96

g/l

0.10

178

Twin gestation

444

1.01

0.00

1.5

1.4

3.18

3.05

g/l

0.22

323

Non-small cell lung cancer, squamous, helper endpoint

131

0.99

0.00

1.4

1.2

2.62

2.87

g/l

—

102

Pedal cyclist injured in other and unspecified transport accidents

542

1.00

0.00

1.4

3.47

2.96

g/l

1.24

395

Malignant neoplasm of colon, including Hilmo

706

1.00

0.00

1.6

1.4

3.06

2.94

g/l

0.25

506

Benign neoplasm of other and unspecified female genital organs

153

0.98

0.00

1.7

1.6

2.70

3.03

g/l

—

117

Postpartum hemorraghe, all women as controls

141

1372

1.00

0.00

1.3

1.4

3.01

3.00

g/l

0.01

106

1006

Colon adenocarcinoma

427

1.01

0.00

1.9

1.4

2.98

2.96

g/l

0.02

309

Rubella [German measles], including avohilmo

145

0.97

0.00

2.8

1.4

3.11

2.90

g/l

—

103

Rubella [German measles]

145

0.97

0.00

2.8

1.4

3.11

2.90

g/l

—

103

Acne varioliformis

0.00

0.0

1.0

—

4.03

—

Microtia (small ears)

0.00

0.0

1.1

—

2.70

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.98

0.00

1.0

1.4

2.43

2.75

g/l

—

Birth injury to skeleton

0.00

0.0

1.4

—

2.41

—

Congenital malposition of the kidney

0.00

-0.00

0.0

1.0

—

2.62

—

Hirsprung

0.00

-0.00

0.0

1.0

—

2.00

—

Hirsutism in women

0.96

-0.00

1.3

1.4

2.62

2.98

g/l

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.2

—

3.12

—

Renal cell carcinoma of kidney

0.91

-0.00

1.3

1.2

2.70

2.76

g/l

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

1.2

—

2.58

—

Atrophy of thyroid (acquired)

0.00

-0.00

0.0

1.0

—

2.42

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.6

—

2.11

—

Intracranial nontraumatic haemorrhage of fetus and newborn

0.00

-0.00

0.0

1.4

—

2.45

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

2.16

—

Malignant neoplasm of other and unspecified urinary organs

0.00

-0.00

0.0

1.4

—

2.63

—

Cellulitis of external ear

1.02

-0.00

1.0

1.3

2.58

2.68

g/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.99

-0.00

1.1

1.2

2.47

2.86

g/l

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.8

—

2.10

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.2

—

3.08

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.99

-0.00

1.1

1.2

2.47

2.86

g/l

—

Other perinatal haematological disorders

0.00

-0.00

0.0

1.1

—

2.33

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 2 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS